Study ID,Patient ID,Sample ID,Diagnosis Age,Neoplasm Disease Stage American Joint Committee on Cancer Code,American Joint Committee on Cancer Publication Version Type,Cancer Type,Cancer Type Detailed,Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage,Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage,Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage,Neoplasm American Joint Committee on Cancer Clinical Group Stage,Days to Sample Collection.,Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value,Days to Sample Procurement,Disease Free (Months),Disease Free Status,Participant Personal Medical History Diabetes Mellitus Ind-3,Disease code,Ethnicity Category,Lymphomatous Extranodal Site Involvement Indicator,Form completion date,Fraction Genome Altered,Neoplasm Histologic Grade,Patient Height,Neoplasm Histologic Type Name,History colorectal cancer,History hormonal contraceptives use,History menopausal hormone therapy,Neoadjuvant Therapy Type Administered Prior To Resection Text,Prior Cancer Diagnosis Occurence,History tamoxifen use,Hypertension diagnosis,ICD-10 Classification,"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code",Informed consent verified,Year Cancer Initial Diagnosis,Is FFPE,Longest Dimension,Lymph nodes aortic examined count,Lymph nodes aortic pos by he,Lymph nodes aortic pos by ihc,Lymph nodes aortic pos total,Lymph nodes pelvic examined count,Lymph nodes pelvic pos by he,Lymph nodes pelvic pos by ihc,Lymph nodes pelvic pos total,Menopause Status,First Pathologic Diagnosis Biospecimen Acquisition Method Type,First Pathologic Diagnosis Biospecimen Acquisition Other Method Type,First Pathologic Diagnosis Biospecimen Acquisition Method Type,Mutation Count,New Neoplasm Event Post Initial Therapy Indicator,Oct embedded,Oncotree Code,Overall Survival (Months),Overall Survival Status,Specimen Collection Method,Other Patient ID,Other Sample ID,American Joint Committee on Cancer Metastasis Stage Code,Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code,American Joint Committee on Cancer Tumor Stage Code,Pathology Report File Name,Pathology report uuid,Peritoneal washing,Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator,Pregnancies full term count,Primary Other Site of Disease Name,Project code,Tissue Prospective Collection Indicator,Race Category,Did patient start adjuvant postoperative radiotherapy?,Surgical Margin Resection Status,Tissue Retrospective Collection Indicator,Number of Samples Per Patient,Sample Initial Weight,Sample Type,Sample type id,Sex,Shortest Dimension,Tumor Tissue Site,Somatic Status,Specimen Current Weight,Specimen Freezing Means,Specimen Second Longest Dimension,Stage Other,Surgical approach at diagnosis,Time between clamping and freezing,Time between excision and freezing,Tissue Source Site,TMB (nonsynonymous),Primary Therapy Outcome Success Type,Tumor invasion percent,Person Neoplasm Status,Vial number,Patient Weight
ucec_tcga,TCGA-2E-A9G8,TCGA-2E-A9G8-01,59,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage III,957,0,NA,13.01,1:Recurred/Progressed,NO,NA,NOT HISPANIC OR LATINO,NA,5/21/14,0.3311,G2,157,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,Yes,Never Used,NO,C54.3,8380/3,C54.3,YES,2011,NO,NA,9,0,0,0,19,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,YES,FALSE,UCEC,41.03,0:LIVING,NA,9583C10B-B21A-4863-98FA-61E735E64EA5,792E23A2-AED7-40F6-966B-281697EB7C85,NA,NA,NA,TCGA-2E-A9G8.921E6140-A03E-4FBD-9FB8-554AE96FD16C.pdf,921E6140-A03E-4FBD-9FB8-554AE96FD16C,[Not Evaluated],NO,2,NA,NA,NO,BLACK OR AFRICAN AMERICAN,YES,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,2E,NA,Progressive Disease,280,TUMOR FREE,A,71
ucec_tcga,TCGA-4E-A92E,TCGA-4E-A92E-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage I,90,0,NA,0.43,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,8/20/14,0.0341,G1,162,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,NO,C54.1,8380/3,C54.1,YES,2013,NO,NA,2,0,0,0,4,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,FALSE,UEC,0.43,0:LIVING,NA,B43DE98D-4BB1-41A1-91F2-CE4E7EA4D0CA,3043A6C9-3DCE-4A5B-BBB1-9AD5A07F21E8,NA,NA,NA,TCGA-4E-A92E.BC43D6CA-235C-4217-BF72-F33B089C532B.pdf,BC43D6CA-235C-4217-BF72-F33B089C532B,negative,NA,1,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,4E,NA,Complete Remission/Response,NA,TUMOR FREE,A,76
ucec_tcga,TCGA-5B-A90C,TCGA-5B-A90C-01,69,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,811,0,NA,16.98,1:Recurred/Progressed,NO,NA,NOT HISPANIC OR LATINO,NA,4/17/14,0.6903,G2,158,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,NA,YES,C54.1,8380/3,C54.1,YES,2011,NO,NA,NA,NA,NA,NA,42,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,YES,FALSE,UEC,39.49,0:LIVING,NA,16AC4341-CF8F-45E2-B90B-2D12D5F74A59,F1FB39E5-8275-4F45-A349-AF82D6CD6FF7,NA,NA,NA,TCGA-5B-A90C.608E2698-6A3A-4673-89D2-3BE98A74EBE5.pdf,608E2698-6A3A-4673-89D2-3BE98A74EBE5,NA,NO,2,NA,NA,NO,BLACK OR AFRICAN AMERICAN,YES,NA,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,5B,NA,NA,NA,TUMOR FREE,A,98
ucec_tcga,TCGA-5S-A9Q8,TCGA-5S-A9Q8-01,51,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,103,0,NA,10.28,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,12/23/13,0.0581,G2,162,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,NO,C54.1,8380/3,C54.1,YES,2013,NO,NA,0,NA,NA,NA,5,0,0,0,NA,Excisional Biopsy,NA,NA,NA,NO,TRUE,UEC,10.28,0:LIVING,NA,8751429B-4A11-451E-B978-DC9E9DB0EB36,E5004B9A-A75D-4908-924F-D46E53D33E6B,NA,NA,NA,TCGA-5S-A9Q8.3F89A501-BE16-4E08-9846-41B4BBDDFCF9.pdf,3F89A501-BE16-4E08-9846-41B4BBDDFCF9,NA,YES,0,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,R0,NO,1,690,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,5S,NA,NA,50,NA,A,86
ucec_tcga,TCGA-A5-A0G1,TCGA-A5-A0G1-01,67,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,5015,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,1/7/11,0.0001,G3,168,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,1996,NO,NA,4,0,0,0,10,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,106.8,1:DECEASED,NA,53707bb3-426a-43cb-830f-3eeed930295f,b7fb82ee-0219-4fd0-b656-0509b9eda5f2,NA,NA,NA,TCGA-A5-A0G1.A2EB7E85-E836-462E-ABBA-65D5110CEB1C.pdf,A2EB7E85-E836-462E-ABBA-65D5110CEB1C,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,10,TUMOR FREE,A,59
ucec_tcga,TCGA-A5-A0G2,TCGA-A5-A0G2-01,57,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIB,4825,0,NA,149.44,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/16/10,0.3729,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,1997,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,149.44,0:LIVING,NA,4abbd258-0f0c-4428-901d-625d47ad363a,771811e3-740e-42fe-be9c-fd485997eaae,NA,NA,NA,TCGA-A5-A0G2.A3CD42AF-D356-415B-958D-D14D7AC52693.pdf,A3CD42AF-D356-415B-958D-D14D7AC52693,NA,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,NA,WITH TUMOR,A,60
ucec_tcga,TCGA-A5-A0G3,TCGA-A5-A0G3-01,61,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,987,0,NA,26.12,1:Recurred/Progressed,NA,NA,NA,NA,9/10/10,NA,G3,165,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2007,NO,NA,2,0,2,2,3,0,2,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,28,NA,TRUE,USC,46.91,0:LIVING,NA,8432401d-799f-4f2f-b536-e79e1e8be064,e462c0f0-4a2e-4571-af18-879e41d01aad,NA,NA,NA,TCGA-A5-A0G3.66DEDB33-CA2C-4967-8074-1EFC1FC3CF29.pdf,66DEDB33-CA2C-4967-8074-1EFC1FC3CF29,NA,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,0.933333333333,NA,50,WITH TUMOR,A,64
ucec_tcga,TCGA-A5-A0G5,TCGA-A5-A0G5-01,73,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,856,0,NA,36.99,0:DiseaseFree,NA,NA,NA,NA,9/13/10,0.2308,G3,160,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8310/3,C54.1,YES,2008,NO,NA,9,0,0,0,21,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,99,NA,TRUE,USC,36.99,0:LIVING,NA,4806d9a6-e65d-4a82-b422-1b287980a0c6,fa7392e8-335e-4465-9272-4a19dc99412e,NA,NA,NA,TCGA-A5-A0G5.C7C6ABB1-32EE-4D2B-898A-91A1F596EC53.pdf,C7C6ABB1-32EE-4D2B-898A-91A1F596EC53,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,3.266666667,NA,NA,TUMOR FREE,A,48
ucec_tcga,TCGA-A5-A0G9,TCGA-A5-A0G9-01,79,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2095,0,NA,83.44,0:DiseaseFree,NA,NA,NA,NA,9/10/10,0.0341,G3,172,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,5,0,0,0,7,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,203,NA,TRUE,UEC,83.44,0:LIVING,NA,45d58088-d3f4-4eb0-b75c-bcb98c0981dc,117a5b33-42c5-4a52-babe-d9712f3e7472,NA,NA,NA,TCGA-A5-A0G9.32FB682E-B73F-4525-A845-7F240F9F40CE.pdf,32FB682E-B73F-4525-A845-7F240F9F40CE,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,6.8,NA,70,TUMOR FREE,A,82
ucec_tcga,TCGA-A5-A0GA,TCGA-A5-A0GA-01,67,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC2,1312,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,9/13/10,0.0391,G3,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,3,3,0,3,3,3,0,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,222,NA,TRUE,UEC,17.84,1:DECEASED,NA,71fed998-8fac-4e6b-b38a-22c83e05e958,5a40330f-9307-4584-9557-5d19f2357fcc,NA,NA,NA,TCGA-A5-A0GA.36A4F391-2F46-4896-8E53-223202E42A38.pdf,36A4F391-2F46-4896-8E53-223202E42A38,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,320,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,7.366666667,NA,46,WITH TUMOR,A,90
ucec_tcga,TCGA-A5-A0GB,TCGA-A5-A0GB-01,65,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,583,0,NA,32.75,0:DiseaseFree,NA,NA,NA,NA,9/10/10,0.0346,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,10,0,0,0,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,514,NA,TRUE,UEC,32.75,0:LIVING,NA,2f4458b6-3caf-4e33-890e-a04722badd1b,130744ca-a9a2-4c99-8abb-20fe76e0a955,NA,NA,NA,TCGA-A5-A0GB.8AC80DBE-46DE-46D5-B900-C807CBE941A6.pdf,8AC80DBE-46DE-46D5-B900-C807CBE941A6,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,17.0,NA,NA,TUMOR FREE,A,122
ucec_tcga,TCGA-A5-A0GD,TCGA-A5-A0GD-01,75,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,4119,0,NA,NA,NA,NA,NA,NA,NA,9/16/10,0.0046,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,1999,NO,NA,3,0,0,0,9,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,3,NA,TRUE,UEC,112.45,1:DECEASED,NA,1486a031-b74d-4976-8b0b-4569e6978f49,f449f50a-7664-4ddc-87aa-6a061ee7190c,NA,NA,NA,TCGA-A5-A0GD.44561792-F2F8-42F7-B697-5D7752F8430E.pdf,44561792-F2F8-42F7-B697-5D7752F8430E,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,0.1,NA,NA,TUMOR FREE,A,74
ucec_tcga,TCGA-A5-A0GE,TCGA-A5-A0GE-01,38,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2941,0,NA,105.29,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/10/10,0.1421,G2,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2002,NO,NA,5,0,0,0,3,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,25,NA,TRUE,UEC,105.29,0:LIVING,NA,a587e62e-430e-4f1b-82b7-6fbe856fdaf1,20c3f64d-acf6-45b3-9ace-2f93b3a951c8,NA,NA,NA,TCGA-A5-A0GE.7686A445-554F-43EF-BE79-6EA5E5C4DB21.pdf,7686A445-554F-43EF-BE79-6EA5E5C4DB21,NA,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,0.833333333333,NA,NA,TUMOR FREE,A,57
ucec_tcga,TCGA-A5-A0GG,TCGA-A5-A0GG-01,76,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2369,0,NA,123.59,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,1/7/11,0.0998,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2003,NO,NA,2,0,0,0,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,123.59,0:LIVING,NA,a8614c49-c7f1-4de9-bd2f-4764b094d604,b5b941e3-f828-4091-b9b1-6b38d1493847,NA,NA,NA,TCGA-A5-A0GG.6867E576-1020-41D7-BC18-25160FE17F81.pdf,6867E576-1020-41D7-BC18-25160FE17F81,NA,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,10,TUMOR FREE,A,64
ucec_tcga,TCGA-A5-A0GH,TCGA-A5-A0GH-01,57,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2256,0,NA,74.05,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/13/10,0.0038,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,NA,0,0,0,NA,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,303,NA,TRUE,UEC,74.05,0:LIVING,NA,32e33897-29c8-48f2-b833-98f37204e0e7,853196b6-8c1d-462f-af8f-acf2551f633d,NA,NA,NA,TCGA-A5-A0GH.8E29A939-5581-4176-B19E-14076F17726B.pdf,8E29A939-5581-4176-B19E-14076F17726B,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,10.13333333,NA,33,TUMOR FREE,A,55
ucec_tcga,TCGA-A5-A0GI,TCGA-A5-A0GI-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1779,0,NA,88.11,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/15/10,0.0439,G2,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,1,0,0,0,6,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,198,NA,TRUE,UEC,88.11,0:LIVING,NA,3b21b47e-a15c-4b10-9702-62a14afdfb8c,dd02a477-06c0-4bda-9752-896491eddd95,NA,NA,NA,TCGA-A5-A0GI.F1D23669-8247-4727-8D38-BD444C16FAAE.pdf,F1D23669-8247-4727-8D38-BD444C16FAAE,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,6.6,NA,19,TUMOR FREE,A,66
ucec_tcga,TCGA-A5-A0GJ,TCGA-A5-A0GJ-01,44,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1708,0,NA,0.39,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,12/17/10,0.4758,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,3,0,0,0,4,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,63,NA,TRUE,UEC,65.7,0:LIVING,NA,94817e78-78f5-4556-9394-610df65605e2,48fa5b7d-e488-4743-a7ce-aceb9945f00b,NA,NA,NA,TCGA-A5-A0GJ.83743C19-A9FF-42F0-947E-5697709151C5.pdf,83743C19-A9FF-42F0-947E-5697709151C5,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,2.166666667,NA,0,TUMOR FREE,A,115
ucec_tcga,TCGA-A5-A0GM,TCGA-A5-A0GM-01,53,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1518,0,NA,60.48,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/15/10,0.0002,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,0,0,0,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,33,NA,TRUE,UEC,60.48,0:LIVING,NA,976bb47a-d999-4e24-ad08-452fea73c846,a0eccb29-0485-459a-a881-9bb5c59f4371,NA,NA,NA,TCGA-A5-A0GM.4AAFF034-45D3-4F4F-A283-262BA641D03A.pdf,4AAFF034-45D3-4F4F-A283-262BA641D03A,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,360,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.1,NA,49,TUMOR FREE,A,97
ucec_tcga,TCGA-A5-A0GN,TCGA-A5-A0GN-01,65,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1354,0,NA,60.48,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/13/10,0.5570,G1,164,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,0,0,0,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,45,NA,TRUE,UEC,60.48,0:LIVING,NA,a2a2dbda-d10c-49c4-86a8-61baf6160cda,f6f9c40b-1e58-47a3-b518-9694fb5ff2cf,NA,NA,NA,TCGA-A5-A0GN.7A76BDC7-62D9-4A8D-AAEF-CECF9F819D58.pdf,7A76BDC7-62D9-4A8D-AAEF-CECF9F819D58,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,340,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.5,NA,56,TUMOR FREE,A,68
ucec_tcga,TCGA-A5-A0GP,TCGA-A5-A0GP-01,58,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1030,0,NA,46.52,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/10/10,0.0001,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,1,0,0,0,1,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,1251,NA,TRUE,UEC,46.52,0:LIVING,NA,0547cdfa-c488-4da0-9bb5-4cc63a637179,1797c4d9-1677-4ff6-ba71-98331d53f6c6,NA,NA,NA,TCGA-A5-A0GP.A730192C-227E-4A86-96B9-8670D3F5EF59.pdf,A730192C-227E-4A86-96B9-8670D3F5EF59,NA,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,41.46666667,NA,NA,TUMOR FREE,A,60
ucec_tcga,TCGA-A5-A0GQ,TCGA-A5-A0GQ-01,76,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1022,0,NA,73.82,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,1/7/11,0.0000,G1,150,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,0,NA,NA,NA,2,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,51,NA,TRUE,UEC,73.82,0:LIVING,NA,c8d672ed-9910-4f80-b222-38c833f55850,4805287e-cd6d-48ff-ac6d-19d01052bf8b,NA,NA,NA,TCGA-A5-A0GQ.7B57FD81-AA42-4C76-BF65-0BA2B3451065.pdf,7B57FD81-AA42-4C76-BF65-0BA2B3451065,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.733333333,NA,50,TUMOR FREE,A,57
ucec_tcga,TCGA-A5-A0GR,TCGA-A5-A0GR-01,69,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,632,0,NA,36.79,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,1/7/11,0.3353,G2,177,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,3,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,36.79,0:LIVING,NA,82c51af5-4ba2-48fe-b5e2-a0f1c9d68f34,1c8de102-85f6-47d5-87ce-50b6fe24bb7a,NA,NA,NA,TCGA-A5-A0GR.009B5049-74B7-49B8-8B64-28184A3ACA2B.pdf,009B5049-74B7-49B8-8B64-28184A3ACA2B,NA,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,10,TUMOR FREE,A,88
ucec_tcga,TCGA-A5-A0GU,TCGA-A5-A0GU-01,58,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,471,0,NA,28.25,0:DiseaseFree,NA,NA,NA,NA,9/10/10,0.1123,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,10,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,41,NA,TRUE,UEC,28.25,0:LIVING,NA,adc22472-e31d-419f-aeae-cb01b9423343,074d4466-e072-42cd-9a6c-a595dc9363e7,NA,NA,NA,TCGA-A5-A0GU.B284E409-4AC1-45E5-9133-39659987D7F9.pdf,B284E409-4AC1-45E5-9133-39659987D7F9,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.366666667,NA,18,TUMOR FREE,A,95
ucec_tcga,TCGA-A5-A0GV,TCGA-A5-A0GV-01,67,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,454,0,NA,9.99,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,9/10/10,0.2282,G1,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,21,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,42,NA,TRUE,UEC,53.98,0:LIVING,NA,5e3b981e-73fe-4cc9-8c89-b420e8e2f426,339926e1-61e6-4256-a808-f931aa2c17d2,NA,NA,NA,TCGA-A5-A0GV.0E6417D3-6E95-4EEF-AE93-40D69D4F6525.pdf,0E6417D3-6E95-4EEF-AE93-40D69D4F6525,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,330,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.4,NA,NA,TUMOR FREE,A,63
ucec_tcga,TCGA-A5-A0GW,TCGA-A5-A0GW-01,46,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,302,0,NA,23.19,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/27/10,0.0502,G3,142,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,5,0,0,0,4,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,209,NA,TRUE,UEC,23.19,0:LIVING,NA,5b6b9d0f-787c-4ae9-afd4-de7ce6c57a42,e84d0533-e892-4c1e-9415-99f92aa9a360,NA,NA,NA,TCGA-A5-A0GW.0EE4FD56-D0BA-43E8-A434-CD86B21F21BF.pdf,0EE4FD56-D0BA-43E8-A434-CD86B21F21BF,NA,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,6.866666667,NA,7,TUMOR FREE,A,49
ucec_tcga,TCGA-A5-A0GX,TCGA-A5-A0GX-01,53,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1654,0,NA,68.59,0:DiseaseFree,NA,NA,NA,NA,9/13/10,0.0299,G2,164,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,32,NA,TRUE,UEC,68.59,0:LIVING,NA,553f0ccd-4e6f-4ae2-9b39-97529eb3d826,983a35a9-c825-4961-86c0-4c6133b5c9c1,NA,NA,NA,TCGA-A5-A0GX.AE5229ED-8906-4D55-9B11-4E8E214D6446.pdf,AE5229ED-8906-4D55-9B11-4E8E214D6446,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.066666667,NA,10,TUMOR FREE,A,108
ucec_tcga,TCGA-A5-A0R6,TCGA-A5-A0R6-01,64,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC1,259,0,NA,31.57,1:Recurred/Progressed,NA,NA,HISPANIC OR LATINO,NA,1/27/11,0.1466,G3,157,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,3,0,0,0,17,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,33,NA,TRUE,USC,37.88,0:LIVING,NA,39609d3c-f5d3-4bc4-b356-1403c6dd1cb5,836bd487-091b-4728-bcd7-8065e5b76465,NA,NA,NA,TCGA-A5-A0R6.2F8BAD18-8A37-4F1A-A1BA-31494035E05F.pdf,2F8BAD18-8A37-4F1A-A1BA-31494035E05F,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.1,NA,82,TUMOR FREE,A,68
ucec_tcga,TCGA-A5-A0R7,TCGA-A5-A0R7-01,55,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,173,0,NA,17.58,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/15/10,0.3529,G2,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,8,0,0,0,8,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,40,NA,TRUE,UEC,17.58,0:LIVING,NA,02b25675-094d-4098-96da-51d121380fec,550c6341-260a-4156-b00c-0ae9031d647f,NA,NA,NA,TCGA-A5-A0R7.3BBA7591-082A-44CE-829F-23D16A91772D.pdf,3BBA7591-082A-44CE-829F-23D16A91772D,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,290,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.333333333,NA,40,TUMOR FREE,A,136
ucec_tcga,TCGA-A5-A0R8,TCGA-A5-A0R8-01,81,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,155,0,NA,1.38,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,12/17/10,0.0000,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,0,0,0,7,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,74,NA,TRUE,UEC,19.58,0:LIVING,NA,06d16b6b-9ca6-4cec-a785-f27aa4323cec,5b5cc2ba-6a10-4279-a0aa-8ddae94d56ea,NA,NA,NA,TCGA-A5-A0R8.CA537524-B83F-4AC5-B721-38570E5B21BB.pdf,CA537524-B83F-4AC5-B721-38570E5B21BB,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,2.4,NA,57,TUMOR FREE,A,62
ucec_tcga,TCGA-A5-A0R9,TCGA-A5-A0R9-01,51,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,471,0,NA,24.61,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,1/7/11,0.0465,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,4,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,36,NA,TRUE,UEC,24.61,0:LIVING,NA,284174fd-1320-4617-9e99-75bd75df9bf3,986ac6ac-087f-412b-bb0c-9be10d104989,NA,NA,NA,TCGA-A5-A0R9.0AAD58D4-7865-4235-AE18-8685DC5F4FE1.pdf,0AAD58D4-7865-4235-AE18-8685DC5F4FE1,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.2,NA,49,TUMOR FREE,A,145
ucec_tcga,TCGA-A5-A0RA,TCGA-A5-A0RA-01,68,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,492,0,NA,29.04,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/15/10,0.0018,G2,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,6,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,71,NA,TRUE,UEC,29.04,0:LIVING,NA,afd710b8-d172-4ac4-9973-e969db1ed231,4ed231ee-0e54-4ac5-8278-1061ad3972a2,NA,NA,NA,TCGA-A5-A0RA.EB6E4309-9CE1-468A-A94B-907874BDE9DE.pdf,EB6E4309-9CE1-468A-A94B-907874BDE9DE,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,2.366666667,NA,75,TUMOR FREE,A,113
ucec_tcga,TCGA-A5-A0VO,TCGA-A5-A0VO-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,133,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,12/6/10,NA,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,4,0,0,0,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,54,NA,TRUE,UEC,28.75,1:DECEASED,NA,0648f046-2206-4b97-9b6e-419c2e325b6d,925bc760-6132-4b03-961e-7570acf33d5e,NA,NA,NA,TCGA-A5-A0VO.6ABBA2C9-8920-4785-BFAB-40E560D2DBE6.pdf,6ABBA2C9-8920-4785-BFAB-40E560D2DBE6,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,320,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,1.8,NA,64,TUMOR FREE,A,86
ucec_tcga,TCGA-A5-A0VP,TCGA-A5-A0VP-01,74,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,930,0,NA,42.31,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/15/10,0.0813,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,0,0,0,14,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,1151,NA,TRUE,UEC,42.31,0:LIVING,NA,2db0fb62-64ce-457c-9e22-dd05ef59f684,f1fbe4ac-f3fd-4609-9a2b-507820abe77e,NA,NA,NA,TCGA-A5-A0VP.960B26D6-F9BA-4099-B6F4-6D1DEA6C0F0F.pdf,960B26D6-F9BA-4099-B6F4-6D1DEA6C0F0F,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,38.2,NA,NA,TUMOR FREE,A,58
ucec_tcga,TCGA-A5-A0VQ,TCGA-A5-A0VQ-01,62,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,133,0,NA,15.93,0:DiseaseFree,NA,NA,HISPANIC OR LATINO,NA,11/15/10,0.0001,G3,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,12,0,0,0,12,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,293,NA,TRUE,UEC,15.93,0:LIVING,NA,23489245-48d7-4f19-8a42-e23b1181412b,952cb6a5-7527-470a-978e-edd44e3a368f,NA,NA,NA,TCGA-A5-A0VQ.6FE81DF0-D9DF-420F-8A91-40421175A12F.pdf,6FE81DF0-D9DF-420F-8A91-40421175A12F,NA,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,320,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,9.8,NA,36,TUMOR FREE,A,89
ucec_tcga,TCGA-A5-A1OF,TCGA-A5-A1OF-01,47,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IA,128,0,NA,31.96,0:DiseaseFree,NA,NA,HISPANIC OR LATINO,NA,8/1/11,0.0009,High Grade,155,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,3,0,0,0,4,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UCEC,31.96,0:LIVING,NA,286c112d-7b73-40a1-b23c-99911388fdef,68c51551-232a-4adc-a0a0-fcecd7125f59,NA,NA,NA,TCGA-A5-A1OF.C0A753A3-5202-4DD2-948E-2921AFBCB3BC.pdf,C0A753A3-5202-4DD2-948E-2921AFBCB3BC,NA,NA,NA,NA,NA,YES,NA,NA,R0,NO,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,13,TUMOR FREE,A,70
ucec_tcga,TCGA-A5-A1OG,TCGA-A5-A1OG-01,65,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,223,0,NA,11.07,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,8/1/11,0.3103,G3,158,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,4,4,0,4,3,3,0,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,USC,31.96,1:DECEASED,NA,5c3f826c-b447-457d-a90e-715bad3c7118,4cbc8fb7-9de4-4e17-8fb2-8571a224fb8d,NA,NA,NA,TCGA-A5-A1OG.7BE01FDF-C4CF-471E-B395-8D7C4531CD6F.pdf,7BE01FDF-C4CF-471E-B395-8D7C4531CD6F,NA,NA,NA,NA,NA,YES,ASIAN,NA,R0,NO,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,70,WITH TUMOR,A,64
ucec_tcga,TCGA-A5-A1OH,TCGA-A5-A1OH-01,86,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,358,0,NA,36.3,0:DiseaseFree,NO,NA,NA,NA,8/3/12,0.5541,G3,155,Serous endometrial adenocarcinoma,NO,Former User,"Yes, I have taken menopausal hormone therapy in the past, but no longer do.",No,No,Never Used,YES,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,USC,36.3,0:LIVING,NA,9BCE44A2-DCEE-4D1A-A522-C2BCB9A8E025,8BF78DAB-9910-48EB-AB6A-FC92502A71A3,NA,NA,NA,TCGA-A5-A1OH.AAF1B591-1A0D-48D2-BF59-95B0D605950A.pdf,AAF1B591-1A0D-48D2-BF59-95B0D605950A,positive,YES,4+,NA,NA,NO,WHITE,YES,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,Complete Remission/Response,100,TUMOR FREE,A,59
ucec_tcga,TCGA-A5-A1OJ,TCGA-A5-A1OJ-01,31,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,161,0,NA,33.05,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,8/1/11,0.0810,G2,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,17,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,33.05,0:LIVING,NA,0f361166-2b7d-4ef5-9f8f-ee2488548a0b,effd3ebc-fa75-4317-a3cb-37ca27d3208c,NA,NA,NA,TCGA-A5-A1OJ.F696BCE9-707C-4825-8A53-EFED20EBF656.pdf,F696BCE9-707C-4825-8A53-EFED20EBF656,NA,NA,NA,NA,NA,YES,ASIAN,NA,R0,NO,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,10,TUMOR FREE,A,94
ucec_tcga,TCGA-A5-A1OK,TCGA-A5-A1OK-01,63,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,113,0,NA,30.12,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,8/1/11,0.0342,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,3,0,0,0,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,30.12,0:LIVING,NA,2fe46394-cfc5-44bb-81a9-e438a0126f5b,0eaf63cf-3cf6-4049-b0ab-aedb65db648d,NA,NA,NA,TCGA-A5-A1OK.1B0C95FC-7AA7-4F82-807D-85C579B6BF74.pdf,1B0C95FC-7AA7-4F82-807D-85C579B6BF74,NA,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,100,TUMOR FREE,A,87
ucec_tcga,TCGA-A5-A2K2,TCGA-A5-A2K2-01,77,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,2812,0,NA,118.1,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/4/11,0.2488,G3,155,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2003,NO,NA,0,NA,NA,NA,6,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,118.1,0:LIVING,NA,840FF11F-F991-4E1B-861B-98D236D573D3,8494B10E-A989-49FA-860C-2B8F0E4F93D9,NA,NA,NA,TCGA-A5-A2K2.D8065FA8-DC0E-4F1C-8FA4-5D8A567AC24C.pdf,D8065FA8-DC0E-4F1C-8FA4-5D8A567AC24C,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,49,TUMOR FREE,A,50
ucec_tcga,TCGA-A5-A2K3,TCGA-A5-A2K3-01,68,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,1431,0,NA,66.1,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/4/11,0.0559,G3,160,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2007,NO,NA,0,NA,NA,NA,9,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,66.1,0:LIVING,NA,C3096984-BD11-44A0-8EE0-47F07AD04D81,B6E6722F-CEFE-4EB7-8545-94383659DB9A,NA,NA,NA,TCGA-A5-A2K3.D38D2FD4-78EF-4F49-976E-529055A6D9A9.pdf,D38D2FD4-78EF-4F49-976E-529055A6D9A9,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,0,TUMOR FREE,A,80
ucec_tcga,TCGA-A5-A2K4,TCGA-A5-A2K4-01,69,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,849,0,NA,17.35,1:Recurred/Progressed,NA,NA,NA,NA,10/6/11,0.2796,G3,168,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,TRUE,USC,28.61,1:DECEASED,NA,C4F8F33F-A07C-4DFB-BE24-C52D577BD640,825524A8-EDE8-44B2-9C4A-8375AC14387A,NA,NA,NA,TCGA-A5-A2K4.CB29CD1C-584B-42EA-BF1D-11B6DF8EA756.pdf,CB29CD1C-584B-42EA-BF1D-11B6DF8EA756,NA,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,53,WITH TUMOR,A,51
ucec_tcga,TCGA-A5-A2K5,TCGA-A5-A2K5-01,76,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,171,0,NA,24.7,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/4/11,0.0001,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,4,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,24.7,0:LIVING,NA,CF77AFE9-3785-45D4-BA2A-61C9CB706225,ECA91844-E767-4045-A87F-E43DAFBCC17A,NA,NA,NA,TCGA-A5-A2K5.FF305857-5814-4815-90D3-B54BAA0DACB4.pdf,FF305857-5814-4815-90D3-B54BAA0DACB4,NA,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,290,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,49,NA,A,127
ucec_tcga,TCGA-A5-A2K7,TCGA-A5-A2K7-01,41,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,195,0,NA,34.92,0:DiseaseFree,NA,NA,HISPANIC OR LATINO,NA,12/19/11,0.0004,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,7,0,0,0,11,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,34.92,0:LIVING,NA,F42868C0-FF59-438B-90A7-489AEA678DE9,B19B35DD-9431-4040-BBF1-E7490B037DE7,NA,NA,NA,TCGA-A5-A2K7.1880F604-34C9-4B58-92DC-D67C7E656E3B.pdf,1880F604-34C9-4B58-92DC-D67C7E656E3B,NA,NA,NA,NA,NA,YES,NA,NA,R0,NO,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,50,TUMOR FREE,A,72
ucec_tcga,TCGA-A5-A3LO,TCGA-A5-A3LO-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,182,0,NA,25.49,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/15/12,0.3955,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,6,0,0,0,7,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,25.49,0:LIVING,NA,2A2BC155-CA7C-48B2-BB77-CCFD6313710A,3BF209DF-55B0-4F3F-B98E-9A13FE5E8955,NA,NA,NA,TCGA-A5-A3LO.2AB1F28D-151D-4AFE-807A-9F98B48C51CE.pdf,2AB1F28D-151D-4AFE-807A-9F98B48C51CE,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,NA,65,TUMOR FREE,A,103
ucec_tcga,TCGA-A5-A3LP,TCGA-A5-A3LP-01,74,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,111,0,NA,14.95,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/15/12,0.5228,G3,159,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,0,0,0,6,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,14.95,0:LIVING,NA,9BECF65D-01F2-4E84-A256-106002E22526,6D328D5D-7225-437A-AFB1-D293D2D45866,NA,NA,NA,TCGA-A5-A3LP.A20CDB07-D90C-42B7-AE0A-254E27C6153B.pdf,A20CDB07-D90C-42B7-AE0A-254E27C6153B,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,A5,NA,NA,90,TUMOR FREE,A,46
ucec_tcga,TCGA-A5-A7WJ,TCGA-A5-A7WJ-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,439,0,NA,11.2,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,4/22/14,0.0346,G2,170,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,3,0,0,0,2,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,UEC,11.2,0:LIVING,NA,A3E728CE-0874-4F4B-A83D-8C679F4BD938,6595C691-70D1-4B5F-A8C3-ED0167E07249,NA,NA,NA,TCGA-A5-A7WJ.402A6ED4-B9EC-43A0-B47C-A0B95282678D.pdf,402A6ED4-B9EC-43A0-B47C-A0B95282678D,negative,NO,1,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,R0,NO,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,A5,NA,Complete Remission/Response,39,TUMOR FREE,A,64
ucec_tcga,TCGA-A5-A7WK,TCGA-A5-A7WK-01,71,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IA,253,0,NA,11.5,1:Recurred/Progressed,YES,NA,NOT HISPANIC OR LATINO,NA,4/22/14,0.2537,G3,168,Mixed serous and endometrioid,NO,Never Used,NA,No,No,Never Used,NO,C54.1,8441/3,C54.1,YES,2013,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,UCEC,18.4,0:LIVING,NA,DED408EE-053A-43ED-9BCF-1D15CD203051,69C891F3-536D-4CB8-BBD4-A387534C1283,NA,NA,NA,TCGA-A5-A7WK.9101DD17-9216-4526-9A87-8C4E94B1F435.pdf,9101DD17-9216-4526-9A87-8C4E94B1F435,negative,YES,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,R0,NO,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,A5,NA,Complete Remission/Response,49,TUMOR FREE,A,97
ucec_tcga,TCGA-A5-AB3J,TCGA-A5-AB3J-01,52,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,126,0,NA,16.82,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,10/8/14,0.1192,G2,160,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,Yes,Never Used,YES,C54.1,8380/3,C54.1,YES,2013,NO,NA,4,0,0,0,6,0,0,0,Peri (6-12 months since last menstrual period),"Other method, specify:",Cervical polypectomy,NA,NA,NO,TRUE,UEC,16.82,0:LIVING,NA,8A67ED86-156F-4B45-B460-000FE33DA26B,396753D3-FAE0-4A1A-B193-4121A47746D2,NA,NA,NA,TCGA-A5-AB3J.41CDFB48-33A6-4FCD-97CA-30C73A9E6FED.pdf,41CDFB48-33A6-4FCD-97CA-30C73A9E6FED,NA,YES,0,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,A5,NA,Complete Remission/Response,49,TUMOR FREE,A,59
ucec_tcga,TCGA-AJ-A23M,TCGA-AJ-A23M-01,61,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage II,274,0,NA,16.95,1:Recurred/Progressed,NA,NA,NA,NA,7/14/11,0.5519,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,4,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,84,NA,FALSE,USC,20.24,1:DECEASED,NA,d39df936-4bc6-404d-9e1d-f6416cc5a34c,acbbc556-4e4e-4ebc-b408-55d69720a87d,NA,NA,NA,TCGA-AJ-A23M.B9651546-290B-405B-8275-24C8A53A10A3.pdf,B9651546-290B-405B-8275-24C8A53A10A3,positive,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AJ,2.833333333,NA,NA,WITH TUMOR,A,141
ucec_tcga,TCGA-AJ-A23N,TCGA-AJ-A23N-01,70,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,84,0,NA,NA,NA,NA,NA,NA,NA,10/4/12,0.4072,G3,NA,Serous endometrial adenocarcinoma,NO,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,NA,NO,FALSE,USC,14.42,1:DECEASED,NA,5D39E9A2-1073-4DB2-B02E-DB05D59563A7,4A5F2624-4F86-44CD-84A3-CD1403E093B6,NA,NA,NA,TCGA-AJ-A23N.38EB6233-9777-4640-A896-26D16A9DBD8E.pdf,38EB6233-9777-4640-A896-26D16A9DBD8E,negative,NA,NA,NA,NA,YES,WHITE,NA,R2,NO,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,27,WITH TUMOR,A,NA
ucec_tcga,TCGA-AJ-A23O,TCGA-AJ-A23O-01,69,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,165,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,7/14/11,0.1019,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,4,0,NA,NA,15,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,10.25,1:DECEASED,NA,70b4b353-10d4-49d0-bcc1-855616d8c8cc,b8e857f7-25b5-481d-b374-075138925fb8,NA,NA,NA,TCGA-AJ-A23O.4D477218-A4D1-4940-AEF5-D8F46931594C.pdf,4D477218-A4D1-4940-AEF5-D8F46931594C,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,81,TUMOR FREE,A,60
ucec_tcga,TCGA-AJ-A2QK,TCGA-AJ-A2QK-01,65,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,146,0,NA,19.91,1:Recurred/Progressed,NA,NA,HISPANIC OR LATINO,NA,10/18/11,0.2657,G3,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,6,0,NA,0,18,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,21.12,0:LIVING,NA,DE5ABE44-6D9D-4797-A57A-5ADFD71383F0,0959F580-CC84-4702-81B8-D6EF96F5469F,NA,NA,NA,TCGA-AJ-A2QK.01A114A2-098F-4AAD-9010-54910FB89B4A.pdf,01A114A2-098F-4AAD-9010-54910FB89B4A,NA,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,25,TUMOR FREE,A,119
ucec_tcga,TCGA-AJ-A2QL,TCGA-AJ-A2QL-01,60,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,138,0,NA,19.78,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/18/11,0.0110,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,7,0,0,0,18,0,1,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,19.78,0:LIVING,NA,9002FC6C-26DE-4B8F-8985-A4814CD3DAF7,9884F8D6-3A49-4613-AA45-855BE115E01B,NA,NA,NA,TCGA-AJ-A2QL.4AD4E8D1-5DA7-4134-A0C0-0AF1C3A8BCD4.pdf,4AD4E8D1-5DA7-4134-A0C0-0AF1C3A8BCD4,negative,NA,NA,NA,NA,YES,WHITE,NA,NA,NO,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,NA,WITH TUMOR,A,112
ucec_tcga,TCGA-AJ-A2QM,TCGA-AJ-A2QM-01,67,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage II,108,0,NA,29.37,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/18/11,0.3679,G3,170,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,13,0,0,0,20,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,29.37,0:LIVING,NA,D9F4A2C1-AC6D-48C6-95FE-FFBC2FA08268,F2748BAD-0575-4258-9186-118BBD471325,NA,NA,NA,TCGA-AJ-A2QM.282D10FF-370D-4252-B1CB-3410A43C8F82.pdf,282D10FF-370D-4252-B1CB-3410A43C8F82,negative,NA,NA,NA,NA,YES,WHITE,NA,NA,NO,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AJ,NA,NA,NA,TUMOR FREE,A,74
ucec_tcga,TCGA-AJ-A2QN,TCGA-AJ-A2QN-01,60,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,289,0,NA,35.12,0:DiseaseFree,NA,NA,NA,NA,10/18/11,0.1558,G3,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,8,0,NA,0,4,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,35.12,0:LIVING,NA,E00F6DC5-BC8B-472D-BAC3-C7823364F01E,3FD07879-B069-4595-A704-CD7D11733F01,NA,NA,NA,TCGA-AJ-A2QN.F92EF591-695A-4E48-9ACF-67497880AC20.pdf,F92EF591-695A-4E48-9ACF-67497880AC20,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,25,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,NA,TUMOR FREE,A,132
ucec_tcga,TCGA-AJ-A2QO,TCGA-AJ-A2QO-01,85,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,174,0,NA,NA,NA,NA,NA,NA,NA,10/18/11,0.0000,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,5,0,NA,0,11,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,34.33,1:DECEASED,NA,DCF1BEB9-BCE4-4F4C-98DD-1226D8E0C125,32BE3043-2DCE-42C7-BB5C-A313F2C5E3A1,NA,NA,NA,TCGA-AJ-A2QO.5351BF98-9E1D-4F4D-A3EE-26A83B867D58.pdf,5351BF98-9E1D-4F4D-A3EE-26A83B867D58,negative,NA,NA,NA,NA,YES,WHITE,NA,NA,NO,1,16,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,84,TUMOR FREE,A,67
ucec_tcga,TCGA-AJ-A3BD,TCGA-AJ-A3BD-01,57,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,170,0,NA,34.13,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.4820,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8460/3,C54.1,YES,2011,NO,NA,9,2,0,2,17,3,0,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,34.13,0:LIVING,NA,AB68CD1B-5075-4B30-A829-D6D0F95871CB,A41BEEBE-3C3A-41FC-A611-0E9B322F638B,NA,NA,NA,TCGA-AJ-A3BD.8B7CB7C6-86B5-41EA-A6CB-FC496C311888.pdf,8B7CB7C6-86B5-41EA-A6CB-FC496C311888,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AJ,NA,NA,NA,TUMOR FREE,A,85
ucec_tcga,TCGA-AJ-A3BF,TCGA-AJ-A3BF-01,65,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,92,0,NA,16.72,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.2474,G3,170,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8460/3,C54.1,YES,2011,NO,NA,14,6,0,6,43,2,0,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,USC,18.1,0:LIVING,NA,40287CDC-19DD-4370-A6A0-F324960E1148,EF33DD67-2E71-4A81-91DC-F5E404FB25F7,NA,NA,NA,TCGA-AJ-A3BF.3673A111-6F2E-4374-A0E7-BA436D644F0D.pdf,3673A111-6F2E-4374-A0E7-BA436D644F0D,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AJ,NA,NA,NA,TUMOR FREE,A,113
ucec_tcga,TCGA-AJ-A3BG,TCGA-AJ-A3BG-01,65,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IA,137,0,NA,15.77,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.0339,G3,163,Mixed serous and endometrioid,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,4,0,0,0,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UCEC,18.07,0:LIVING,NA,77ED36AD-222F-4693-8668-0ECF9073D6E8,0EEB2802-5276-4A2F-AE20-926A3FECED91,NA,NA,NA,TCGA-AJ-A3BG.3D42566F-92B2-4530-BF6A-624DA6E979B9.pdf,3D42566F-92B2-4530-BF6A-624DA6E979B9,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,24,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AJ,NA,NA,33,TUMOR FREE,A,66
ucec_tcga,TCGA-AJ-A3BH,TCGA-AJ-A3BH-01,NA,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,NA,NA,NA,NA,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.1476,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,NA,NA,NA,NA,1,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,NA,NA,FALSE,UEC,NA,0:LIVING,NA,A7D07151-5FC8-4C2A-A1CD-E7C7A2A9A7A7,5F692F2B-3736-4B1F-8FFE-A0EE085975DF,NA,NA,NA,TCGA-AJ-A3BH.469A2D52-09E6-4B67-B8D0-D6292AC22285.pdf,469A2D52-09E6-4B67-B8D0-D6292AC22285,NA,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AJ,NA,NA,69,TUMOR FREE,A,71
ucec_tcga,TCGA-AJ-A3BI,TCGA-AJ-A3BI-01,67,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,137,0,NA,12.25,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.4537,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,6,0,NA,0,10,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,18.89,0:LIVING,NA,525FB4FC-2167-4506-B4FA-FB896BF64CD0,B4D093EC-48A4-4EDD-A88C-DE51130A368C,NA,NA,NA,TCGA-AJ-A3BI.19B5518D-075F-40BE-A104-75C925F133A4.pdf,19B5518D-075F-40BE-A104-75C925F133A4,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,19,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,15,TUMOR FREE,A,100
ucec_tcga,TCGA-AJ-A3BK,TCGA-AJ-A3BK-01,68,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,547,0,NA,33.87,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.1333,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,22,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,33.87,0:LIVING,NA,503E6C30-1B62-4F85-BCB4-E34C009894AB,610660F1-07AA-489F-B09F-8DA0B91FEE6F,NA,NA,NA,TCGA-AJ-A3BK.026350F0-3203-49E5-8CCC-9DE88B2C8625.pdf,026350F0-3203-49E5-8CCC-9DE88B2C8625,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,66,TUMOR FREE,A,92
ucec_tcga,TCGA-AJ-A3EJ,TCGA-AJ-A3EJ-01,74,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IIIC2,332,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,2/15/12,0.4940,G3,168,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,11,2,NA,2,26,9,NA,9,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UCEC,1.64,1:DECEASED,NA,672DE064-3378-4004-A3EA-F79885E10D78,3960CC6D-3C1D-48C6-8DDB-4FC700060E1B,NA,NA,NA,TCGA-AJ-A3EJ.FB99D237-4583-4298-844F-43B2F99F83E3.pdf,FB99D237-4583-4298-844F-43B2F99F83E3,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,20,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,85,WITH TUMOR,A,73
ucec_tcga,TCGA-AJ-A3EK,TCGA-AJ-A3EK-01,53,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,127,0,NA,14.65,0:DiseaseFree,NA,NA,HISPANIC OR LATINO,NA,2/15/12,0.0002,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,9,0,NA,0,10,0,NA,0,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,14.65,0:LIVING,NA,14DB56EF-EC5E-4775-A229-5D83E58E027C,01747185-0D0D-4B27-B956-115DF4D90BED,NA,NA,NA,TCGA-AJ-A3EK.F153EAC2-7347-4CEF-916A-995C7BB8B0F1.pdf,F153EAC2-7347-4CEF-916A-995C7BB8B0F1,negative,NA,NA,NA,NA,YES,WHITE,NA,NA,NO,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,5,TUMOR FREE,A,60
ucec_tcga,TCGA-AJ-A3EL,TCGA-AJ-A3EL-01,47,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,317,0,NA,22.47,0:DiseaseFree,NA,NA,NA,NA,2/15/12,0.0008,G3,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,13,0,NA,0,15,0,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,22.47,0:LIVING,NA,23E1D96E-6175-4145-8267-8F0A88F54C4D,F82EEAF4-AA1A-422B-B16E-790241EEA904,NA,NA,NA,TCGA-AJ-A3EL.CB5EF343-EDD4-46B1-82DD-48C49FF7E778.pdf,CB5EF343-EDD4-46B1-82DD-48C49FF7E778,negative,NA,NA,NA,NA,YES,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,R0,NO,1,20,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,6,TUMOR FREE,A,57
ucec_tcga,TCGA-AJ-A3EM,TCGA-AJ-A3EM-01,69,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,296,0,NA,22.24,0:DiseaseFree,NA,NA,NA,NA,2/15/12,0.6265,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,8,0,NA,0,6,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,22.24,0:LIVING,NA,C856E031-BBD0-431F-B44F-B3AD9B39AF7B,7DC99437-730F-44F3-88E8-EA6D7E9DBCC1,NA,NA,NA,TCGA-AJ-A3EM.E5CE38FD-DB53-49D9-92B3-BA075BDDC5CF.pdf,E5CE38FD-DB53-49D9-92B3-BA075BDDC5CF,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,9,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,3.6,TUMOR FREE,A,82
ucec_tcga,TCGA-AJ-A3I9,TCGA-AJ-A3I9-01,52,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,84,0,NA,12.16,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/12,0.1598,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,7,0,0,0,11,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,17.05,1:DECEASED,NA,E5D64754-15E8-494E-B7F7-25CF2819FE4C,53E1FEB9-81C1-473D-A8AE-EB481A26B726,NA,NA,NA,TCGA-AJ-A3I9.095789FC-7C20-4A6A-A6F0-13315481EBD0.pdf,095789FC-7C20-4A6A-A6F0-13315481EBD0,NA,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,27,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,NA,TUMOR FREE,A,72
ucec_tcga,TCGA-AJ-A3IA,TCGA-AJ-A3IA-01,77,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,66,0,NA,20.8,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/12,0.4993,G3,157,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,9,0,0,0,17,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,20.8,0:LIVING,NA,8A0A58A0-5C12-4366-AF43-4FD25F8FF454,0FB7CEAE-CF5D-4E98-8AD8-114947B6E7E3,NA,NA,NA,TCGA-AJ-A3IA.883486F6-0EDF-4BBC-8412-67F31351427B.pdf,883486F6-0EDF-4BBC-8412-67F31351427B,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,35,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,88,TUMOR FREE,A,58
ucec_tcga,TCGA-AJ-A3NC,TCGA-AJ-A3NC-01,63,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,282,0,NA,36.96,0:DiseaseFree,NA,NA,NA,NA,4/17/12,0.0816,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,36.96,0:LIVING,NA,C8FB94DD-C535-48F4-9419-AAC2BF47BBB4,2398C565-2432-4FE9-BF9A-13ED877BADEA,NA,NA,NA,TCGA-AJ-A3NC.B6DB87F4-E88A-4209-92E2-75ADB364FB28.pdf,B6DB87F4-E88A-4209-92E2-75ADB364FB28,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,21,TUMOR FREE,A,110
ucec_tcga,TCGA-AJ-A3NE,TCGA-AJ-A3NE-01,46,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,134,0,NA,20.63,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/17/12,0.0062,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,12,0,NA,0,24,0,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,20.63,0:LIVING,NA,1DCF33E9-4C9B-4B2B-914E-15E6BE5DCD07,A1EC8680-C144-4A99-8D51-AE9A68F15D67,NA,NA,NA,TCGA-AJ-A3NE.4618A1F6-B969-4746-8190-7D856A21C25F.pdf,4618A1F6-B969-4746-8190-7D856A21C25F,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,23,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,4,TUMOR FREE,A,80
ucec_tcga,TCGA-AJ-A3NF,TCGA-AJ-A3NF-01,60,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,85,0,NA,21.19,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/17/12,0.1269,G3,160,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,9,0,0,0,23,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,USC,21.19,0:LIVING,NA,9FCBEF9E-2CCA-4033-B574-DAAB2A42198B,964FFD81-4B84-4045-ABDC-63E79975158E,NA,NA,NA,TCGA-AJ-A3NF.7003815D-F09A-46A0-8A8E-E0685A765788.pdf,7003815D-F09A-46A0-8A8E-E0685A765788,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,22,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,54,NA,A,117
ucec_tcga,TCGA-AJ-A3NG,TCGA-AJ-A3NG-01,83,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage II,101,0,NA,15.6,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/17/12,0.1254,G3,155,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,7,0,NA,0,10,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UCEC,15.6,0:LIVING,NA,1ADDCD66-79AB-4976-9679-37F0F31BA1DF,C19DE866-BEC5-4CE7-9D50-883FEC094838,NA,NA,NA,TCGA-AJ-A3NG.32C3C850-5F65-424E-894C-75B4725BBD09.pdf,32C3C850-5F65-424E-894C-75B4725BBD09,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,60,TUMOR FREE,A,93
ucec_tcga,TCGA-AJ-A3NH,TCGA-AJ-A3NH-01,90,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,67,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,4/17/12,0.7584,G3,162,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,USC,10.18,1:DECEASED,NA,7186180A-688A-4FCC-9A67-166EFF032E4B,892763D2-7038-479E-A623-8F56EEAB1A27,NA,NA,NA,TCGA-AJ-A3NH.8FC0BB09-C917-4552-96A4-B4868FD33D27.pdf,8FC0BB09-C917-4552-96A4-B4868FD33D27,positive,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,NA,TUMOR FREE,A,65
ucec_tcga,TCGA-AJ-A3OJ,TCGA-AJ-A3OJ-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,97,0,NA,15.34,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/19/12,0.0003,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,11,0,NA,0,14,0,NA,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,15.34,0:LIVING,NA,76F98002-E8DF-4DFA-926E-8BB2D5114966,654F67ED-7295-4360-ADA6-830D4528B17D,NA,NA,NA,TCGA-AJ-A3OJ.89CAF35B-187A-499C-9E01-3992A0DEBCFD.pdf,89CAF35B-187A-499C-9E01-3992A0DEBCFD,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,260,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,95,TUMOR FREE,A,104
ucec_tcga,TCGA-AJ-A3OK,TCGA-AJ-A3OK-01,73,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,162,0,NA,15.93,0:DiseaseFree,NA,NA,NA,NA,4/19/12,0.0000,G3,160,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,3,0,NA,0,21,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,15.93,0:LIVING,NA,12DF24C6-1229-4777-AD90-7DD66259B65F,D349D257-56DA-4693-815E-9B90AEE59B23,NA,NA,NA,TCGA-AJ-A3OK.54D4BBBE-D458-44B2-8F7C-0185DD16D961.pdf,54D4BBBE-D458-44B2-8F7C-0185DD16D961,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,20,TUMOR FREE,A,75
ucec_tcga,TCGA-AJ-A3OL,TCGA-AJ-A3OL-01,55,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,81,0,NA,13.93,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/19/12,0.0844,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,6,0,NA,0,9,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,14.75,1:DECEASED,NA,7F91A0C5-D639-48EA-B3F7-B6F385E047ED,029E5E0D-9F4E-4031-A5F2-0187C2B70879,NA,NA,NA,TCGA-AJ-A3OL.B42FF342-34F0-4611-A275-B979D7658510.pdf,B42FF342-34F0-4611-A275-B979D7658510,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,80,TUMOR FREE,A,64
ucec_tcga,TCGA-AJ-A3QS,TCGA-AJ-A3QS-01,57,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,129,0,NA,16.85,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,9/28/12,0.2386,G3,165,Serous endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,YES,C54.1,8441/3,C54.1,YES,2011,NO,NA,6,0,NA,0,1,1,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,USC,16.85,0:LIVING,NA,69FC74BC-E961-40E2-9169-D7B51658EB10,0D33F3BB-F849-4FFA-8192-C95BF69DD5CC,NA,NA,NA,TCGA-AJ-A3QS.73D1F890-5799-4166-9F9A-F9852979FD29.pdf,73D1F890-5799-4166-9F9A-F9852979FD29,negative,NA,3,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,34,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,0,TUMOR FREE,A,71
ucec_tcga,TCGA-AJ-A3TW,TCGA-AJ-A3TW-01,78,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,71,0,NA,16.85,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,8/6/12,0.5385,G3,160,Serous endometrial adenocarcinoma,NO,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2012,NO,NA,1,0,NA,0,18,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,USC,16.85,0:LIVING,NA,9EE944EF-4293-4228-B750-CC34AB388EB3,25C226FA-C084-4128-8B49-62F1D5538AA0,NA,NA,NA,TCGA-AJ-A3TW.1271A645-AF29-453E-BEA8-420ECCD0DFDC.pdf,1271A645-AF29-453E-BEA8-420ECCD0DFDC,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,NA,TUMOR FREE,A,55
ucec_tcga,TCGA-AJ-A4ZG,TCGA-AJ-A4ZG-01,53,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,57,0,NA,16.36,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/15/13,NA,G3,163,Serous endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,NA,C54.1,8441/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,0,NA,NA,NA,NA,Cytology (e.g. Peritoneal or pleural fluid),NA,NA,NA,NO,FALSE,USC,16.36,0:LIVING,NA,FAE3DBD7-1C4E-45C0-8187-C09892279565,E8625CB2-1502-4174-9ADC-E9BDE7E483FE,NA,NA,NA,TCGA-AJ-A4ZG.639D98FB-EFCA-4FDC-A4A0-308951C91710.pdf,639D98FB-EFCA-4FDC-A4A0-308951C91710,positive,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,RX,NO,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,31,WITH TUMOR,A,85
ucec_tcga,TCGA-AJ-A5DV,TCGA-AJ-A5DV-01,65,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,220,0,NA,22.31,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,7/12/13,0.0000,G3,160,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,5,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","Biopsy, NOS",NA,NA,NO,FALSE,UEC,22.31,0:LIVING,NA,C7B3AC87-5260-4042-895A-279CD8CDA620,0E933A81-858A-4A82-9ECE-B56AF448A510,NA,NA,NA,TCGA-AJ-A5DV.049C45D6-6FC6-42EE-BD51-AC344D1E3CD9.pdf,049C45D6-6FC6-42EE-BD51-AC344D1E3CD9,negative,NA,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,RX,NO,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,Complete Remission/Response,3,TUMOR FREE,A,147
ucec_tcga,TCGA-AJ-A5DW,TCGA-AJ-A5DW-01,56,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,133,0,NA,12.81,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,7/12/13,0.0001,G2,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2012,NO,NA,13,0,NA,0,12,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","Biopsy, NOS",NA,NA,NO,FALSE,UEC,12.81,0:LIVING,NA,C0B684D1-B96C-4420-9285-172402B7B123,AE83512D-3739-4E4D-9F27-8B01E6400479,NA,NA,NA,TCGA-AJ-A5DW.8B641F9B-ACF5-448B-9AC3-8C8E6B1F0724.pdf,8B641F9B-ACF5-448B-9AC3-8C8E6B1F0724,NA,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,AJ,NA,NA,NA,TUMOR FREE,A,109
ucec_tcga,TCGA-AJ-A6NU,TCGA-AJ-A6NU-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,439,0,NA,20.76,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,6/30/14,0.2061,G1,165,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,NA,C54.1,8380/3,C54.1,YES,2012,NO,NA,0,0,NA,0,10,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,20.76,0:LIVING,NA,41E14A71-95DF-46D3-A357-A227A00029CF,C1D8A26D-4B1F-455E-A378-06D4AD191C02,NA,NA,NA,TCGA-AJ-A6NU.43BA8AFC-DE95-4260-88BF-EB184430B5A4.pdf,43BA8AFC-DE95-4260-88BF-EB184430B5A4,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,Complete Remission/Response,0,TUMOR FREE,A,167
ucec_tcga,TCGA-AJ-A8CT,TCGA-AJ-A8CT-01,58,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,587,0,NA,2.69,0:DiseaseFree,NA,NA,NA,NA,2/27/14,0.0004,G1,165,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,NA,C54.1,8380/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,18,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NO,FALSE,UEC,2.69,0:LIVING,NA,6C2232B2-80CE-4156-A0B4-FFA411B0963E,BFE80D89-F6E6-4EC9-9D0A-8A46ED80082C,NA,NA,NA,TCGA-AJ-A8CT.67EF8128-8F99-4B19-9B64-9C5E5BD0786F.pdf,67EF8128-8F99-4B19-9B64-9C5E5BD0786F,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,60,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,NA,17,TUMOR FREE,A,115
ucec_tcga,TCGA-AJ-A8CV,TCGA-AJ-A8CV-01,58,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,966,0,NA,35.09,0:DiseaseFree,NA,NA,NA,NA,2/27/14,0.0000,G2,156,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,14,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,35.09,0:LIVING,NA,4557D1FB-9786-4780-BD33-02E9DA04B7E3,9388A1B3-FB16-4CFB-9359-B1A3FB7FB048,NA,NA,NA,TCGA-AJ-A8CV.9A08EA28-EF0B-40CE-B2B4-0A0B0EE1EDA7.pdf,9A08EA28-EF0B-40CE-B2B4-0A0B0EE1EDA7,NA,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,30,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AJ,NA,Complete Remission/Response,65,TUMOR FREE,A,86
ucec_tcga,TCGA-AJ-A8CW,TCGA-AJ-A8CW-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,840,0,NA,0.13,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/27/14,0.0951,G2,168,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,28,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NO,FALSE,UEC,0.13,0:LIVING,NA,43E08773-767E-4B81-94E4-8848565C23E9,CA2DA155-5CE0-4FE9-B82E-877295E4AD5E,NA,NA,NA,TCGA-AJ-A8CW.146E0540-B6F0-495F-ADD5-90F7564C14CA.pdf,146E0540-B6F0-495F-ADD5-90F7564C14CA,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AJ,NA,NA,6,TUMOR FREE,A,134
ucec_tcga,TCGA-AP-A051,TCGA-AP-A051-01,69,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2475,0,NA,129.7,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0341,G3,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2003,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,6782,NA,TRUE,UEC,129.7,0:LIVING,NA,b045f24b-f822-4df9-9ffa-47308edcec8c,417cff62-b034-4197-9cfd-e640d55f3094,NA,NA,NA,TCGA-AP-A051.2146A2FC-99EE-4939-AD9F-086BB77D2B21.pdf,2146A2FC-99EE-4939-AD9F-086BB77D2B21,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,430,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,225.8666667,NA,37,TUMOR FREE,A,97
ucec_tcga,TCGA-AP-A052,TCGA-AP-A052-01,59,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,2211,0,NA,12.94,1:Recurred/Progressed,NA,NA,NA,NA,9/23/10,0.2774,G3,165,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2004,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,26,NA,TRUE,USC,21.98,1:DECEASED,NA,bd4284a7-260d-48b3-9b48-a1c578c30d27,33c21dca-f3b3-48cd-9fc5-ad316598f23e,NA,NA,NA,TCGA-AP-A052.830EF496-4672-4E9A-B662-DCB4678E99B0.pdf,830EF496-4672-4E9A-B662-DCB4678E99B0,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R2,YES,1,500,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,0.866666666667,NA,0,WITH TUMOR,A,126
ucec_tcga,TCGA-AP-A053,TCGA-AP-A053-01,90,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2163,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,2/1/11,0.1891,G3,156,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,3,0,0,0,12,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,45,NA,TRUE,UEC,110.55,1:DECEASED,NA,af37d8f0-fea0-47f6-be0a-2fb55a5da5c4,e1121a9e-bc27-44eb-a1ad-eb0ab10b7c3a,NA,NA,NA,TCGA-AP-A053.6179478F-93BE-4C03-9F65-D74E66AFE449.pdf,6179478F-93BE-4C03-9F65-D74E66AFE449,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.533333333,NA,25,TUMOR FREE,A,48
ucec_tcga,TCGA-AP-A054,TCGA-AP-A054-01,64,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,2086,0,NA,18.59,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,9/23/10,0.0545,G3,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,4,0,0,0,22,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,839,NA,TRUE,UEC,23.29,1:DECEASED,NA,d77e4dbc-b239-4742-8cb7-efd427010d13,ddffb9c7-185f-402f-99b8-8058b40086d9,NA,NA,NA,TCGA-AP-A054.72028DF7-DAD0-487E-914B-C3AA69A1E6C4.pdf,72028DF7-DAD0-487E-914B-C3AA69A1E6C4,positive,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,410,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,27.86666667,NA,100,WITH TUMOR,A,75
ucec_tcga,TCGA-AP-A056,TCGA-AP-A056-01,64,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,2017,0,NA,86.01,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0011,G3,151,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,18,0,0,0,20,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Pap Smear,NA,7228,NA,TRUE,UEC,86.01,0:LIVING,NA,585a1f31-3804-43ca-81e9-4e571fe03642,1d811231-b972-4977-890d-1fbb9109d61d,NA,NA,NA,TCGA-AP-A056.008786AD-6CA8-488D-A5AC-BA558985E765.pdf,008786AD-6CA8-488D-A5AC-BA558985E765,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,400,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,240.9666667,NA,96,TUMOR FREE,A,56
ucec_tcga,TCGA-AP-A059,TCGA-AP-A059-01,69,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1476,0,NA,48,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/1/11,0.0001,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,6,0,0,0,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,9255,NA,TRUE,UEC,48,0:LIVING,NA,4549bff6-6886-4102-a1de-02691b664c52,6d6c8e8b-3423-4380-a498-6cf5bc8b070b,NA,NA,NA,TCGA-AP-A059.29A150D3-D5F0-4222-B082-6ABE35A2BB46.pdf,29A150D3-D5F0-4222-B082-6ABE35A2BB46,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,308.4333333,NA,12,TUMOR FREE,A,99
ucec_tcga,TCGA-AP-A05A,TCGA-AP-A05A-01,81,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage II,1479,0,NA,NA,NA,NA,NA,NA,NA,9/23/10,0.1828,G3,NA,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2006,NO,NA,0,0,0,0,6,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,64,NA,TRUE,USC,63.86,1:DECEASED,NA,c350b53b-3c27-4b9e-8b57-d7b6a1205a1f,482153fb-e69d-4748-9cf4-e281ec141518,NA,NA,NA,TCGA-AP-A05A.1DAE9968-7D20-45A9-B2BC-5F32F6EC7A08.pdf,1DAE9968-7D20-45A9-B2BC-5F32F6EC7A08,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,260,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,2.1,NA,91,TUMOR FREE,A,NA
ucec_tcga,TCGA-AP-A05D,TCGA-AP-A05D-01,67,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,1063,0,NA,57.75,0:DiseaseFree,NA,NA,NA,NA,2/1/11,0.2183,G3,161,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2007,NO,NA,8,1,0,1,29,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,32,NA,TRUE,USC,57.75,0:LIVING,NA,f7e06a10-74ca-4f52-a944-b3f22c016998,5b19af28-1179-42cb-a474-856ef2048d5b,NA,NA,NA,TCGA-AP-A05D.3312F531-00A3-4104-8C9C-8734C32C89C0.pdf,3312F531-00A3-4104-8C9C-8734C32C89C0,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.066666667,NA,73,TUMOR FREE,A,98
ucec_tcga,TCGA-AP-A05H,TCGA-AP-A05H-01,75,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,706,0,NA,45.5,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.6909,G3,153,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,7,0,0,0,24,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,69,NA,TRUE,USC,45.5,0:LIVING,NA,fe5f4822-37a3-4f9e-8d33-8b9f36bf6895,e417cb26-f6e8-4a31-b7e0-5bb43fd587b1,NA,NA,NA,TCGA-AP-A05H.805B997D-9755-4AC1-8695-294806148F25.pdf,805B997D-9755-4AC1-8695-294806148F25,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,2.3,NA,61,TUMOR FREE,A,89
ucec_tcga,TCGA-AP-A05J,TCGA-AP-A05J-01,66,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage II,566,0,NA,36.86,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.1747,G3,168,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,1,0,0,0,14,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,45,NA,TRUE,USC,36.86,0:LIVING,NA,38f9fe64-de79-498c-b3ca-1c83af0ed72a,203c6ed3-2e18-400d-83ee-69a8fd9bb386,NA,NA,NA,TCGA-AP-A05J.C6426DA0-86C5-49CC-9983-A0002DA0D4F2.pdf,C6426DA0-86C5-49CC-9983-A0002DA0D4F2,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.5,NA,0,TUMOR FREE,A,79
ucec_tcga,TCGA-AP-A05N,TCGA-AP-A05N-01,58,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,232,0,NA,NA,NA,NA,NA,NA,NA,9/23/10,0.0004,G1,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,2,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,162,NA,TRUE,UEC,23.85,1:DECEASED,NA,08b11e0e-5b8e-45ea-9b6b-30e3185b03d7,67a90941-d6ec-4465-a727-7193504c8982,NA,NA,NA,TCGA-AP-A05N.E4FF43F2-5CBD-4B68-9CD5-BE4E84AD67D5.pdf,E4FF43F2-5CBD-4B68-9CD5-BE4E84AD67D5,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,350,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,5.466666667,NA,23,TUMOR FREE,A,123
ucec_tcga,TCGA-AP-A05O,TCGA-AP-A05O-01,68,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,209,0,NA,11.17,1:Recurred/Progressed,NA,NA,NA,NA,2/1/11,0.0197,G3,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,23,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,12.61,0:LIVING,NA,49431740-7ed1-4c67-8d66-730629825895,4f1edc7f-e2ff-40f5-8227-d89a1006042c,NA,NA,NA,TCGA-AP-A05O.9C8BD34A-DC49-4547-850A-80DCD2D073F8.pdf,9C8BD34A-DC49-4547-850A-80DCD2D073F8,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,NA,NA,80,TUMOR FREE,A,103
ucec_tcga,TCGA-AP-A05P,TCGA-AP-A05P-01,54,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,203,0,NA,20.89,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/23/10,0.1359,G1,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,4,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,30,NA,TRUE,UEC,20.89,0:LIVING,NA,3cb83517-78a4-47b8-8b1e-57e765dbdd2e,f51f7b0e-3ea6-4232-9de4-a4dd63b23bb5,NA,NA,NA,TCGA-AP-A05P.5BA23C70-805A-4356-B739-AFBAFD29D7FC.pdf,5BA23C70-805A-4356-B739-AFBAFD29D7FC,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,1.0,NA,0,TUMOR FREE,A,74
ucec_tcga,TCGA-AP-A0L8,TCGA-AP-A0L8-01,70,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,3510,0,NA,47.73,1:Recurred/Progressed,NA,NA,NA,NA,9/23/10,0.7370,G3,NA,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2000,NO,NA,6,1,0,1,6,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,54,NA,TRUE,USC,48.75,1:DECEASED,NA,9aa8c2b4-db32-4899-bf0c-d578cb175e90,d1a7a58f-7a35-4a94-a337-051ae56ded00,NA,NA,NA,TCGA-AP-A0L8.A708C154-A635-4423-A1A0-BB1FC23D3613.pdf,A708C154-A635-4423-A1A0-BB1FC23D3613,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.8,NA,87,WITH TUMOR,A,61
ucec_tcga,TCGA-AP-A0L9,TCGA-AP-A0L9-01,71,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,3402,0,NA,125.33,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.5243,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2001,NO,NA,2,0,0,0,12,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,56,NA,TRUE,USC,125.33,0:LIVING,NA,7b9947d5-e86b-4006-8890-ea5209584a88,53d0521f-10d6-4f70-9277-d99025a6b963,NA,NA,NA,TCGA-AP-A0L9.62E44C56-838D-4318-B8F7-80476A148C03.pdf,62E44C56-838D-4318-B8F7-80476A148C03,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.866666667,NA,0,TUMOR FREE,A,60
ucec_tcga,TCGA-AP-A0LD,TCGA-AP-A0LD-01,63,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2993,0,NA,117.9,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.1300,G3,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2002,NO,NA,12,0,0,0,20,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,356,NA,TRUE,UEC,117.9,0:LIVING,NA,1200c8b7-a058-4c01-bbe2-04ec09a65245,649dadda-5823-4b0d-b5a2-49f501adc029,NA,NA,NA,TCGA-AP-A0LD.10B9E917-C1FB-480D-9DB2-8E93FA446ADC.pdf,10B9E917-C1FB-480D-9DB2-8E93FA446ADC,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,11.9,NA,87,TUMOR FREE,A,68
ucec_tcga,TCGA-AP-A0LE,TCGA-AP-A0LE-01,57,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2988,0,NA,110.28,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0341,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2002,NO,NA,5,0,0,0,19,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,373,NA,TRUE,UEC,110.28,0:LIVING,NA,dcff8659-ecca-4798-80a3-dd6e7642ba2b,9c4a32cf-de40-4996-91a9-56f1c18d69a4,NA,NA,NA,TCGA-AP-A0LE.3EA84930-6B34-43B8-A5A8-3D2B3754155F.pdf,3EA84930-6B34-43B8-A5A8-3D2B3754155F,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,12.43333333,NA,5,TUMOR FREE,A,75
ucec_tcga,TCGA-AP-A0LF,TCGA-AP-A0LF-01,82,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,2891,0,NA,93.92,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/1/11,0.3339,G3,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2002,NO,NA,10,0,0,0,32,14,0,14,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,179,NA,TRUE,UEC,93.92,0:LIVING,NA,748e38b1-2ead-4a0a-8881-d640617b856b,902e2dd8-81e5-4949-a57b-92b3efd86c63,NA,NA,NA,TCGA-AP-A0LF.7112CE75-9EFD-4989-9F2A-4D0F517B8EDE.pdf,7112CE75-9EFD-4989-9F2A-4D0F517B8EDE,NA,NA,NA,NA,NA,NO,WHITE,NA,R2,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,5.933333333,NA,17,WITH TUMOR,A,72
ucec_tcga,TCGA-AP-A0LG,TCGA-AP-A0LG-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2833,0,NA,66.2,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0000,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2002,NO,NA,2,0,0,0,3,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,296,NA,TRUE,UEC,66.2,0:LIVING,NA,cca5717d-226d-4390-a99b-c7aed6d9d70e,031667f8-38d9-4df3-a18e-32cc426d234b,NA,NA,NA,TCGA-AP-A0LG.7343A9B5-276E-4EE1-AC06-27835D63B0E2.pdf,7343A9B5-276E-4EE1-AC06-27835D63B0E2,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,360,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,9.833333333,NA,18,TUMOR FREE,A,76
ucec_tcga,TCGA-AP-A0LH,TCGA-AP-A0LH-01,60,NA,NA,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IA,2772,0,NA,9.92,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,9/23/10,0.1132,G3,164,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2002,NO,NA,14,0,0,0,17,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,108,NA,TRUE,UCEC,36.33,1:DECEASED,NA,7dce4215-01f6-43e9-9378-9e22c26c23a2,4c657ad4-2c53-4ea9-82b5-52996e74e3ff,NA,NA,NA,TCGA-AP-A0LH.78E73020-1173-45DA-BDBA-DFB1CF7BCB41.pdf,78E73020-1173-45DA-BDBA-DFB1CF7BCB41,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,3.566666667,NA,0,WITH TUMOR,A,83
ucec_tcga,TCGA-AP-A0LI,TCGA-AP-A0LI-01,67,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,2567,0,NA,97.63,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.3668,G3,161,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2003,NO,NA,3,2,0,2,26,NA,0,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Cervical biopsy,NA,74,NA,TRUE,USC,97.63,0:LIVING,NA,e1e8dc66-467c-48a5-be56-3db4f665b9f1,981d9e3b-63c5-41e9-827f-7f1d268d62f4,NA,NA,NA,TCGA-AP-A0LI.EFEA05D7-E720-4FE4-977C-6A6369B1BA2E.pdf,EFEA05D7-E720-4FE4-977C-6A6369B1BA2E,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R2,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,2.466666667,NA,83,TUMOR FREE,A,86
ucec_tcga,TCGA-AP-A0LJ,TCGA-AP-A0LJ-01,42,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2290,0,NA,46.68,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0469,G1,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,6,0,0,0,14,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,38,NA,TRUE,UEC,46.68,0:LIVING,NA,b4a520ae-f259-48c8-823e-c10b9b8a133a,be3ed392-4d9f-4eaf-8a56-d251846df4da,NA,NA,NA,TCGA-AP-A0LJ.859CBF70-D72E-4843-B3AA-6226B707AA2B.pdf,859CBF70-D72E-4843-B3AA-6226B707AA2B,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,680,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.3,NA,0,TUMOR FREE,A,80
ucec_tcga,TCGA-AP-A0LL,TCGA-AP-A0LL-01,56,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2066,0,NA,25.95,1:Recurred/Progressed,NA,NA,NA,NA,9/23/10,0.0344,G1,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,8,0,0,0,29,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,42,NA,TRUE,UEC,83.9,0:LIVING,NA,d17668c4-5d66-4e16-8b70-b54616581aae,488a7462-8348-422c-91d3-7d9f0c39d25e,NA,NA,NA,TCGA-AP-A0LL.B4A6F5DE-E477-48FD-ADA1-EAE436FBC576.pdf,B4A6F5DE-E477-48FD-ADA1-EAE436FBC576,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.4,NA,8,WITH TUMOR,A,72
ucec_tcga,TCGA-AP-A0LM,TCGA-AP-A0LM-01,33,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC2,2019,0,NA,27.1,0:DiseaseFree,NA,NA,NA,NA,2/1/11,0.0001,G3,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,13,1,0,1,40,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,10543,NA,TRUE,UEC,27.1,0:LIVING,NA,43e228ae-c890-444f-afbd-49385562e33a,c8ab800a-ec4d-4a1c-bccf-8e17f7976978,NA,NA,NA,TCGA-AP-A0LM.BF380986-0279-41FC-AAE8-BA9772456CE6.pdf,BF380986-0279-41FC-AAE8-BA9772456CE6,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,350.4666667,NA,71,TUMOR FREE,A,100
ucec_tcga,TCGA-AP-A0LN,TCGA-AP-A0LN-01,56,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1907,0,NA,82.46,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0465,G1,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,0,NA,NA,NA,36,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,45,NA,TRUE,UEC,82.46,0:LIVING,NA,60fcf50a-8598-475d-8dd0-6b3044661233,90a221e7-8579-4af2-9b39-40de3c42f71c,NA,NA,NA,TCGA-AP-A0LN.D50C7207-D840-48A2-8D73-E1C71FFA73E1.pdf,D50C7207-D840-48A2-8D73-E1C71FFA73E1,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.5,NA,0,TUMOR FREE,A,119
ucec_tcga,TCGA-AP-A0LO,TCGA-AP-A0LO-01,45,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1894,0,NA,16.95,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,9/23/10,0.2933,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,6,0,0,0,15,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,27,NA,TRUE,UEC,33.38,1:DECEASED,NA,a081da6f-51f3-4555-a6b8-736f8c6cda39,9846d8f3-5b22-48e9-b972-a0fe9f509fb4,NA,NA,NA,TCGA-AP-A0LO.DC0116C2-788E-46F5-A4AC-115D857C1F85.pdf,DC0116C2-788E-46F5-A4AC-115D857C1F85,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,0.9,NA,0,WITH TUMOR,A,67
ucec_tcga,TCGA-AP-A0LP,TCGA-AP-A0LP-01,76,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1884,0,NA,61.6,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0000,G1,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,10,0,0,0,17,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,206,NA,TRUE,UEC,61.6,0:LIVING,NA,efae3940-d3cc-4988-bdb4-fa05d977aff5,d67450c1-8848-4b28-9c16-83aa7132e8c8,NA,NA,NA,TCGA-AP-A0LP.ECA6E3D1-141B-4DB1-90B6-FE6A2E355AD3.pdf,ECA6E3D1-141B-4DB1-90B6-FE6A2E355AD3,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,6.866666667,NA,12,TUMOR FREE,A,60
ucec_tcga,TCGA-AP-A0LQ,TCGA-AP-A0LQ-01,59,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1848,0,NA,80.72,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0464,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,6,0,0,0,33,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,42,NA,TRUE,UEC,80.72,0:LIVING,NA,252500d2-86a3-4090-a57f-1e8c3d44c573,b75648dc-b25b-4ee6-850a-7d1f3a353e83,NA,NA,NA,TCGA-AP-A0LQ.D37DBE11-B7EA-4356-901C-35AF3A7FCC89.pdf,D37DBE11-B7EA-4356-901C-35AF3A7FCC89,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,1.4,NA,5,TUMOR FREE,A,95
ucec_tcga,TCGA-AP-A0LS,TCGA-AP-A0LS-01,63,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1421,0,NA,95.4,0:DiseaseFree,NA,NA,NA,NA,6/22/11,0.0001,G2,169,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,NA,NA,NA,14,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,95.4,0:LIVING,NA,c5a797d3-82ae-49dc-b2fe-0da64da271a2,c6f914f3-0888-4890-9323-6386f1035d81,NA,NA,NA,TCGA-AP-A0LS.E802CEF6-BC3F-4C35-85E8-2B37531571CD.pdf,E802CEF6-BC3F-4C35-85E8-2B37531571CD,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,NA,NA,21,TUMOR FREE,A,81
ucec_tcga,TCGA-AP-A0LT,TCGA-AP-A0LT-01,57,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,1404,0,NA,49.18,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0000,G2,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,0,0,0,16,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,477,NA,TRUE,UEC,49.18,0:LIVING,NA,43714e9a-e9c4-4206-af92-1d00d2a8ae35,c94dd7a5-dd58-4702-a7d1-8199d3f8c9cc,NA,NA,NA,TCGA-AP-A0LT.4A25211C-354E-4FC8-B81B-29766B7962D4.pdf,4A25211C-354E-4FC8-B81B-29766B7962D4,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,15.8,NA,38,TUMOR FREE,A,91
ucec_tcga,TCGA-AP-A0LV,TCGA-AP-A0LV-01,39,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,341,0,NA,25.07,0:DiseaseFree,NA,NA,NA,NA,9/23/10,0.0001,G1,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,16,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,19,NA,TRUE,UEC,25.07,0:LIVING,NA,5dfdfcfc-72cc-4e33-aa3f-0d744eb94330,f5c82191-3e5a-479a-b0e4-77f6ac14b3cc,NA,NA,NA,TCGA-AP-A0LV.75767B04-9FDF-4EE9-8DFF-350B60AF281C.pdf,75767B04-9FDF-4EE9-8DFF-350B60AF281C,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,0.633333333333,NA,36,TUMOR FREE,A,76
ucec_tcga,TCGA-AP-A1DH,TCGA-AP-A1DH-01,62,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1843,0,NA,71.62,0:DiseaseFree,NA,NA,NA,NA,5/9/11,0.0000,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,0,0,0,0,25,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,71.62,0:LIVING,NA,07d1aef3-31c7-4c44-a078-16a9eb096d58,da4b6bf2-0e9d-495a-8220-93359d2afa67,NA,NA,NA,TCGA-AP-A1DH.B77EE1CD-716C-4441-B4A9-CCCC37BD1379.pdf,B77EE1CD-716C-4441-B4A9-CCCC37BD1379,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,NA,NA,41,TUMOR FREE,A,127
ucec_tcga,TCGA-AP-A1DK,TCGA-AP-A1DK-01,53,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1541,0,NA,90.9,0:DiseaseFree,NA,NA,NA,NA,5/9/11,0.0003,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,7,0,0,0,20,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,90.9,0:LIVING,NA,51de7e94-e2fa-420b-9aa2-3637d17fc6ea,1cb12a0f-0081-441f-a86e-71d76ef5b8d0,NA,NA,NA,TCGA-AP-A1DK.9A3BB88B-F16F-4773-8912-CF519B847354.pdf,9A3BB88B-F16F-4773-8912-CF519B847354,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,NA,NA,36,TUMOR FREE,A,56
ucec_tcga,TCGA-AP-A1DM,TCGA-AP-A1DM-01,60,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1309,0,NA,55.85,0:DiseaseFree,NA,NA,NA,NA,5/9/11,0.0415,G1,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,4,0,0,0,22,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,55.85,0:LIVING,NA,ca7f9d8b-2abc-4606-bf95-4c42791b38bd,7f4344cf-a5d7-4623-abe8-9f046723ea0a,NA,NA,NA,TCGA-AP-A1DM.E25BA7AD-5C24-4953-B9C3-7509AE6E9F4C.pdf,E25BA7AD-5C24-4953-B9C3-7509AE6E9F4C,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,NA,NA,23,TUMOR FREE,A,92
ucec_tcga,TCGA-AP-A1DO,TCGA-AP-A1DO-01,62,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1210,0,NA,31.27,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/9/11,0.2144,G2,156,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,9,0,0,0,17,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,31.27,0:LIVING,NA,3348a7aa-f5c3-4fba-9968-68da5cedfd7e,f2b59490-86fe-409a-89f1-e11f744e0d75,NA,NA,NA,TCGA-AP-A1DO.EAC1A113-68BB-4D45-AB57-E59E392029BC.pdf,EAC1A113-68BB-4D45-AB57-E59E392029BC,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,NA,NA,24,TUMOR FREE,A,80
ucec_tcga,TCGA-AP-A1DP,TCGA-AP-A1DP-01,70,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1105,0,NA,27.3,1:Recurred/Progressed,NA,NA,NA,NA,5/9/11,0.0341,G2,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,7,0,0,0,17,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,35.51,1:DECEASED,NA,a93c47a9-65b5-4785-af4f-a2078db4514e,b5206087-88de-4963-9239-189d159f7b35,NA,NA,NA,TCGA-AP-A1DP.20EEB047-0185-4B65-9A6A-43D6C97307C8.pdf,20EEB047-0185-4B65-9A6A-43D6C97307C8,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,NA,NA,46,WITH TUMOR,A,83
ucec_tcga,TCGA-AP-A1DQ,TCGA-AP-A1DQ-01,76,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC1,1074,0,NA,29.73,1:Recurred/Progressed,NA,NA,NA,NA,5/9/11,0.5010,High Grade,163,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,1,0,0,0,20,6,0,6,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,27,NA,TRUE,USC,46.75,1:DECEASED,NA,ad0806a5-df9e-48ea-bc8b-d4a3c9ea7ea0,812485e9-fbb8-431b-8c49-d2f1a9391457,NA,NA,NA,TCGA-AP-A1DQ.F5983E58-F466-42CF-8905-B942D2BDF702.pdf,F5983E58-F466-42CF-8905-B942D2BDF702,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,0.9,NA,82,WITH TUMOR,A,60
ucec_tcga,TCGA-AP-A1DR,TCGA-AP-A1DR-01,59,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,1095,0,NA,49.11,0:DiseaseFree,NA,NA,NA,NA,5/9/11,0.0002,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,0,0,0,18,0,2,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,49.11,0:LIVING,NA,0f064588-2d7e-439a-90a6-dfa17bb8af15,438480e7-9b80-44a4-89d8-6b7a27028f35,NA,NA,NA,TCGA-AP-A1DR.75A10A08-04CB-49C2-8086-5F7B1D57524E.pdf,75A10A08-04CB-49C2-8086-5F7B1D57524E,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,NA,NA,27,TUMOR FREE,A,109
ucec_tcga,TCGA-AP-A1DV,TCGA-AP-A1DV-01,59,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,876,0,NA,6.7,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/9/11,0.0195,G3,147,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,5,0,0,0,21,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,6.7,0:LIVING,NA,1b685c46-57b3-4052-b5b9-1f704809bf04,a03f9020-3ded-4c1c-bf7e-1fa3a47e76de,NA,NA,NA,TCGA-AP-A1DV.F3163501-DD37-4C13-A921-3C2A74928BA7.pdf,F3163501-DD37-4C13-A921-3C2A74928BA7,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,NA,NA,94,TUMOR FREE,A,46
ucec_tcga,TCGA-AP-A1E0,TCGA-AP-A1E0-01,40,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC2,582,0,NA,60.18,0:DiseaseFree,NA,NA,NA,NA,5/9/11,0.0004,G2,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,9,1,0,1,3,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,60.18,0:LIVING,NA,84b96f93-6273-4101-a259-9602000ae491,9862bae4-6ad0-4607-ab28-cc6bf73d77d0,NA,NA,NA,TCGA-AP-A1E0.700FD29A-69DC-4B34-B841-FFFA7E76A5AF.pdf,700FD29A-69DC-4B34-B841-FFFA7E76A5AF,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,NA,NA,35,TUMOR FREE,A,59
ucec_tcga,TCGA-AP-A1E1,TCGA-AP-A1E1-01,74,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,470,0,NA,45.83,0:DiseaseFree,NA,NA,NA,NA,5/9/11,0.0338,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,2,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,45.83,0:LIVING,NA,2b85b84f-e680-4b5c-93ea-3c71567227e8,1a9a1020-c9ee-4bbf-98e8-fbe5041a6099,NA,NA,NA,TCGA-AP-A1E1.E8873536-294D-4E41-9165-EE403A11B439.pdf,E8873536-294D-4E41-9165-EE403A11B439,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,260,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,NA,NA,10,TUMOR FREE,A,73
ucec_tcga,TCGA-AP-A1E3,TCGA-AP-A1E3-01,45,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,440,0,NA,27.83,0:DiseaseFree,NA,NA,NA,NA,5/9/11,0.0001,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,1,1,0,1,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,27.83,0:LIVING,NA,44ac7093-a733-4c55-a964-0ba9ec141d2d,86b9fab8-8a90-4610-ac48-53f952665ac9,NA,NA,NA,TCGA-AP-A1E3.FDA2C217-5267-41CC-AC07-CBACFF8E7B8D.pdf,FDA2C217-5267-41CC-AC07-CBACFF8E7B8D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,350,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,NA,NA,77,WITH TUMOR,A,130
ucec_tcga,TCGA-AP-A1E4,TCGA-AP-A1E4-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,154,0,NA,5.19,1:Recurred/Progressed,NA,NA,NA,NA,5/9/11,0.1270,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,0,0,0,3,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,51.08,0:LIVING,NA,0b2eb188-dd23-4dbf-91bb-02e3c81a69bc,0e845d2c-7928-46a8-a751-a5df677e8041,NA,NA,NA,TCGA-AP-A1E4.1E33ABA3-0B55-4021-A370-DB8E2CA4C022.pdf,1E33ABA3-0B55-4021-A370-DB8E2CA4C022,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AP,NA,NA,58,WITH TUMOR,A,54
ucec_tcga,TCGA-AP-A3K1,TCGA-AP-A3K1-01,56,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,450,0,NA,6.5,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/16/12,0.4611,High Grade,157,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,29,12,0,12,34,3,0,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,NA,NA,TRUE,USC,21.88,1:DECEASED,NA,211B2C52-1AD8-4D33-AF0B-69EC1A56C821,8A78F37C-8BC5-4A51-BB76-E77DED648289,NA,NA,NA,TCGA-AP-A3K1.A2E4C9FE-F82D-440E-AA52-88379EBC2442.pdf,A2E4C9FE-F82D-440E-AA52-88379EBC2442,positive,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,NA,NA,58.8,WITH TUMOR,A,60
ucec_tcga,TCGA-AP-A5FX,TCGA-AP-A5FX-01,68,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IIIC1,878,0,NA,13.37,1:Recurred/Progressed,YES,NA,NA,NA,5/26/13,0.4774,G3,168,Mixed serous and endometrioid,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8255/3,C54.1,YES,2010,NO,NA,0,0,0,0,4,4,0,4,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,YES,TRUE,UCEC,36.1,1:DECEASED,NA,A633D316-59A4-45AE-8BF8-135CFBD27656,B37BA34A-5F2E-46A9-9334-79E6782D40DC,NA,NA,NA,TCGA-AP-A5FX.AF38CD86-2F5A-46A3-903A-81A8067F2456.pdf,AF38CD86-2F5A-46A3-903A-81A8067F2456,positive,YES,4+,NA,NA,NO,BLACK OR AFRICAN AMERICAN,YES,RX,YES,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AP,NA,Complete Remission/Response,96,WITH TUMOR,A,80
ucec_tcga,TCGA-AW-A1PO,TCGA-AW-A1PO-01,66,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,331,0,NA,0.56,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,8/5/11,0.9487,G3,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,0,0,0,7,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,TRUE,UEC,0.56,0:LIVING,NA,4cb4dd07-0ce5-4de7-a0bd-546183949efe,1576c6c1-b9f0-4acd-9a75-e5f2d5a4ecc1,NA,NA,NA,TCGA-AW-A1PO.B5351001-32B2-4BA9-998D-F6631F6BE705.pdf,B5351001-32B2-4BA9-998D-F6631F6BE705,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AW,NA,NA,70,TUMOR FREE,A,58
ucec_tcga,TCGA-AX-A05S,TCGA-AX-A05S-01,81,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,507,0,NA,11.1,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/23/11,0.0904,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,4,0,NA,0,18,5,NA,5,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,376,NA,FALSE,UEC,13.57,1:DECEASED,NA,3a4a6aff-4720-41fc-a114-85f38610ebb1,3d8f263f-6866-4b92-aaee-743ec5514865,NA,NA,NA,TCGA-AX-A05S.571B1EC2-3698-4FF2-89DD-7C5A8A048660.pdf,571B1EC2-3698-4FF2-89DD-7C5A8A048660,negative,NA,NA,NA,NA,NO,WHITE,NA,R2,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,12.6,NA,50,WITH TUMOR,A,48
ucec_tcga,TCGA-AX-A05T,TCGA-AX-A05T-01,82,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,310,0,NA,33.18,0:DiseaseFree,NA,NA,NA,NA,5/23/11,0.0464,G1,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,7,0,NA,0,14,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,41,NA,FALSE,UEC,33.18,0:LIVING,NA,0119eab6-00e7-4346-aa52-cbbeeba3621d,bc2885b5-c7cd-4467-88a3-a32cf602b3d5,NA,NA,NA,TCGA-AX-A05T.85F75553-6E10-4AF5-9BDF-DAB52D00615B.pdf,85F75553-6E10-4AF5-9BDF-DAB52D00615B,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,1.366666667,NA,50,TUMOR FREE,A,61
ucec_tcga,TCGA-AX-A05U,TCGA-AX-A05U-01,56,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,500,0,NA,29.66,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/23/11,0.0586,G1,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,11,0,NA,0,12,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,29,NA,FALSE,UEC,29.66,0:LIVING,NA,e56c6abc-b36c-4667-a347-0a541ce4791d,6327ef54-8216-4fd3-bde4-01f3192c653f,NA,NA,NA,TCGA-AX-A05U.1F51E982-37A1-40C6-BFAC-782B93D9967F.pdf,1F51E982-37A1-40C6-BFAC-782B93D9967F,negative,NA,NA,NA,NA,NO,AMERICAN INDIAN OR ALASKA NATIVE,NA,R0,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,0.966666666667,NA,50,TUMOR FREE,A,62
ucec_tcga,TCGA-AX-A05W,TCGA-AX-A05W-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,1935,0,NA,80.49,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/23/11,0.2216,G1,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,6,0,NA,0,15,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,44,NA,FALSE,UEC,80.49,0:LIVING,NA,87e44856-eb9a-475f-96b1-047b7f77b0da,dbdf67e1-e4c2-499c-b701-f1f322242e84,NA,NA,NA,TCGA-AX-A05W.4C960E79-D109-4C4C-B99F-F73D4DD73B40.pdf,4C960E79-D109-4C4C-B99F-F73D4DD73B40,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,1.5,NA,50,TUMOR FREE,A,74
ucec_tcga,TCGA-AX-A05Y,TCGA-AX-A05Y-01,57,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1967,0,NA,6.37,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/23/11,0.0411,G1,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,6,0,NA,0,24,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,131,NA,FALSE,UEC,88.17,0:LIVING,NA,cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf,60e1de46-8c8f-4fa9-bc51-ce975d02d5ac,NA,NA,NA,TCGA-AX-A05Y.7E7D9403-AA77-4F14-9017-3B69F66D8EBC.pdf,7E7D9403-AA77-4F14-9017-3B69F66D8EBC,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,4.333333333,NA,50,TUMOR FREE,A,92
ucec_tcga,TCGA-AX-A05Z,TCGA-AX-A05Z-01,37,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,1416,0,NA,71.45,0:DiseaseFree,NA,NA,HISPANIC OR LATINO,NA,5/24/11,0.0190,G2,150,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,7,0,NA,0,13,0,NA,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,5724,NA,FALSE,UEC,71.45,0:LIVING,NA,bf632368-8ce7-4b4b-8842-d1b1801e62ef,acda9261-6c73-4b31-aab3-97a40eddb9bd,NA,NA,NA,TCGA-AX-A05Z.5938A010-17E7-41FB-9F4D-8B4F1A3C0F2F.pdf,5938A010-17E7-41FB-9F4D-8B4F1A3C0F2F,negative,NA,NA,NA,NA,NO,NA,NA,R1,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,190.2666667,NA,50,TUMOR FREE,A,66
ucec_tcga,TCGA-AX-A060,TCGA-AX-A060-01,77,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,1033,0,NA,35.32,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/24/11,0.0342,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,6,0,NA,0,17,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,514,NA,FALSE,UEC,35.32,0:LIVING,NA,d1b615f4-50c9-497b-8a69-8de78aa17e09,7b7fd42b-451a-40d8-8b00-cbf745493115,NA,NA,NA,TCGA-AX-A060.9086A79B-F764-42D4-BD9A-4C4F9F65C92B.pdf,9086A79B-F764-42D4-BD9A-4C4F9F65C92B,negative,NA,NA,NA,NA,NO,AMERICAN INDIAN OR ALASKA NATIVE,NA,R1,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,17.13333333,NA,50,TUMOR FREE,A,87
ucec_tcga,TCGA-AX-A062,TCGA-AX-A062-01,53,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1610,0,NA,45.96,0:DiseaseFree,NA,NA,NA,NA,5/24/11,0.0001,G1,173,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,8,0,NA,0,25,0,NA,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,27,NA,FALSE,UEC,45.96,0:LIVING,NA,4af65655-a3bd-4252-9b2f-2b2c4394f95c,9eac701b-9927-4aca-81eb-b516f90c643c,NA,NA,NA,TCGA-AX-A062.FAAFB078-A6DF-4E1B-BD5F-A3B30E45BE1E.pdf,FAAFB078-A6DF-4E1B-BD5F-A3B30E45BE1E,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,0.933333333333,NA,50,TUMOR FREE,A,122
ucec_tcga,TCGA-AX-A063,TCGA-AX-A063-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1950,0,NA,79.4,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/24/11,0.0440,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,3,0,NA,0,19,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,719,NA,FALSE,UEC,79.4,0:LIVING,NA,e8909bdf-460c-4291-8e9b-7be12f343eae,d5c708b2-29b0-42e0-980d-f54fe5e7fea1,NA,NA,NA,TCGA-AX-A063.E911408A-8447-4CB8-8A3F-B2C24875ACF0.pdf,E911408A-8447-4CB8-8A3F-B2C24875ACF0,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,23.93333333,NA,50,TUMOR FREE,A,88
ucec_tcga,TCGA-AX-A064,TCGA-AX-A064-01,81,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIA,1024,0,NA,49.84,0:DiseaseFree,NA,NA,NA,NA,9/29/10,0.0341,G2,154,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,5,0,NA,0,29,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,193,NA,FALSE,UEC,49.84,0:LIVING,NA,633e6994-3e8b-4c0b-9b79-06cf4ab6f9bc,3d85e546-d9f4-49ba-adbd-301118cd1307,NA,NA,NA,TCGA-AX-A064.F760DFF2-7A11-4465-8581-397ABAA76BE4.pdf,F760DFF2-7A11-4465-8581-397ABAA76BE4,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,6.433333333,NA,50,TUMOR FREE,A,48
ucec_tcga,TCGA-AX-A06B,TCGA-AX-A06B-01,72,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIA,1563,0,NA,67.61,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/25/11,0.5106,G3,151,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,8,NA,NA,0,13,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,32,NA,FALSE,UEC,67.61,0:LIVING,NA,95e6d327-9ab7-45de-9527-f5634b3995c3,a43f90b7-4a6c-423c-82de-ad2c330ae0fb,NA,NA,NA,TCGA-AX-A06B.394E8BCD-1BE6-44C4-BDAC-D251A6C08E2B.pdf,394E8BCD-1BE6-44C4-BDAC-D251A6C08E2B,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,1.066666667,NA,50,TUMOR FREE,A,93
ucec_tcga,TCGA-AX-A06D,TCGA-AX-A06D-01,82,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,1066,0,NA,8.31,1:Recurred/Progressed,NA,NA,NA,NA,5/13/11,0.1137,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,3,0,NA,0,7,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,12.25,1:DECEASED,NA,905291b0-f077-48f7-9c14-5cfa9d8a3e6e,f97bb30a-759e-44b9-889a-b5bde9855b29,NA,NA,NA,TCGA-AX-A06D.B523C3E8-6FE7-4D6A-B6CE-7DEA1C32D33F.pdf,B523C3E8-6FE7-4D6A-B6CE-7DEA1C32D33F,positive,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,NA,NA,50,WITH TUMOR,A,91
ucec_tcga,TCGA-AX-A06F,TCGA-AX-A06F-01,59,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVA,1267,0,NA,57.42,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/25/11,0.0013,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,1,0,NA,0,16,2,NA,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,57.42,0:LIVING,NA,f17e446a-c145-45be-8335-a856acb0b9b8,38df14c0-30d9-404f-a10c-f8ed4c947cea,NA,NA,NA,TCGA-AX-A06F.4904C404-B17E-4471-AA2F-6DC705E4FBF2.pdf,4904C404-B17E-4471-AA2F-6DC705E4FBF2,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,84
ucec_tcga,TCGA-AX-A06H,TCGA-AX-A06H-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,654,0,NA,27.37,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/17/11,0.0004,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,4,0,NA,0,20,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,284,NA,FALSE,UEC,27.37,0:LIVING,NA,e5d74e47-b63f-410a-8b7a-c9aacc9aa337,b26a6c7e-5eef-4129-b635-cc40e60df0dd,NA,NA,NA,TCGA-AX-A06H.493C5DDA-E629-4324-8574-AEC67223DA9E.pdf,493C5DDA-E629-4324-8574-AEC67223DA9E,negative,NA,NA,NA,NA,NO,AMERICAN INDIAN OR ALASKA NATIVE,NA,R1,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,9.433333333,NA,50,WITH TUMOR,A,98
ucec_tcga,TCGA-AX-A06J,TCGA-AX-A06J-01,71,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,662,0,NA,29.99,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/26/11,0.0464,G3,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,10,0,NA,0,15,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,29.99,0:LIVING,NA,b6819b52-6f01-4011-9bd3-a1a00397e0c9,fa750459-78d8-4dd7-890b-45729bad112a,NA,NA,NA,TCGA-AX-A06J.553324CE-44B8-416F-B965-074CE5FF9834.pdf,553324CE-44B8-416F-B965-074CE5FF9834,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,NA,NA,50,TUMOR FREE,A,119
ucec_tcga,TCGA-AX-A06L,TCGA-AX-A06L-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1499,0,NA,60.61,0:DiseaseFree,NA,NA,NA,NA,5/17/11,0.0002,G1,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,4,0,NA,0,21,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,31,NA,FALSE,UEC,60.61,0:LIVING,NA,f4a7f2ff-be76-48d3-9f59-9223db33680e,cacec107-78de-47c7-9386-dbefcfc1f07a,NA,NA,NA,TCGA-AX-A06L.926937F8-6057-4D39-BB3B-0115B0ACFE1A.pdf,926937F8-6057-4D39-BB3B-0115B0ACFE1A,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,1.0,NA,50,WITH TUMOR,A,112
ucec_tcga,TCGA-AX-A0IS,TCGA-AX-A0IS-01,52,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,805,0,NA,14.72,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/17/11,0.1065,G2,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,4,0,NA,0,10,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Endocervical Biopsy,NA,50,NA,FALSE,UEC,61.04,1:DECEASED,NA,2e5cf721-90b1-4470-b430-f055a1297c7f,f46f87a5-2edd-469d-9d28-a37284bd077a,NA,NA,NA,TCGA-AX-A0IS.35606B48-9820-4F59-8090-1F8D448DB9FB.pdf,35606B48-9820-4F59-8090-1F8D448DB9FB,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,1.7,NA,50,WITH TUMOR,A,132
ucec_tcga,TCGA-AX-A0IU,TCGA-AX-A0IU-01,79,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,636,0,NA,35.71,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/23/11,0.2139,G3,158,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,6,1,NA,1,7,1,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,40,NA,FALSE,USC,35.71,0:LIVING,NA,7e64ea6c-a3db-48eb-91be-131361510a92,dc4b3695-ce62-48d5-9f1d-7dd70d049c97,NA,NA,NA,TCGA-AX-A0IU.454539FB-7B1B-43DF-87D1-E7E47C1776E7.pdf,454539FB-7B1B-43DF-87D1-E7E47C1776E7,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,1.3,NA,50,TUMOR FREE,A,76
ucec_tcga,TCGA-AX-A0IW,TCGA-AX-A0IW-01,67,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,854,0,NA,37.75,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/23/11,0.6545,G3,163,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,9,0,NA,0,24,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,41,NA,FALSE,USC,37.75,0:LIVING,NA,db21fccf-40cb-4235-a34d-336a03b8c8f4,874a1c5c-229b-4bce-b612-55eff238d533,NA,NA,NA,TCGA-AX-A0IW.DE971C2D-31E8-42AC-A943-29E76FCD8F68.pdf,DE971C2D-31E8-42AC-A943-29E76FCD8F68,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,1.366666667,NA,50,TUMOR FREE,A,61
ucec_tcga,TCGA-AX-A0IZ,TCGA-AX-A0IZ-01,53,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1114,0,NA,43.79,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/18/11,0.0004,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,3,0,NA,0,21,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,43.79,0:LIVING,NA,11285dc5-8742-477a-8692-af1b6e2c1434,4c64f7c4-f1ee-4590-8bdc-b6a81e92b328,NA,NA,NA,TCGA-AX-A0IZ.1DEA7C0C-3280-4E11-B0A4-13562DDF307B.pdf,1DEA7C0C-3280-4E11-B0A4-13562DDF307B,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,60
ucec_tcga,TCGA-AX-A0J0,TCGA-AX-A0J0-01,47,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1581,0,NA,40.08,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/23/11,0.0006,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,3,0,NA,0,26,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,6985,NA,FALSE,UEC,40.08,0:LIVING,NA,1c7b41fc-daa7-4a6e-b553-aff73e8ebac6,e5dea504-d715-4682-ab51-fc6f52fc39a3,NA,NA,NA,TCGA-AX-A0J0.EC377A34-B219-4A4F-95DB-DF6E0050A63A.pdf,EC377A34-B219-4A4F-95DB-DF6E0050A63A,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,232.6333333,NA,50,TUMOR FREE,A,53
ucec_tcga,TCGA-AX-A0J1,TCGA-AX-A0J1-01,80,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1721,0,NA,77.33,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/23/11,0.0341,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,7,0,NA,0,15,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,3878,NA,FALSE,UEC,77.33,0:LIVING,NA,ec7a9d74-8b3f-4747-8926-1739a016ab2b,ac14e378-2de1-458a-b8cd-7c60131aa927,NA,NA,NA,TCGA-AX-A0J1.38FCBC4A-2CAB-46EF-805D-121BEF85912E.pdf,38FCBC4A-2CAB-46EF-805D-121BEF85912E,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,129.0666667,NA,50,TUMOR FREE,A,57
ucec_tcga,TCGA-AX-A1C4,TCGA-AX-A1C4-01,52,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,575,0,NA,13.27,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/12/11,0.0853,G2,178,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,8,0,NA,0,13,0,NA,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,13.27,0:LIVING,NA,40ce24c6-b331-4be2-baf9-2fa7dc855f9b,48977d80-9f8f-488d-9292-661d7487e089,NA,NA,NA,TCGA-AX-A1C4.81C6DDE6-ACC3-4659-91EC-D986671B592A.pdf,81C6DDE6-ACC3-4659-91EC-D986671B592A,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,115
ucec_tcga,TCGA-AX-A1C5,TCGA-AX-A1C5-01,47,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,517,0,NA,32.88,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/12/11,0.0040,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,1,1,NA,1,2,1,NA,1,Indeterminate (neither Pre or Postmenopausal),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,32.88,0:LIVING,NA,caebdce0-f954-471a-ac63-5daaa2e76d97,cb8bc1f7-c7a2-4378-9f91-a4d76a70435b,NA,NA,NA,TCGA-AX-A1C5.6F79B83A-90B4-45DF-8542-A6BC2F93470D.pdf,6F79B83A-90B4-45DF-8542-A6BC2F93470D,negative,NA,NA,NA,NA,NO,WHITE,NA,R2,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,WITH TUMOR,A,107
ucec_tcga,TCGA-AX-A1C7,TCGA-AX-A1C7-01,77,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,423,0,NA,12.81,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/11/11,0.3689,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,9,0,NA,0,24,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,39,NA,FALSE,USC,34.63,0:LIVING,NA,755d7ab7-4563-408a-9135-f852048af975,a4b56935-7bb9-4c84-9176-e8d694f37faa,NA,NA,NA,TCGA-AX-A1C7.10458026-49D7-40EC-BC7B-0D6A381FB025.pdf,10458026-49D7-40EC-BC7B-0D6A381FB025,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,1.333333333,NA,50,NA,A,60
ucec_tcga,TCGA-AX-A1C8,TCGA-AX-A1C8-01,77,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,475,0,NA,25.49,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/11/11,0.2344,G3,156,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,3,0,NA,0,12,1,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,53,NA,FALSE,USC,25.49,0:LIVING,NA,bad34c92-1e64-4187-a0b4-061105fd13ba,83e4dfb0-f240-476b-bc25-f9f52c960af5,NA,NA,NA,TCGA-AX-A1C8.5F0E78BA-B827-4DB6-99EB-5FA3D3598793.pdf,5F0E78BA-B827-4DB6-99EB-5FA3D3598793,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,1.766666667,NA,50,NA,A,66
ucec_tcga,TCGA-AX-A1C9,TCGA-AX-A1C9-01,73,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,521,0,NA,26.35,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/10/11,0.0989,G2,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,3,0,NA,0,17,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,26.35,0:LIVING,NA,2714af93-e200-4b4a-9df8-7d837b37489f,227cdca5-931d-4cda-a885-8e3aeb874d99,NA,NA,NA,TCGA-AX-A1C9.54E63A5C-C0E4-408B-9911-CE822CECD362.pdf,54E63A5C-C0E4-408B-9911-CE822CECD362,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,NA,NA,50,TUMOR FREE,A,73
ucec_tcga,TCGA-AX-A1CA,TCGA-AX-A1CA-01,70,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,591,0,NA,32,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/11/11,0.5031,G3,157,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,4,0,NA,0,10,0,NA,0,NA,Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,32,0:LIVING,NA,3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee,b627e715-006f-45ac-a168-85d37e9dc6e1,NA,NA,NA,TCGA-AX-A1CA.5906346F-CB34-421F-BBC3-3B6D2239AA7F.pdf,5906346F-CB34-421F-BBC3-3B6D2239AA7F,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R1,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,77
ucec_tcga,TCGA-AX-A1CC,TCGA-AX-A1CC-01,65,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IC,356,0,NA,25.89,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/11/11,0.0123,G3,156,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,9,0,NA,0,11,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,25.89,0:LIVING,NA,bc02493a-0296-4329-939a-bf91a4d0c16a,86f051d5-f4a3-47e2-b377-88a516c29bc3,NA,NA,NA,TCGA-AX-A1CC.C621C7A6-FF3F-453E-94A2-9789F66750E3.pdf,C621C7A6-FF3F-453E-94A2-9789F66750E3,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,99
ucec_tcga,TCGA-AX-A1CE,TCGA-AX-A1CE-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,504,0,NA,34.07,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/11/11,0.0013,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,5,0,NA,0,12,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","Total hysterectomy, bilateral salpingo-oophorectomy with pelvic and para-aortic lymph node dissection",NA,NA,NA,FALSE,UEC,34.07,0:LIVING,NA,4db38349-28d2-4af5-a12f-3d861937b0e0,cb0ceff2-34e2-420e-8924-51bb5872c6c5,NA,NA,NA,TCGA-AX-A1CE.79482353-F9A0-4A36-97B3-F270241B2B50.pdf,79482353-F9A0-4A36-97B3-F270241B2B50,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,NA,NA,50,NA,A,58
ucec_tcga,TCGA-AX-A1CF,TCGA-AX-A1CF-01,69,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,2284,0,NA,28.75,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/10/11,0.5489,G3,150,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,7,0,NA,0,0,NA,NA,0,NA,Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,76.77,0:LIVING,NA,20dcf91a-0529-4e96-99a2-362a41fbe4a4,4c219685-44e4-489b-a72f-cfcba405588c,NA,NA,NA,TCGA-AX-A1CF.CB16E769-AFE1-4555-A65D-691266C4898E.pdf,CB16E769-AFE1-4555-A65D-691266C4898E,positive,NA,NA,NA,NA,NO,WHITE,NA,R2,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,WITH TUMOR,A,79
ucec_tcga,TCGA-AX-A1CI,TCGA-AX-A1CI-01,61,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2222,0,NA,85.41,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/10/11,0.0488,G1,164,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,3,0,NA,0,13,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,85.41,0:LIVING,NA,fba80122-d8b2-4d8d-a032-9767e8160f9f,ddd2f9e0-0aa3-425b-9d74-74fcc638cb08,NA,NA,NA,TCGA-AX-A1CI.7F264403-0A76-4FAD-9A57-7C555F69375C.pdf,7F264403-0A76-4FAD-9A57-7C555F69375C,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,74
ucec_tcga,TCGA-AX-A1CJ,TCGA-AX-A1CJ-01,59,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,1758,0,NA,73.36,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/10/11,0.0811,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,NA,NA,0,0,NA,NA,0,Indeterminate (neither Pre or Postmenopausal),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,73.36,0:LIVING,NA,abaf757b-f79f-40bd-96e3-e2c0f63061f0,72d06ddf-9fb2-4577-bfdb-b0e463105b4a,NA,NA,NA,TCGA-AX-A1CJ.AC9C3BB1-9B41-4B1F-BCEA-F6A0C68921B3.pdf,AC9C3BB1-9B41-4B1F-BCEA-F6A0C68921B3,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,115
ucec_tcga,TCGA-AX-A1CK,TCGA-AX-A1CK-01,58,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2115,0,NA,80.19,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/10/11,0.1396,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,3,0,NA,0,14,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,80.19,0:LIVING,NA,45effb44-0b5f-4081-a202-d85969c72f2b,7028ec96-26a1-4ec7-a044-9b263e50ca8d,NA,NA,NA,TCGA-AX-A1CK.5810919B-7778-4566-A024-2D70BDE9A4F5.pdf,5810919B-7778-4566-A024-2D70BDE9A4F5,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,NA,A,72
ucec_tcga,TCGA-AX-A1CN,TCGA-AX-A1CN-01,54,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,701,0,NA,36.3,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/10/11,0.0690,G3,175,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,5,0,NA,0,13,0,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,37.55,0:LIVING,NA,d70b3c6e-04da-4abc-a832-a461e4cfcc94,785a9c46-0629-4e15-90c0-9437644ff9bf,NA,NA,NA,TCGA-AX-A1CN.D0FB2179-60D4-4B3C-9D88-B07D802F772E.pdf,D0FB2179-60D4-4B3C-9D88-B07D802F772E,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,146
ucec_tcga,TCGA-AX-A1CP,TCGA-AX-A1CP-01,84,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,1080,0,NA,23.72,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/12/11,0.1854,G3,156,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,5,0,NA,0,11,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,NA,NA,23,NA,FALSE,USC,36.37,0:LIVING,NA,e297551c-a662-4677-b00d-0d9be232adca,28542436-6afd-4198-9efe-2b69768277b0,NA,NA,NA,TCGA-AX-A1CP.E2F94D2B-C53B-4112-AFBB-06A6751CAE4B.pdf,E2F94D2B-C53B-4112-AFBB-06A6751CAE4B,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,AX,0.766666666667,NA,0,NA,A,55
ucec_tcga,TCGA-AX-A1CR,TCGA-AX-A1CR-01,70,NA,1988,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IIB,274,0,NA,23.03,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/12/11,0.3765,G3,165,Mixed serous and endometrioid,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,12,NA,NA,0,17,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UCEC,23.03,0:LIVING,NA,3abaa1b6-7513-40e0-b79c-b968e788e932,8d14edd5-b754-48af-b636-4e655fce9cbe,NA,NA,NA,TCGA-AX-A1CR.7623CA86-87C5-43E8-A0A7-25BD9526D1AA.pdf,7623CA86-87C5-43E8-A0A7-25BD9526D1AA,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,50,TUMOR FREE,A,97
ucec_tcga,TCGA-AX-A2H2,TCGA-AX-A2H2-01,86,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIA,1079,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.6405,G3,162,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,0,NA,NA,0,5,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,4.76,1:DECEASED,NA,E4510C66-A60B-4B09-A4E8-74EC5B26A3A5,6D3FB251-74E8-40D5-8262-F265A5A3395A,NA,NA,NA,TCGA-AX-A2H2.1BDF6880-A5E1-4DD8-A7E5-1E91BBCF8F60.pdf,1BDF6880-A5E1-4DD8-A7E5-1E91BBCF8F60,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,65
ucec_tcga,TCGA-AX-A2H4,TCGA-AX-A2H4-01,66,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,1981,0,NA,17.08,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.5642,G3,157,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2006,NO,NA,0,NA,NA,0,0,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,30.09,1:DECEASED,NA,AFA79B18-2AC6-4179-9C8C-5FA4D1D09A7E,47B7FD2A-3437-4991-8C7C-7FF6BA88EF86,NA,NA,NA,TCGA-AX-A2H4.5230A27B-4AA6-4ED9-90BB-98C6671E0B2E.pdf,5230A27B-4AA6-4ED9-90BB-98C6671E0B2E,negative,NA,NA,NA,NA,NO,WHITE,NA,R2,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,WITH TUMOR,A,84
ucec_tcga,TCGA-AX-A2H5,TCGA-AX-A2H5-01,67,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,2206,0,NA,71.19,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.2890,G3,161,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2005,NO,NA,5,NA,NA,3,13,NA,NA,9,NA,Office Endometrial Biopsy,NA,NA,43,NA,FALSE,USC,71.19,0:LIVING,NA,C88E3901-F3EE-436A-BA80-143C8EAB7D69,44EB96B4-5E4F-460B-BC51-ADD38CBC76A1,NA,NA,NA,TCGA-AX-A2H5.BF4BE7F8-7D37-4CB2-B340-FAE14155F257.pdf,BF4BE7F8-7D37-4CB2-B340-FAE14155F257,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R1,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,1.433333333,NA,NA,NA,A,87
ucec_tcga,TCGA-AX-A2H7,TCGA-AX-A2H7-01,87,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,951,0,NA,22.47,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.2716,G3,151,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,3,NA,NA,0,12,NA,NA,0,NA,Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,40.77,1:DECEASED,NA,A1780432-860E-4BFF-9B66-A1E25C0076FE,7077CE1B-D224-4313-9D71-1A3EEE54FFAF,NA,NA,NA,TCGA-AX-A2H7.76630DF8-2D08-4CF8-8B07-ACCE872B3ED1.pdf,76630DF8-2D08-4CF8-8B07-ACCE872B3ED1,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,60
ucec_tcga,TCGA-AX-A2H8,TCGA-AX-A2H8-01,64,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1974,0,NA,61.14,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/31/11,0.2494,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,17,NA,NA,0,22,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,61.14,0:LIVING,NA,DA0474B3-48AB-4398-AE4B-F15E27E99B2D,5B39CF2F-3ADA-4C86-AAB1-05734E817664,NA,NA,NA,TCGA-AX-A2H8.1D1AF737-8A5A-4274-B9AD-2F4BA3127DDD.pdf,1D1AF737-8A5A-4274-B9AD-2F4BA3127DDD,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,TUMOR FREE,A,113
ucec_tcga,TCGA-AX-A2HA,TCGA-AX-A2HA-01,35,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2188,0,NA,81.31,0:DiseaseFree,NA,NA,NA,NA,10/31/11,0.0934,G3,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,3,NA,NA,0,24,NA,NA,0,NA,Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,81.31,0:LIVING,NA,9D84DFF8-6C19-4881-93C6-56C98A3049B5,76742CF8-A932-47BD-ACF9-C507184E02C3,NA,NA,NA,TCGA-AX-A2HA.E44408C9-53DE-4FF7-8D8E-6BFAB24302C3.pdf,E44408C9-53DE-4FF7-8D8E-6BFAB24302C3,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,TUMOR FREE,A,60
ucec_tcga,TCGA-AX-A2HC,TCGA-AX-A2HC-01,53,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,1786,0,NA,24.84,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,11/1/11,0.0764,G3,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,1,NA,NA,1,20,NA,NA,3,NA,Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,34.3,0:LIVING,NA,53E8E07E-18F9-4C9B-9783-A5B67CEDDCF7,1BACDCAB-F02F-4C6E-89E5-4A221C2E3BC0,NA,NA,NA,TCGA-AX-A2HC.90DC9BBA-4666-4702-8BA1-F57253E43CDD.pdf,90DC9BBA-4666-4702-8BA1-F57253E43CDD,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,WITH TUMOR,A,118
ucec_tcga,TCGA-AX-A2HD,TCGA-AX-A2HD-01,69,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,1175,0,NA,46.45,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/26/11,0.0300,G3,149,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,5,NA,NA,0,21,NA,NA,0,NA,Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,46.45,0:LIVING,NA,A8DEF1A0-A136-47F4-9AD9-60EBCF9B726B,5A2EDE97-0CF7-44D7-A789-92EE9BDA3D6C,NA,NA,NA,TCGA-AX-A2HD.83BDA3FE-254F-4F99-B41E-FC1F8C128906.pdf,83BDA3FE-254F-4F99-B41E-FC1F8C128906,positive,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,WITH TUMOR,A,51
ucec_tcga,TCGA-AX-A2HF,TCGA-AX-A2HF-01,67,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,440,0,NA,27.86,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/31/11,0.9162,G3,157,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,9,NA,NA,0,27,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,29,NA,FALSE,USC,27.86,0:LIVING,NA,7A077812-F6EE-4820-A084-1A52C7EF062C,137E9776-CA5C-47F3-9EF7-8726D021FBB2,NA,NA,NA,TCGA-AX-A2HF.5454BF58-3D26-4D61-B0A8-30A06ECD0E60.pdf,5454BF58-3D26-4D61-B0A8-30A06ECD0E60,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,0.966666666667,NA,NA,TUMOR FREE,A,70
ucec_tcga,TCGA-AX-A2HG,TCGA-AX-A2HG-01,56,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,582,0,NA,38.21,0:DiseaseFree,NA,NA,HISPANIC OR LATINO,NA,10/31/11,0.0004,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,2,NA,NA,0,27,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,38.21,0:LIVING,NA,7A2CF5CE-8317-4FFF-946E-B9937AFAB815,5E3D8501-5E81-443F-8B64-E02A0E0B3D1F,NA,NA,NA,TCGA-AX-A2HG.EF863B73-4C80-42E6-8AAF-2EF72559212A.pdf,EF863B73-4C80-42E6-8AAF-2EF72559212A,NA,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,67,TUMOR FREE,A,115
ucec_tcga,TCGA-AX-A2HH,TCGA-AX-A2HH-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,462,0,NA,17.74,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/31/11,0.2247,G3,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,4,NA,NA,0,18,NA,NA,0,NA,Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,17.74,0:LIVING,NA,52FEF8A9-6860-48BD-B992-A56CCAD1243C,0E73EEAC-251A-43FA-9141-636262EE3129,NA,NA,NA,TCGA-AX-A2HH.2EE7245F-7069-456A-A215-41E59D9FE606.pdf,2EE7245F-7069-456A-A215-41E59D9FE606,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,WITH TUMOR,A,65
ucec_tcga,TCGA-AX-A2HJ,TCGA-AX-A2HJ-01,35,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,779,0,NA,30.72,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/31/11,0.0524,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,11,NA,NA,0,7,NA,NA,0,NA,Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,30.72,0:LIVING,NA,32398808-C46A-41BF-A0A8-E08723B40EA2,CCED4976-8C11-4910-B5D4-6279BE4851BE,NA,NA,NA,TCGA-AX-A2HJ.84FF1AB9-47F4-4884-9345-43878BDEF379.pdf,84FF1AB9-47F4-4884-9345-43878BDEF379,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,80,TUMOR FREE,A,56
ucec_tcga,TCGA-AX-A2HK,TCGA-AX-A2HK-01,77,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,2045,0,NA,NA,NA,NA,NA,NA,NA,10/31/11,0.5945,G3,154,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,6,NA,NA,2,25,NA,NA,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,2.96,1:DECEASED,NA,6FA99AE9-1D72-455E-938E-0EC0D240F5A3,EBE937B7-B2BF-45B9-8517-009E6F67B6DE,NA,NA,NA,TCGA-AX-A2HK.DBC5CE66-3BC0-4A86-A53C-06DEF90A752B.pdf,DBC5CE66-3BC0-4A86-A53C-06DEF90A752B,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,84,NA,A,73
ucec_tcga,TCGA-AX-A2IN,TCGA-AX-A2IN-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,1321,0,NA,11.76,1:Recurred/Progressed,NA,NA,NA,NA,10/27/11,0.0341,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,4,NA,NA,0,21,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,31.11,1:DECEASED,NA,FE79EBE1-CD0A-4CE2-A86D-637C28354ED9,C28C7656-4790-485F-BD27-C8A6A35D2DD1,NA,NA,NA,TCGA-AX-A2IN.3C67A037-8A4C-4345-B842-43F1F0A6A53E.pdf,3C67A037-8A4C-4345-B842-43F1F0A6A53E,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,60,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,85,WITH TUMOR,A,100
ucec_tcga,TCGA-AX-A2IO,TCGA-AX-A2IO-01,83,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIA,1262,0,NA,64.88,0:DiseaseFree,NA,NA,NA,NA,11/1/11,0.3254,G3,162,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,3,NA,NA,0,7,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,64.88,0:LIVING,NA,8A235D4D-5EE1-4D6B-839E-E71CADCD8C39,4873BDCA-1153-4187-95B8-30EE31880DDF,NA,NA,NA,TCGA-AX-A2IO.5482CC06-7854-459E-8A23-81ABC45DD076.pdf,5482CC06-7854-459E-8A23-81ABC45DD076,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,40,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,TUMOR FREE,A,64
ucec_tcga,TCGA-AX-A3FS,TCGA-AX-A3FS-01,82,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,609,0,NA,0.23,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.0371,G3,139,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,16,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","Laparoscopy, robotic-assisted lysis of adhesions, robotic-assisted lysis total hysterectomy, bso, bilateral pelvic lymphadenectomy and cystoscopy",NA,NA,NA,FALSE,UEC,0.23,0:LIVING,NA,8C6B9B54-58EB-4D5F-B8A9-8007163DB457,272D64F9-0B4B-4136-ADFF-66C5401FC1D2,NA,NA,NA,TCGA-AX-A3FS.1AEA9AC0-3B22-4819-9542-1F6A6AD474BC.pdf,1AEA9AC0-3B22-4819-9542-1F6A6AD474BC,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,98
ucec_tcga,TCGA-AX-A3FT,TCGA-AX-A3FT-01,64,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,524,0,NA,0.2,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/6/12,0.0499,G3,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,4,NA,NA,0,21,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","Exploratory Laparotomy, TAH, BSO, Pelvic and pariaortic LND.",NA,NA,NA,FALSE,UEC,0.2,0:LIVING,NA,8B4CF993-1E16-4009-A37F-A629528B7D7E,6176A2E7-9C0B-4A9C-B8D6-CF669419959D,NA,NA,NA,TCGA-AX-A3FT.EF16D53F-14A2-4127-B5F7-F318EC60C5C0.pdf,EF16D53F-14A2-4127-B5F7-F318EC60C5C0,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,82
ucec_tcga,TCGA-AX-A3FV,TCGA-AX-A3FV-01,62,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,799,0,NA,-0.2,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.7134,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,NA,Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,-0.2,0:LIVING,NA,A033FBEA-7CD0-4E65-94C4-B54F2F80B895,1661922C-CD0A-4B1E-A9BF-4AEFE10654A6,NA,NA,NA,TCGA-AX-A3FV.0D1601D0-E0F4-4DBA-91EA-62092FE8621F.pdf,0D1601D0-E0F4-4DBA-91EA-62092FE8621F,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,113
ucec_tcga,TCGA-AX-A3FW,TCGA-AX-A3FW-01,66,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,723,0,NA,0.56,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.1587,G3,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,12,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Robotic hysterectomy with Lymph Node Dissection,NA,NA,NA,FALSE,UEC,0.56,0:LIVING,NA,3052065A-B8B1-48D3-971D-9D605292249C,D3DEB563-5420-4890-B763-01CA855B4B61,NA,NA,NA,TCGA-AX-A3FW.AAB4F0FC-D6D5-4D5F-B36C-E4D4869E1A15.pdf,AAB4F0FC-D6D5-4D5F-B36C-E4D4869E1A15,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,27,NA,A,84
ucec_tcga,TCGA-AX-A3FX,TCGA-AX-A3FX-01,69,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,736,0,NA,40.47,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.2339,G3,149,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,2,NA,NA,0,24,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",TAH/BSO/LND/Panniculectomy,NA,NA,NA,FALSE,UEC,43.79,1:DECEASED,NA,6F45A2E9-1CA5-438C-B06F-1CD8EB845465,375BEC4C-5E9B-4BC0-9F28-5854A159D655,NA,NA,NA,TCGA-AX-A3FX.B3326BA1-71E3-4207-9727-B157A3E195E7.pdf,B3326BA1-71E3-4207-9727-B157A3E195E7,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,85
ucec_tcga,TCGA-AX-A3FZ,TCGA-AX-A3FZ-01,33,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIB,658,0,NA,0.2,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.3266,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,9,NA,NA,0,NA,"Other method, specify:","Exploratory laparotomy, total abdominal hysterectomy, bso, major debulking, omentectomy, appendectomy, bilateral pelvic lymphadenectomy, segmental small bowel resection, cystoscopy",NA,NA,NA,FALSE,UEC,0.2,0:LIVING,NA,5262D82D-FC43-41F4-9B23-C9AC6F237FF0,3E114D9B-A96E-4B58-84A0-AD0ECF10B199,NA,NA,NA,TCGA-AX-A3FZ.4989F66F-57F8-4B1C-97DD-69F3036EB0BA.pdf,4989F66F-57F8-4B1C-97DD-69F3036EB0BA,positive,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,113
ucec_tcga,TCGA-AX-A3G1,TCGA-AX-A3G1-01,84,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,765,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,2/3/12,0.3476,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,6,NA,NA,0,21,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Total abdominal hysterectomy with bso,NA,NA,NA,FALSE,UEC,20.5,1:DECEASED,NA,9CC1B44A-AC26-408D-B12B-084E982CCADF,582513C5-474C-484E-AD98-811F0D4E07C6,NA,NA,NA,TCGA-AX-A3G1.AEAB9EBE-7BDA-45E4-B2D8-82680BE9B4D4.pdf,AEAB9EBE-7BDA-45E4-B2D8-82680BE9B4D4,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,40,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,61
ucec_tcga,TCGA-AX-A3G3,TCGA-AX-A3G3-01,58,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,713,0,NA,1.38,0:DiseaseFree,NA,NA,NA,NA,2/2/12,0.5551,G3,167,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,3,NA,NA,0,14,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","total laparascopic hysterectomy, bso, bilateral pelvic and obturator lymphadenectomy, omentectomy and staging biopsies",NA,NA,NA,FALSE,USC,1.38,0:LIVING,NA,16745DFB-8B28-4F5D-9EF1-2AA31CCB7293,5EFDACE8-5790-4239-8E8A-6349F88B10DD,NA,NA,NA,TCGA-AX-A3G3.3D86258F-2C9B-4DF2-86C5-E12B3FCB480D.pdf,3D86258F-2C9B-4DF2-86C5-E12B3FCB480D,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,55
ucec_tcga,TCGA-AX-A3G4,TCGA-AX-A3G4-01,60,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,463,0,NA,0.3,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/6/12,0.4534,G3,167,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,4,NA,NA,2,2,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","TAH, BSO, bilateral pelvic and periaortic lymphadenectomy and omentecomy.",NA,NA,NA,FALSE,USC,0.3,0:LIVING,NA,83F2CD11-0DD7-47A6-B4B3-8212FAAC94BB,BB0D2369-9133-4189-A386-25FEAA78C6E9,NA,NA,NA,TCGA-AX-A3G4.7E8857D6-4347-4BC5-8655-40AAD7197789.pdf,7E8857D6-4347-4BC5-8655-40AAD7197789,NA,NA,NA,NA,NA,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,NA,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,107
ucec_tcga,TCGA-AX-A3G6,TCGA-AX-A3G6-01,67,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,456,0,NA,0.26,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/6/12,0.5603,G2,167,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,5,NA,NA,0,11,NA,NA,0,NA,"Other method, specify:","TAH, BSO, bilateral pelvic lymphadenectomy, periaortic node dissection",NA,NA,NA,FALSE,USC,0.26,0:LIVING,NA,E31DB89C-15AC-45A4-9788-AFB339B0F3BC,576AB148-2110-4F35-948A-4A0D00B4F48E,NA,NA,NA,TCGA-AX-A3G6.53586ED5-5C68-4517-8543-7508AF37F68C.pdf,53586ED5-5C68-4517-8543-7508AF37F68C,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,60
ucec_tcga,TCGA-AX-A3G7,TCGA-AX-A3G7-01,71,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,520,0,NA,0.3,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/7/12,0.1583,G3,154,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,NA,"Other method, specify:","Exploratory laparotomy, TAH, BSO, radical optimal tumor debulking with gastrocolic omentectomy",NA,NA,NA,FALSE,USC,0.3,0:LIVING,NA,71ED7D6D-8C44-4D37-A04A-7A78DF21E514,B44FAB01-7AE7-4628-AEA8-0BE35EA93180,NA,NA,NA,TCGA-AX-A3G7.81608C78-6495-4FC7-9210-1132E9335D01.pdf,81608C78-6495-4FC7-9210-1132E9335D01,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,74
ucec_tcga,TCGA-AX-A3G8,TCGA-AX-A3G8-01,76,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,350,0,NA,1.18,0:DiseaseFree,NA,NA,NA,NA,2/7/12,0.0345,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,2,NA,NA,0,30,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,1.18,0:LIVING,NA,6D3FDB58-FDC0-4937-AD38-3A455225EA51,DFE35835-D03E-4CE3-A76A-FDB15E601257,NA,NA,NA,TCGA-AX-A3G8.FD22A233-9333-4DA2-A913-4DBA90600247.pdf,FD22A233-9333-4DA2-A913-4DBA90600247,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,62
ucec_tcga,TCGA-AX-A3G9,TCGA-AX-A3G9-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,560,0,NA,18.33,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/7/12,0.0001,G3,154,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,1,NA,NA,0,4,NA,NA,1,NA,"Other method, specify:","Robotic laparoscopic hysterectomy, BSO, pelvic and periaortic LND",NA,NA,NA,FALSE,UEC,18.33,0:LIVING,NA,F7527B5E-5330-49EA-82CE-F6F2CDCCBADC,739CF2F3-E9EB-4F4A-8310-2D7413E323E4,NA,NA,NA,TCGA-AX-A3G9.FADFF649-7518-4EFB-B96C-9390DD308DBD.pdf,FADFF649-7518-4EFB-B96C-9390DD308DBD,negative,NA,NA,NA,NA,NO,WHITE,NA,R1,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,60
ucec_tcga,TCGA-AX-A3GB,TCGA-AX-A3GB-01,73,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,469,0,NA,14.45,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/7/12,0.0345,G3,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,6,NA,NA,0,19,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","TAH, BSO, pelvic and paraaortic LND, intracolic omentectomy",NA,NA,NA,FALSE,UEC,14.45,0:LIVING,NA,AA3AD7C0-37CF-4337-945E-CEFEEE801BBB,B473B052-E1F3-40D2-BF32-7873263973C9,NA,NA,NA,TCGA-AX-A3GB.50C8217A-6834-46E9-9727-5B6B3D37347D.pdf,50C8217A-6834-46E9-9727-5B6B3D37347D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,87
ucec_tcga,TCGA-AX-A3GI,TCGA-AX-A3GI-01,66,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,300,0,NA,0.39,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/7/12,0.7361,G3,167,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,4,NA,NA,3,4,NA,NA,4,NA,"Other method, specify:","Exploratory Laparotomy, TAH, BSO, bilateral pelvic and periaortic LND.",NA,NA,NA,FALSE,USC,0.39,0:LIVING,NA,E4787C7B-40E7-483C-98C0-38DA03E26B56,C5CDB056-0DE5-496F-A301-87F11CE50DDE,NA,NA,NA,TCGA-AX-A3GI.A803E376-399C-4841-A6AE-E82B99CD57B7.pdf,A803E376-399C-4841-A6AE-E82B99CD57B7,NA,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,AX,NA,NA,NA,NA,A,87
ucec_tcga,TCGA-B5-A0JN,TCGA-B5-A0JN-01,84,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,2164,0,NA,80.32,0:DiseaseFree,NA,NA,NA,NA,2/23/11,0.5279,G3,154,Serous endometrial adenocarcinoma,NA,NA,NA,Yes,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2004,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,97,NA,TRUE,USC,80.32,0:LIVING,NA,b60f22ac-a659-4f33-b01d-820e86a9a5c9,684c6894-fd49-4934-8962-9628ece734fb,NA,NA,NA,TCGA-B5-A0JN.A22F4C33-7630-4595-8415-24C87949B211.pdf,A22F4C33-7630-4595-8415-24C87949B211,positive,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,440,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,3.2,NA,0,TUMOR FREE,A,58
ucec_tcga,TCGA-B5-A0JR,TCGA-B5-A0JR-01,73,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1407,0,NA,56.87,0:DiseaseFree,NA,NA,NA,NA,12/7/10,0.1187,G3,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,6,0,0,0,32,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,442,NA,TRUE,UEC,56.87,0:LIVING,NA,a766d113-bc3f-4448-a4e5-f391fb0c0e22,07381a09-5cbd-4744-86ec-41a81e470204,NA,NA,NA,TCGA-B5-A0JR.B3CF4DE2-8755-4585-92C5-F8EE350C1C50.pdf,B3CF4DE2-8755-4585-92C5-F8EE350C1C50,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,14.7,NA,71,TUMOR FREE,A,105
ucec_tcga,TCGA-B5-A0JS,TCGA-B5-A0JS-01,54,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1183,0,NA,86.3,0:DiseaseFree,NA,NA,NA,NA,12/8/10,0.0195,G1,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,0,NA,NA,NA,28,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,27,NA,TRUE,UEC,86.3,0:LIVING,NA,0da7bbd4-ed8d-474b-b494-cb93c5fa811e,d0b88b1c-150d-4abc-9f9e-8c51cb208efa,NA,NA,NA,TCGA-B5-A0JS.56BA86BF-9345-4956-952A-8EBA8C05926A.pdf,56BA86BF-9345-4956-952A-8EBA8C05926A,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,0.9,NA,11,TUMOR FREE,A,110
ucec_tcga,TCGA-B5-A0JT,TCGA-B5-A0JT-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,1128,0,NA,55.26,0:DiseaseFree,NA,NA,NA,NA,1/25/11,0.3758,G1,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,0,NA,NA,0,14,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,49,NA,TRUE,UEC,55.26,0:LIVING,NA,d5f2bae1-7cd1-49bf-ae41-12d2aa44408e,4188c8ea-fe84-4c30-a390-0bd9a6b10c7b,NA,NA,NA,TCGA-B5-A0JT.CC6EE5B1-5548-4DE7-873F-332DBF81710F.pdf,CC6EE5B1-5548-4DE7-873F-332DBF81710F,positive,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,750,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.6,NA,12,TUMOR FREE,A,119
ucec_tcga,TCGA-B5-A0JU,TCGA-B5-A0JU-01,57,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1345,0,NA,59.2,0:DiseaseFree,NA,NA,NA,NA,8/5/11,0.0000,G2,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,0,NA,NA,0,17,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,59.2,0:LIVING,NA,65ef7168-69c6-4910-a141-d7558d0027c9,a4e7601a-9828-453a-8616-17f19de6f997,NA,NA,NA,TCGA-B5-A0JU.1EB80878-50FF-4E79-AF16-E809E6EE7DEC.pdf,1EB80878-50FF-4E79-AF16-E809E6EE7DEC,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,19,TUMOR FREE,B,137
ucec_tcga,TCGA-B5-A0JV,TCGA-B5-A0JV-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1001,0,NA,22.93,1:Recurred/Progressed,NA,NA,NA,NA,12/10/10,0.0359,G2,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,2,0,0,0,16,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,210,NA,TRUE,UEC,85.94,0:LIVING,NA,233e947a-d5e2-48e5-a8ce-5da1abb20681,42199e5a-9f4f-4445-9e6e-114d47ba67fa,NA,NA,NA,TCGA-B5-A0JV.71A1DE5B-7CE5-4884-A91E-3BE753036E4F.pdf,71A1DE5B-7CE5-4884-A91E-3BE753036E4F,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,40,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,6.966666667,NA,26,TUMOR FREE,A,94
ucec_tcga,TCGA-B5-A0JX,TCGA-B5-A0JX-01,62,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,952,0,NA,58.71,0:DiseaseFree,NA,NA,NA,NA,8/5/11,0.1203,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,2,NA,NA,0,40,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,58.71,0:LIVING,NA,586d7b3f-67a8-4a22-862f-cf50de3c1598,f4c448e1-8415-42a4-b8d4-b71bf57ad00b,NA,NA,NA,TCGA-B5-A0JX.E511CFF9-9687-4134-B85D-37C037B71643.pdf,E511CFF9-9687-4134-B85D-37C037B71643,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,23,TUMOR FREE,A,113
ucec_tcga,TCGA-B5-A0JY,TCGA-B5-A0JY-01,50,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,632,0,NA,69.22,0:DiseaseFree,NA,NA,NA,NA,1/4/11,0.0003,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8020/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,17,NA,NA,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,8976,NA,TRUE,UEC,69.22,0:LIVING,NA,61935424-44d0-4211-81c1-c925e436eac5,95f418ce-fcd9-4402-bc24-1520f45cb6b7,NA,NA,NA,TCGA-B5-A0JY.9708BE95-175D-458B-8BA1-02D9C488225D.pdf,9708BE95-175D-458B-8BA1-02D9C488225D,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,1170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,299.1333333,NA,100,TUMOR FREE,A,67
ucec_tcga,TCGA-B5-A0JZ,TCGA-B5-A0JZ-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,642,0,NA,11.7,1:Recurred/Progressed,NA,NA,NA,NA,1/5/11,0.0001,G3,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,8,NA,NA,0,19,NA,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,352,NA,TRUE,UEC,71.39,0:LIVING,NA,d129ebb4-db21-4342-8d9b-318a67aefa56,5e55ac8b-23b4-4cde-825a-753ed8c9208c,NA,NA,NA,TCGA-B5-A0JZ.B275A085-067D-42ED-8E41-8461D5183A6E.pdf,B275A085-067D-42ED-8E41-8461D5183A6E,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,400,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,11.76666667,NA,61,TUMOR FREE,A,87
ucec_tcga,TCGA-B5-A0K0,TCGA-B5-A0K0-01,48,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,615,0,NA,48.55,0:DiseaseFree,NA,NA,NA,NA,1/5/11,0.0888,G1,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,15,NA,NA,0,Indeterminate (neither Pre or Postmenopausal),Dilation and curettage procedure,NA,NA,21,NA,TRUE,UEC,48.55,0:LIVING,NA,29c8f468-5ac1-4d6c-8376-e36e6d246926,11c43948-e7c9-4436-a654-82fa8033b625,NA,NA,NA,TCGA-B5-A0K0.6284E0A9-FACB-4297-ABC6-308715ABAFCD.pdf,6284E0A9-FACB-4297-ABC6-308715ABAFCD,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,440,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,0.7,NA,0,TUMOR FREE,A,140
ucec_tcga,TCGA-B5-A0K1,TCGA-B5-A0K1-01,69,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,636,0,NA,36.47,0:DiseaseFree,NA,NA,NA,NA,1/5/11,0.0000,G1,174,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,22,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,39,NA,TRUE,UEC,36.47,0:LIVING,NA,40a3ed98-3892-449c-b07e-7b7612bd997e,b514f636-dee3-45f3-bb31-197ca6a171f1,NA,NA,NA,TCGA-B5-A0K1.826BF8E6-F928-4962-9322-78FA74F9FB0E.pdf,826BF8E6-F928-4962-9322-78FA74F9FB0E,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,1.3,NA,45,TUMOR FREE,A,117
ucec_tcga,TCGA-B5-A0K2,TCGA-B5-A0K2-01,54,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,534,0,NA,72.57,0:DiseaseFree,NA,NA,NA,NA,1/5/11,0.0004,G1,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,25,NA,NA,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,195,NA,TRUE,UEC,72.57,0:LIVING,NA,a8079ea5-c37b-4f77-aca0-b043bf420675,17122498-71c0-4094-a86e-863da3116463,NA,NA,NA,TCGA-B5-A0K2.5D780459-F4E6-4BB8-939D-5FDFD9BF7073.pdf,5D780459-F4E6-4BB8-939D-5FDFD9BF7073,positive,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,6.533333333,NA,0,TUMOR FREE,A,84
ucec_tcga,TCGA-B5-A0K3,TCGA-B5-A0K3-01,62,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,523,0,NA,17.38,1:Recurred/Progressed,NA,NA,NA,NA,1/5/11,0.2142,G3,164,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,11,NA,NA,0,27,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,35,NA,TRUE,UEC,27.27,1:DECEASED,NA,79ecc142-8f6e-4260-a7ce-c8e2a6212c35,ed31ddc2-feda-496e-a642-0c4b5dce014d,NA,NA,NA,TCGA-B5-A0K3.2D78431C-7385-4BD3-B597-85E613D89BF6.pdf,2D78431C-7385-4BD3-B597-85E613D89BF6,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,390,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.166666667,NA,10,WITH TUMOR,A,88
ucec_tcga,TCGA-B5-A0K4,TCGA-B5-A0K4-01,51,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,264,0,NA,57.72,0:DiseaseFree,NA,NA,NA,NA,1/5/11,0.3111,G2,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,3,NA,NA,0,23,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,50,NA,TRUE,UEC,57.72,0:LIVING,NA,a8f38e37-978b-4435-b676-e8d4c34da909,a4ac1f6e-3411-47ae-9592-513b3d32223f,NA,NA,NA,TCGA-B5-A0K4.80DE2981-089A-47A2-B221-F7C28ECAF3F2.pdf,80DE2981-089A-47A2-B221-F7C28ECAF3F2,negative,NA,NA,NA,NA,NO,NA,NA,NA,YES,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.666666667,NA,87,TUMOR FREE,A,75
ucec_tcga,TCGA-B5-A0K6,TCGA-B5-A0K6-01,58,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,206,0,NA,64.16,0:DiseaseFree,NA,NA,NA,NA,1/19/11,0.0488,G1,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,182,NA,TRUE,UEC,64.16,0:LIVING,NA,5cba9441-6812-49c0-a0f6-7928ed4e5b81,69bf0d3a-b7ae-4ee1-b7d1-18a32fcfa67c,NA,NA,NA,TCGA-B5-A0K6.B7F34F79-DB7F-4C98-B1B3-80C3187AE91C.pdf,B7F34F79-DB7F-4C98-B1B3-80C3187AE91C,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,6.1,NA,7,TUMOR FREE,A,132
ucec_tcga,TCGA-B5-A0K7,TCGA-B5-A0K7-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,184,0,NA,10.58,1:Recurred/Progressed,NA,NA,NA,NA,1/20/11,0.1183,G1,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,6,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,39,NA,TRUE,UEC,63.5,0:LIVING,NA,2f0640bc-598c-4714-9e9b-7e0f2ca4567f,51e8577d-6849-422e-8f37-2ea8c400bbe5,NA,NA,NA,TCGA-B5-A0K7.5C3818CE-5DA9-403E-B895-61DEA4BBFA57.pdf,5C3818CE-5DA9-403E-B895-61DEA4BBFA57,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,1160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.3,NA,0,TUMOR FREE,A,61
ucec_tcga,TCGA-B5-A0K8,TCGA-B5-A0K8-01,71,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,191,0,NA,27.83,0:DiseaseFree,NA,NA,NA,NA,8/5/11,0.3133,G3,160,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,12,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,39,NA,TRUE,USC,27.83,0:LIVING,NA,24118b8f-59fe-482a-aed3-7b1bde1571b7,66184035-af3e-4c2b-901a-0709c49dc54e,NA,NA,NA,TCGA-B5-A0K8.1E7C9CA2-73AA-4443-A125-D5588F93BEF9.pdf,1E7C9CA2-73AA-4443-A125-D5588F93BEF9,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,260,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.333333333,NA,5,TUMOR FREE,A,61
ucec_tcga,TCGA-B5-A0K9,TCGA-B5-A0K9-01,88,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,182,0,NA,NA,NA,NA,NA,NA,NA,1/20/11,0.1183,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,530,NA,TRUE,UEC,13.44,1:DECEASED,NA,4485cc98-5d58-4eb4-8325-7d1a617b6461,52a96216-708f-43f2-a923-130a1c35922d,NA,NA,NA,TCGA-B5-A0K9.8278F457-C0A5-4441-9105-3FC015E3F0EF.pdf,8278F457-C0A5-4441-9105-3FC015E3F0EF,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,600,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,17.53333333,NA,87,TUMOR FREE,A,65
ucec_tcga,TCGA-B5-A0KB,TCGA-B5-A0KB-01,62,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,368,0,NA,22.63,1:Recurred/Progressed,NA,NA,NA,NA,8/5/11,0.3567,G3,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,Yes,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,0,0,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,27.07,0:LIVING,NA,e604f5d4-f2c0-4404-9073-b8dbc8396778,fb68c314-c79f-41fb-8a28-afe26c8e5580,NA,NA,NA,TCGA-B5-A0KB.2C744545-8FF8-4A07-A8F2-A47D28B2A8E2.pdf,2C744545-8FF8-4A07-A8F2-A47D28B2A8E2,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,430,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,72,TUMOR FREE,B,76
ucec_tcga,TCGA-B5-A11E,TCGA-B5-A11E-01,53,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,198,0,NA,59.79,0:DiseaseFree,NA,NA,NA,NA,3/22/11,0.0790,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,4,NA,NA,0,20,NA,NA,0,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,8249,NA,TRUE,UEC,59.79,0:LIVING,NA,38a3ea92-8965-4bda-9dbd-144832975cdd,cd68a1a9-039f-4da5-9a53-3cd60a261f7f,NA,NA,NA,TCGA-B5-A11E.2058131C-09EA-4DC7-A84A-EB055A68F1B6.pdf,2058131C-09EA-4DC7-A84A-EB055A68F1B6,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,890,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,274.4333333,NA,69,TUMOR FREE,A,52
ucec_tcga,TCGA-B5-A11F,TCGA-B5-A11F-01,55,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,5482,0,NA,52.89,1:Recurred/Progressed,NA,NA,NA,NA,1/26/11,0.0629,G2,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,1995,NO,NA,0,NA,NA,0,13,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,39,NA,TRUE,UEC,185.64,0:LIVING,NA,3ea53b15-37f0-446e-a130-6bb2dee56865,a4dabdb5-4a72-4e31-981b-2c501c8dc7ab,NA,NA,NA,TCGA-B5-A11F.228E437D-FB45-452B-A5A0-299C125F4CC4.pdf,228E437D-FB45-452B-A5A0-299C125F4CC4,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,380,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.266666667,NA,7,TUMOR FREE,A,NA
ucec_tcga,TCGA-B5-A11G,TCGA-B5-A11G-01,71,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,3248,0,NA,113.27,0:DiseaseFree,NA,NA,NA,NA,1/27/11,0.0360,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2001,NO,NA,0,NA,NA,0,10,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,388,NA,TRUE,UEC,113.27,0:LIVING,NA,d2aa7d70-a25f-4a9e-9d52-37e372461824,fe5d8e64-98b1-4ea7-adda-f28d12349a7e,NA,NA,NA,TCGA-B5-A11G.7021DC28-67C3-4BB6-9C8B-0FE7EFBCA1E1.pdf,7021DC28-67C3-4BB6-9C8B-0FE7EFBCA1E1,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,12.93333333,NA,0,TUMOR FREE,A,77
ucec_tcga,TCGA-B5-A11H,TCGA-B5-A11H-01,67,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,2324,0,NA,88.27,0:DiseaseFree,NA,NA,NA,NA,1/27/11,0.0670,G2,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,0,NA,NA,0,15,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,736,NA,TRUE,UEC,88.27,0:LIVING,NA,dee43082-4aa7-4650-981c-a779e9fe7b55,d78d2f6b-3eb3-4082-a7ea-f7b6202cdc58,NA,NA,NA,TCGA-B5-A11H.40813C61-4B78-4677-89A4-4B9488613F57.pdf,40813C61-4B78-4677-89A4-4B9488613F57,positive,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,620,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,24.23333333,NA,0,TUMOR FREE,A,101
ucec_tcga,TCGA-B5-A11I,TCGA-B5-A11I-01,65,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,1974,0,NA,63.73,1:Recurred/Progressed,NA,NA,NA,NA,1/27/11,0.2983,G3,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8140/3,C54.1,YES,2005,NO,NA,7,NA,NA,0,6,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,37,NA,TRUE,UEC,75.66,0:LIVING,NA,f6d136c7-c250-4361-9fed-50f513959a40,56652dde-33da-451e-a1c2-6e9884f9915a,NA,NA,NA,TCGA-B5-A11I.850EFCC5-484B-4E09-801A-2FAFB4CFD72B.pdf,850EFCC5-484B-4E09-801A-2FAFB4CFD72B,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,970,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,1.233333333,NA,8,WITH TUMOR,A,124
ucec_tcga,TCGA-B5-A11J,TCGA-B5-A11J-01,64,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1536,0,NA,54.4,0:DiseaseFree,NA,NA,NA,NA,2/9/11,0.0000,G2,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,NA,NA,0,17,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,320,NA,TRUE,UEC,54.4,0:LIVING,NA,027b2a29-2fad-4ca8-a7cd-eb913d0205f8,1eccac56-e4de-4ffd-a0d8-f93d7b8b63f7,NA,NA,NA,TCGA-B5-A11J.1F9E7FAB-ADA0-4EFF-8A86-F5344357ADED.pdf,1F9E7FAB-ADA0-4EFF-8A86-F5344357ADED,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,10.6,NA,9,TUMOR FREE,A,134
ucec_tcga,TCGA-B5-A11L,TCGA-B5-A11L-01,71,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,1297,0,NA,4.3,1:Recurred/Progressed,NA,NA,NA,NA,8/9/11,0.0678,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,0,NA,0,NA,9,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,73.59,1:DECEASED,NA,07b24a23-3d9f-4591-800f-8738cc232f9a,790ace35-d090-4933-bd57-5efc61889c85,NA,NA,NA,TCGA-B5-A11L.ABA26FE8-0C80-459A-9DF8-537D1A08A92E.pdf,ABA26FE8-0C80-459A-9DF8-537D1A08A92E,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,85,TUMOR FREE,B,92
ucec_tcga,TCGA-B5-A11M,TCGA-B5-A11M-01,43,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1085,0,NA,44.74,0:DiseaseFree,NA,NA,NA,NA,2/10/11,NA,G1,153,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,0,NA,NA,0,0,NA,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Dilation and curettage procedure,NA,NA,29,NA,TRUE,UEC,44.74,0:LIVING,NA,fd370e9d-2719-45e0-b8f1-048ed1ee602f,82f33c0d-f9dc-4463-8ab5-ae7283e85431,NA,NA,NA,TCGA-B5-A11M.3C00B510-8D9C-4DD4-9E7C-FC058230BE97.pdf,3C00B510-8D9C-4DD4-9E7C-FC058230BE97,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,40,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,1.0,NA,4,TUMOR FREE,A,139
ucec_tcga,TCGA-B5-A11N,TCGA-B5-A11N-01,69,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1140,0,NA,61.63,0:DiseaseFree,NA,NA,NA,NA,2/10/11,0.0279,G1,174,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,0,NA,NA,NA,46,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,1570,NA,TRUE,UEC,61.63,0:LIVING,NA,ca594f56-9c68-4b7e-84b2-669f1004e3a4,d3222a2c-6715-4eea-88b0-4006f61c736b,NA,NA,NA,TCGA-B5-A11N.A4C1DE15-A45A-4D31-B363-C6652370C09C.pdf,A4C1DE15-A45A-4D31-B363-C6652370C09C,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,370,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,52.36666667,NA,5,TUMOR FREE,A,90
ucec_tcga,TCGA-B5-A11O,TCGA-B5-A11O-01,62,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,993,0,NA,63.21,1:Recurred/Progressed,NA,NA,NA,NA,2/11/11,0.0001,G1,177,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,0,18,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,54,NA,TRUE,UEC,85.71,0:LIVING,NA,a59a79fd-433d-44dc-9601-4c63d599ab28,f3d85f05-bd2c-46fc-ac6a-0e2a7248c630,NA,NA,NA,TCGA-B5-A11O.078AA8A2-E812-4603-9084-8414937B88E1.pdf,078AA8A2-E812-4603-9084-8414937B88E1,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.8,NA,13,TUMOR FREE,A,114
ucec_tcga,TCGA-B5-A11P,TCGA-B5-A11P-01,87,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,979,0,NA,52,0:DiseaseFree,NA,NA,NA,NA,8/9/11,0.6382,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,52,0:LIVING,NA,d1c65e6a-098e-4c10-9183-c303ba66015a,64bf25f8-67bb-4f32-bad5-e879d1ad7736,NA,NA,NA,TCGA-B5-A11P.77639636-9C18-4C81-9FCF-04BA2D92110E.pdf,77639636-9C18-4C81-9FCF-04BA2D92110E,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,20,TUMOR FREE,B,74
ucec_tcga,TCGA-B5-A11Q,TCGA-B5-A11Q-01,64,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,702,0,NA,32.06,0:DiseaseFree,NA,NA,NA,NA,2/11/11,0.1120,G1,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,0,8,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,42,NA,TRUE,UEC,32.06,0:LIVING,NA,af852215-5a4b-44b4-8e8e-b887dcb3cf8c,c9b18c70-4d2b-4cd8-b0a8-a4226edab816,NA,NA,NA,TCGA-B5-A11Q.5117F490-9CE1-465F-BDF7-7B545B314703.pdf,5117F490-9CE1-465F-BDF7-7B545B314703,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.4,NA,34,TUMOR FREE,A,88
ucec_tcga,TCGA-B5-A11R,TCGA-B5-A11R-01,51,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,734,0,NA,77.17,0:DiseaseFree,NA,NA,NA,NA,2/22/11,0.3046,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,12,NA,NA,0,6,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,536,NA,TRUE,UEC,77.17,0:LIVING,NA,f04befed-6c81-4676-8715-b8c6a33cb9d1,1583391d-1489-4489-9cb8-30cd6529b307,NA,NA,NA,TCGA-B5-A11R.0AC5670B-7EA6-438C-9326-843BB7A6A81C.pdf,0AC5670B-7EA6-438C-9326-843BB7A6A81C,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,17.86666667,NA,60,TUMOR FREE,A,89
ucec_tcga,TCGA-B5-A11S,TCGA-B5-A11S-01,63,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,615,0,NA,1.35,1:Recurred/Progressed,NA,NA,NA,NA,2/22/11,0.1509,G2,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,2,NA,NA,0,28,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,43,NA,TRUE,UEC,73.23,0:LIVING,NA,cfd096ac-4d0f-4b89-8822-00656bc7f516,f36e52ee-22b3-4e9a-aacd-d74e7f7d4a51,NA,NA,NA,TCGA-B5-A11S.A1E96BA3-7DFB-4E3C-A6CF-B0B99D4C44FA.pdf,A1E96BA3-7DFB-4E3C-A6CF-B0B99D4C44FA,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.433333333,NA,17,TUMOR FREE,A,118
ucec_tcga,TCGA-B5-A11U,TCGA-B5-A11U-01,74,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,371,0,NA,16.72,0:DiseaseFree,NA,NA,NA,NA,2/22/11,0.0001,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,NA,NA,NA,0,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,228,NA,TRUE,UEC,16.72,0:LIVING,NA,0b672aa4-fc13-476f-b61e-5f2c3a615c23,52265b60-6f79-4e28-92a9-f4f5bee5a95e,NA,NA,NA,TCGA-B5-A11U.1EF2CB28-A515-4E9D-9148-CC1A2DF77F60.pdf,1EF2CB28-A515-4E9D-9148-CC1A2DF77F60,NA,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,7.633333333,NA,23,TUMOR FREE,A,61
ucec_tcga,TCGA-B5-A11V,TCGA-B5-A11V-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,294,0,NA,19.55,0:DiseaseFree,NA,NA,NA,NA,3/4/11,0.1219,G1,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,0,3,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,52,NA,TRUE,UEC,19.55,0:LIVING,NA,d3c83c5e-acb1-4cb0-8f56-96341822582f,1eb9c43a-17d8-4fa7-b779-9277ff828cb1,NA,NA,NA,TCGA-B5-A11V.E1B5A941-5EEB-4207-84DC-F3BF22D5FC29.pdf,E1B5A941-5EEB-4207-84DC-F3BF22D5FC29,positive,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,760,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.666666667,NA,29,TUMOR FREE,A,71
ucec_tcga,TCGA-B5-A11W,TCGA-B5-A11W-01,61,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,258,0,NA,19.48,0:DiseaseFree,NA,NA,NA,NA,3/4/11,0.0009,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,0,17,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,65,NA,TRUE,UEC,19.48,0:LIVING,NA,f5bd3902-ff7f-4233-8f74-beef3676af9a,ac3c028c-d36b-489b-a3d9-a7f4783de5eb,NA,NA,NA,TCGA-B5-A11W.C5762F7C-AB69-40D0-A9D0-71A6281F30AF.pdf,C5762F7C-AB69-40D0-A9D0-71A6281F30AF,positive,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,310,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,2.166666667,NA,52,TUMOR FREE,A,102
ucec_tcga,TCGA-B5-A11X,TCGA-B5-A11X-01,66,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC2,246,0,NA,13.04,1:Recurred/Progressed,NA,NA,NA,NA,3/8/11,NA,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8020/3,C54.1,YES,2010,NO,NA,5,NA,NA,5,5,NA,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,51,NA,TRUE,UEC,19.58,0:LIVING,NA,f70a64a8-3faa-468a-a6f3-4815eb01e5a3,0a9e02d6-62db-4b0e-ac92-677db018ec9c,NA,NA,NA,TCGA-B5-A11X.89C9704E-F43C-440C-970F-872835910268.pdf,89C9704E-F43C-440C-970F-872835910268,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,530,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,1.733333333,NA,100,WITH TUMOR,A,71
ucec_tcga,TCGA-B5-A11Y,TCGA-B5-A11Y-01,59,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,244,0,NA,18.4,0:DiseaseFree,NA,NA,NA,NA,3/11/11,0.0000,G1,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8382/3,C54.1,YES,2010,NO,NA,NA,NA,NA,NA,8,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,811,NA,TRUE,UEC,18.4,0:LIVING,NA,c0db966b-1024-4ee3-899a-f12e3c71a42c,24ddff8e-237c-47a0-acde-ce602cd70739,NA,NA,NA,TCGA-B5-A11Y.4FA7876E-EF1B-4EBA-99F9-1D26099B2CA1.pdf,4FA7876E-EF1B-4EBA-99F9-1D26099B2CA1,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,580,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,27.16666667,NA,54,TUMOR FREE,A,63
ucec_tcga,TCGA-B5-A11Z,TCGA-B5-A11Z-01,61,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,213,0,NA,17.35,0:DiseaseFree,NA,NA,NA,NA,3/22/11,0.0343,G1,172,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,47,NA,TRUE,UEC,17.35,0:LIVING,NA,cc141997-edab-4aae-a056-0c079eaa7362,2a8af07b-b514-4cd0-bf20-03a5f5abdb38,NA,NA,NA,TCGA-B5-A11Z.62C170A9-710F-45C0-B6BB-3F491A86A7E4.pdf,62C170A9-710F-45C0-B6BB-3F491A86A7E4,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,340,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.566666667,NA,0,TUMOR FREE,A,84
ucec_tcga,TCGA-B5-A121,TCGA-B5-A121-01,57,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,188,0,NA,16.56,0:DiseaseFree,NA,NA,NA,NA,3/23/11,0.0001,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,0,0,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,26,NA,TRUE,UEC,16.56,0:LIVING,NA,19511f9e-7b0e-4a06-998d-c1837d37c6ec,d7a7ecf1-7771-49c0-9756-302adba3a2c9,NA,NA,NA,TCGA-B5-A121.82B20A1F-99AC-4CC8-BAF2-B7132809D4F2.pdf,82B20A1F-99AC-4CC8-BAF2-B7132809D4F2,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,0.833333333333,NA,48,TUMOR FREE,A,80
ucec_tcga,TCGA-B5-A1MR,TCGA-B5-A1MR-01,65,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,5556,0,NA,225.33,0:DiseaseFree,NA,NA,NA,NA,7/19/11,0.0499,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,1995,NO,NA,7,NA,NA,0,15,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,225.33,0:LIVING,NA,02af18ee-ab8e-4ac3-b22e-dec80c201058,f2d9d82b-aa3f-44f8-b882-1381704f6cc5,NA,NA,NA,TCGA-B5-A1MR.BA4793F4-FBB3-4953-8204-A9C360D32D76.pdf,BA4793F4-FBB3-4953-8204-A9C360D32D76,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,NA,NA,4,TUMOR FREE,A,58
ucec_tcga,TCGA-B5-A1MS,TCGA-B5-A1MS-01,60,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IC,3117,0,NA,88.9,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/10/12,0.3454,G3,166,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2003,NO,NA,4,NA,NA,0,25,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,USC,102.23,1:DECEASED,NA,B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9,077A804E-8053-4319-80BE-65D33BC2CF41,NA,NA,NA,TCGA-B5-A1MS.5FF9FC65-FBCD-40E8-8382-DDD0B8EFD22B.pdf,5FF9FC65-FBCD-40E8-8382-DDD0B8EFD22B,negative,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,440,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,55,WITH TUMOR,B,74
ucec_tcga,TCGA-B5-A1MU,TCGA-B5-A1MU-01,79,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,1834,0,NA,44.84,1:Recurred/Progressed,NA,NA,NA,NA,7/19/11,0.1350,G3,147,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2006,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,26,NA,TRUE,USC,50.85,1:DECEASED,NA,f5261330-596e-4632-a5a3-8d3a2aa5de38,bb3bdc38-8011-4427-a863-eba7a6cfff69,NA,NA,NA,TCGA-B5-A1MU.FC3D9B79-4CAD-4F62-892C-C830B24E50DD.pdf,FC3D9B79-4CAD-4F62-892C-C830B24E50DD,positive,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,260,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,0.866666666667,NA,100,WITH TUMOR,A,44
ucec_tcga,TCGA-B5-A1MV,TCGA-B5-A1MV-01,84,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,226,0,NA,51.41,0:DiseaseFree,NA,NA,NA,NA,2/15/12,0.1008,G2,151,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,7,NA,NA,0,19,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,51.41,0:LIVING,NA,0f36c3a2-0ba5-4c43-a3f0-78d125e5d0ac,efd221c1-8513-4129-99ba-43ab94d1a6b9,NA,NA,NA,TCGA-B5-A1MV.E536759E-F47A-4EE9-B855-AFEC6BCF5EE0.pdf,E536759E-F47A-4EE9-B855-AFEC6BCF5EE0,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,470,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,NA,NA,47,TUMOR FREE,A,72
ucec_tcga,TCGA-B5-A1MW,TCGA-B5-A1MW-01,55,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,148,0,NA,10.22,1:Recurred/Progressed,NA,NA,NA,NA,2/16/12,0.0499,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,8,NA,NA,0,31,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,14.68,0:LIVING,NA,E2B48D0D-57CA-400B-8598-55EF132E350E,F886AACC-64F9-4F9E-8123-8AD25CE54D0C,NA,NA,NA,TCGA-B5-A1MW.870882D8-D89A-4A89-B516-DADAB95BE285.pdf,870882D8-D89A-4A89-B516-DADAB95BE285,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,340,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,31,TUMOR FREE,A,62
ucec_tcga,TCGA-B5-A1MX,TCGA-B5-A1MX-01,47,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,103,0,NA,48.39,0:DiseaseFree,NA,NA,NA,NA,2/16/12,0.0008,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,2,NA,NA,0,14,NA,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Tumor resection,NA,NA,NA,NA,TRUE,UEC,48.39,0:LIVING,NA,37bac6ba-be93-42cc-892b-efd0bdb850bd,68e7d2d6-3313-4ffc-bb4f-ba9167a7b669,NA,NA,NA,TCGA-B5-A1MX.C8962646-1A09-4EAA-8864-2539A0CCEC4C.pdf,C8962646-1A09-4EAA-8864-2539A0CCEC4C,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,560,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,100,TUMOR FREE,A,58
ucec_tcga,TCGA-B5-A1MY,TCGA-B5-A1MY-01,62,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,128,0,NA,10.94,1:Recurred/Progressed,NA,NA,NA,NA,2/17/12,0.5939,G3,146,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,5,NA,NA,2,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,43,NA,TRUE,USC,11.86,1:DECEASED,NA,5d2f1a0f-a01b-48c2-b749-1ca710aa2bb4,26189cf5-ae49-44cf-842b-35a3063ab93c,NA,NA,NA,TCGA-B5-A1MY.A5328E25-1433-4331-83B8-148780F6A6DA.pdf,A5328E25-1433-4331-83B8-148780F6A6DA,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,360,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,1.433333333,NA,100,WITH TUMOR,A,67
ucec_tcga,TCGA-B5-A1MZ,TCGA-B5-A1MZ-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,114,0,NA,20.14,1:Recurred/Progressed,NA,NA,NA,NA,2/22/12,0.0341,G1,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,NA,NA,NA,NA,32,NA,NA,0,Indeterminate (neither Pre or Postmenopausal),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,52.5,0:LIVING,NA,838fcc2b-48b4-49dd-b8fc-ff27bbd16b17,cba2dcfb-5988-435c-99c1-445a36c6082f,NA,NA,NA,TCGA-B5-A1MZ.071A53F9-6E40-4402-8353-BB963AFE5C33.pdf,071A53F9-6E40-4402-8353-BB963AFE5C33,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,31,TUMOR FREE,A,114
ucec_tcga,TCGA-B5-A1N2,TCGA-B5-A1N2-01,70,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC1,93,0,NA,26.41,1:Recurred/Progressed,NA,NA,NA,NA,2/22/12,0.5747,G3,168,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,NA,NA,NA,NA,1,NA,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,31.34,1:DECEASED,NA,d79e692c-5053-4484-a180-01a094c5ff45,a5058d90-cea2-4886-9823-501ff2262e13,NA,NA,NA,TCGA-B5-A1N2.CB8D6955-D74A-4A05-ACC3-F0DE49CC60A9.pdf,CB8D6955-D74A-4A05-ACC3-F0DE49CC60A9,positive,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,540,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,12.5,TUMOR FREE,A,114
ucec_tcga,TCGA-B5-A3F9,TCGA-B5-A3F9-01,56,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,3159,0,NA,136.5,0:DiseaseFree,NA,NA,NA,NA,3/19/12,0.0636,G3,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2003,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,136.5,0:LIVING,NA,21941181-8ED5-4211-867D-516AD09FBE06,7FC15CFC-2CD8-49AF-BF92-913F0BC4C1A8,NA,NA,NA,TCGA-B5-A3F9.E4AD1574-653C-444D-BB43-B4DE701B109F.pdf,E4AD1574-653C-444D-BB43-B4DE701B109F,NA,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,6,TUMOR FREE,A,155
ucec_tcga,TCGA-B5-A3FA,TCGA-B5-A3FA-01,73,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,2679,0,NA,96.22,0:DiseaseFree,NA,NA,NA,NA,3/19/12,0.0003,G3,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,2,NA,NA,0,11,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,96.22,0:LIVING,NA,AC9EC63A-C3B6-4D0C-B1A9-7C72DBAD456C,6BA7181F-0FD1-4158-AD8D-2CE4513AB53F,NA,NA,NA,TCGA-B5-A3FA.1CA1DEC3-AD70-40F7-859B-24A27F47C904.pdf,1CA1DEC3-AD70-40F7-859B-24A27F47C904,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,510,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,52,TUMOR FREE,A,74
ucec_tcga,TCGA-B5-A3FB,TCGA-B5-A3FB-01,73,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2066,0,NA,93.43,0:DiseaseFree,NA,NA,NA,NA,3/23/12,0.0111,G3,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,NA,NA,NA,33,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,93.43,0:LIVING,NA,0C1946A8-EE54-4B9B-8054-9A7BECE74D33,0CEA1BDE-18ED-4E42-B5F6-3D4FF182B0C0,NA,NA,NA,TCGA-B5-A3FB.FA278AFC-C294-48A5-BE7B-B26F4AE3FC5B.pdf,FA278AFC-C294-48A5-BE7B-B26F4AE3FC5B,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,350,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,4,TUMOR FREE,A,115
ucec_tcga,TCGA-B5-A3FC,TCGA-B5-A3FC-01,53,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,1814,0,NA,71.78,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/23/12,0.0043,G3,169,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,71.78,0:LIVING,NA,EC2040A3-788B-4F2C-A093-C5C4B3DC4B6C,CB538AFF-C08C-455D-8DD8-E3CD0D404E00,NA,NA,NA,TCGA-B5-A3FC.4A63436E-BBC1-4F02-9B72-7ED4CC2AC1CD.pdf,4A63436E-BBC1-4F02-9B72-7ED4CC2AC1CD,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,B5,NA,NA,0,TUMOR FREE,A,76
ucec_tcga,TCGA-B5-A3FD,TCGA-B5-A3FD-01,70,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,679,0,NA,32.59,1:Recurred/Progressed,NA,NA,NA,NA,3/26/12,0.7669,G3,174,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,7,NA,NA,0,34,NA,NA,0,Indeterminate (neither Pre or Postmenopausal),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,39.32,1:DECEASED,NA,EEB327B4-B705-4161-BA94-647F0E14F5B4,D496DC3A-FC5B-4177-8570-E8725778D186,NA,NA,NA,TCGA-B5-A3FD.7AC30D60-097A-4FED-A928-7A4BCAFB6C8D.pdf,7AC30D60-097A-4FED-A928-7A4BCAFB6C8D,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,370,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,30,TUMOR FREE,A,115
ucec_tcga,TCGA-B5-A3FH,TCGA-B5-A3FH-01,74,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,97,0,NA,27.63,0:DiseaseFree,NA,NA,NA,NA,3/23/12,0.0477,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,9,NA,NA,0,17,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,27.63,0:LIVING,NA,139E2C5A-CC0C-43A2-B30E-B8AC17C0B5F2,F7C02F75-CA0A-4D2D-BD45-D40E77FE74FC,NA,NA,NA,TCGA-B5-A3FH.05AD8EE1-E2F8-42F7-8E6A-380A8EE4770E.pdf,05AD8EE1-E2F8-42F7-8E6A-380A8EE4770E,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,480,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,6,TUMOR FREE,A,85
ucec_tcga,TCGA-B5-A3S1,TCGA-B5-A3S1-01,71,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC1,127,0,NA,29.63,0:DiseaseFree,NA,NA,NA,NA,5/9/12,0.4083,G3,155,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,7,NA,NA,0,24,NA,NA,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,29.63,0:LIVING,NA,3789AE3F-286B-42F0-A805-320AD69EA1DF,4715FDA8-7E8E-40F5-9DDB-80349A38C626,NA,NA,NA,TCGA-B5-A3S1.72F97A0D-1245-4C80-B2D2-B7B217BEC06B.pdf,72F97A0D-1245-4C80-B2D2-B7B217BEC06B,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,B5,NA,NA,87.6,WITH TUMOR,A,68
ucec_tcga,TCGA-B5-A5OC,TCGA-B5-A5OC-01,71,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIB,732,0,NA,41.03,0:DiseaseFree,NA,NA,NA,NA,8/20/13,0.0796,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO,TRUE,UEC,41.03,0:LIVING,NA,AE8A4958-5407-4C01-93C3-8090862533AE,69AC12C0-A986-44AC-8687-134CCB12AC21,NA,NA,NA,TCGA-B5-A5OC.2B1515A6-001A-46AF-952C-D393944DE57F.pdf,2B1515A6-001A-46AF-952C-D393944DE57F,NA,YES,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R2,NO,1,750,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,B5,NA,NA,NA,NA,A,NA
ucec_tcga,TCGA-B5-A5OD,TCGA-B5-A5OD-01,67,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,662,0,NA,34.1,0:DiseaseFree,NA,NA,NA,NA,8/20/13,0.6366,G3,NA,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO,TRUE,USC,34.1,0:LIVING,NA,3E240DC0-80B7-41EA-81B3-33ECE2753C2B,71994580-4A7F-433D-80D3-71E408D44EB3,NA,NA,NA,TCGA-B5-A5OD.8A0B9737-98D2-4A61-95FF-18842056A6DE.pdf,8A0B9737-98D2-4A61-95FF-18842056A6DE,NA,YES,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,NA,NO,1,370,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,B5,NA,NA,NA,NA,A,NA
ucec_tcga,TCGA-B5-A5OE,TCGA-B5-A5OE-01,68,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,609,0,NA,34.92,0:DiseaseFree,NA,NA,NA,NA,8/20/13,0.4046,G3,NA,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NO,TRUE,USC,34.92,0:LIVING,NA,D5EE39E8-A1D2-4244-9C38-07D7C5C1BABA,DF9184EC-0A56-4227-A0F7-CE92E5E6203E,NA,NA,NA,TCGA-B5-A5OE.82A668E5-6B89-4C94-BEED-F4FF227BD0B1.pdf,82A668E5-6B89-4C94-BEED-F4FF227BD0B1,NA,YES,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,NA,NO,1,1540,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,B5,NA,NA,NA,NA,A,NA
ucec_tcga,TCGA-BG-A0LW,TCGA-BG-A0LW-01,47,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,107,0,NA,18.59,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/1/10,0.0001,G2,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,6,0,0,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,26,NA,TRUE,UEC,18.59,0:LIVING,NA,68181bc9-aa8b-44ec-8601-564b30ea0561,6527ec31-1d41-49c2-93ff-11615a6cba8b,NA,NA,NA,TCGA-BG-A0LW.75A97BED-AB64-46CC-AE6B-59860673D53E.pdf,75A97BED-AB64-46CC-AE6B-59860673D53E,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,0.9,NA,5,TUMOR FREE,A,141
ucec_tcga,TCGA-BG-A0LX,TCGA-BG-A0LX-01,57,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,120,0,NA,20.17,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/1/10,0.0811,G2,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,7,0,0,0,15,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,325,NA,TRUE,UEC,20.17,0:LIVING,NA,ac1d3946-fe6c-4bd8-b02c-638799cb0f67,99cdf3a0-90dc-4992-b75a-11dd41928d43,NA,NA,NA,TCGA-BG-A0LX.4306E592-FA36-4AB9-BF84-7232CC599A64.pdf,4306E592-FA36-4AB9-BF84-7232CC599A64,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,10.76666667,NA,90,TUMOR FREE,A,96
ucec_tcga,TCGA-BG-A0M0,TCGA-BG-A0M0-01,66,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,147,0,NA,19.32,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/1/10,0.1187,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,1,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,111,NA,TRUE,UEC,19.32,0:LIVING,NA,8bf0b156-6eb4-45e8-9cbb-0979efbea898,e3f599db-19cf-4086-8e5d-d3527119120f,NA,NA,NA,TCGA-BG-A0M0.BDDACDFC-E3D4-4EA7-9591-DB6371713E8E.pdf,BDDACDFC-E3D4-4EA7-9591-DB6371713E8E,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,800,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,3.666666667,NA,6,TUMOR FREE,A,117
ucec_tcga,TCGA-BG-A0M2,TCGA-BG-A0M2-01,62,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,185,0,NA,20.93,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/1/10,0.3315,G2,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,1,0,0,0,8,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,25,NA,TRUE,UEC,20.93,0:LIVING,NA,9731e0b3-c62d-43cb-8ae7-8f973d69ab19,2af18345-2a71-4574-ac8e-83ddeed3ad57,NA,NA,NA,TCGA-BG-A0M2.A0087300-81E9-4733-8497-95E0F95575B4.pdf,A0087300-81E9-4733-8497-95E0F95575B4,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,510,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,0.8,NA,59,TUMOR FREE,A,76
ucec_tcga,TCGA-BG-A0M3,TCGA-BG-A0M3-01,74,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,597,0,NA,35.18,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/1/10,0.1516,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,5,0,0,0,12,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,59,NA,TRUE,UEC,35.18,0:LIVING,NA,8bdd4e0e-5bec-43f2-b9fa-d6e94a72fe05,1802cd6b-4d4a-45fa-b839-7450071e41ee,NA,NA,NA,TCGA-BG-A0M3.19AABBD8-3DC5-418E-9B62-37CF7500F174.pdf,19AABBD8-3DC5-418E-9B62-37CF7500F174,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.966666667,NA,53,TUMOR FREE,A,75
ucec_tcga,TCGA-BG-A0M4,TCGA-BG-A0M4-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,643,0,NA,71.19,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/1/10,0.1939,G3,178,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,3,0,0,0,14,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,337,NA,TRUE,UEC,71.19,0:LIVING,NA,73e5310d-ba8c-4cbc-aa4f-e06206f898f4,e6e7e411-45cf-47a1-bcf0-7ae800a61a8d,NA,NA,NA,TCGA-BG-A0M4.95002D96-C9D8-43BE-ADD1-072E93994194.pdf,95002D96-C9D8-43BE-ADD1-072E93994194,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,11.13333333,NA,5,TUMOR FREE,A,97
ucec_tcga,TCGA-BG-A0M6,TCGA-BG-A0M6-01,73,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,618,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,12/1/10,0.6552,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,5,3,0,3,16,5,0,5,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,38,NA,TRUE,USC,22.04,1:DECEASED,NA,002724fa-7051-49fa-9c58-4bcb7eba4ac6,66e4b080-e6ef-4531-9b69-1b27f15c5669,NA,NA,NA,TCGA-BG-A0M6.39EC3673-5B31-403B-8328-9DEA5FF7CD1A.pdf,39EC3673-5B31-403B-8328-9DEA5FF7CD1A,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,320,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.266666667,NA,100,TUMOR FREE,A,55
ucec_tcga,TCGA-BG-A0M7,TCGA-BG-A0M7-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,659,0,NA,63.63,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/1/10,0.0001,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,45,NA,TRUE,UEC,63.63,0:LIVING,NA,1d9c2113-ddcb-4440-89c3-cd21cee6d401,d053fa9e-5d19-4940-8915-4a03cb479263,NA,NA,NA,TCGA-BG-A0M7.F9128DAE-F3D0-4738-AC20-E665F22DDC63.pdf,F9128DAE-F3D0-4738-AC20-E665F22DDC63,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,260,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.5,NA,75,TUMOR FREE,A,102
ucec_tcga,TCGA-BG-A0M8,TCGA-BG-A0M8-01,50,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,734,0,NA,66.36,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/8/10,0.3080,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Indeterminate (neither Pre or Postmenopausal),Dilation and curettage procedure,NA,NA,46,NA,TRUE,UEC,66.36,0:LIVING,NA,e055db71-f3da-43d3-a9b2-2f65dfb23d3e,9cfb7290-ef60-4fda-abd7-9552ae11e4e7,NA,NA,NA,TCGA-BG-A0M8.42DBC6F7-E413-41A6-994E-1391099818A0.pdf,42DBC6F7-E413-41A6-994E-1391099818A0,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,630,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.5,NA,50,TUMOR FREE,A,209
ucec_tcga,TCGA-BG-A0M9,TCGA-BG-A0M9-01,73,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,772,0,NA,74.57,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/8/10,0.0498,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,4,0,0,0,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,47,NA,TRUE,UEC,74.57,0:LIVING,NA,4fd1cb59-6c50-4355-9d37-a341e1f4fad9,dc487bbf-555b-423b-b7c0-3e92defa5a79,NA,NA,NA,TCGA-BG-A0M9.08D832C7-9B5F-4B6E-9C3E-2F3E58305016.pdf,08D832C7-9B5F-4B6E-9C3E-2F3E58305016,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.533333333,NA,75,TUMOR FREE,A,93
ucec_tcga,TCGA-BG-A0MA,TCGA-BG-A0MA-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,805,0,NA,2.3,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,12/8/10,0.0499,G3,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,6,0,0,0,10,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,10.71,1:DECEASED,NA,F85BC60B-AB07-4B24-820B-6860B198E910,8B7459ED-D1D7-4499-B057-12BC9A5BC488,NA,NA,NA,TCGA-BG-A0MA.E5908692-5B04-407B-818A-D202756DD880.pdf,E5908692-5B04-407B-818A-D202756DD880,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,NA,NA,78,WITH TUMOR,A,111
ucec_tcga,TCGA-BG-A0MC,TCGA-BG-A0MC-01,74,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,779,0,NA,41.49,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/8/10,0.0296,G1,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,43,NA,TRUE,UEC,41.49,0:LIVING,NA,884fd57d-bd8e-40e7-82f6-0ba1c71101a9,46b48bf8-346b-4f25-916e-26a3cddfa00d,NA,NA,NA,TCGA-BG-A0MC.100F4900-491A-438B-9704-51D4E016B325.pdf,100F4900-491A-438B-9704-51D4E016B325,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,630,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,1.466666667,NA,0,TUMOR FREE,A,135
ucec_tcga,TCGA-BG-A0MG,TCGA-BG-A0MG-01,73,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,980,0,NA,48.52,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/8/10,0.0938,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,2,0,0,0,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,84,NA,TRUE,UEC,48.52,0:LIVING,NA,9cde90c8-2be0-4328-a032-ff1dc19e66fd,96b6826d-8a4c-45f5-8cd3-b5988aa5fd0e,NA,NA,NA,TCGA-BG-A0MG.65A0B84A-72AD-42E2-B0DB-DA8D2BD54E9B.pdf,65A0B84A-72AD-42E2-B0DB-DA8D2BD54E9B,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,2.833333333,NA,36,TUMOR FREE,A,61
ucec_tcga,TCGA-BG-A0MH,TCGA-BG-A0MH-01,61,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,1000,0,NA,63.4,0:DiseaseFree,NA,NA,NA,NA,9/8/11,NA,G2,154,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,NA,NA,NA,NA,8,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,63.4,0:LIVING,NA,bfac45a6-fa01-4edb-9807-6898ea82e80e,8ad77275-6034-4d01-832f-d8bf3668e6bb,NA,NA,NA,TCGA-BG-A0MH.F641C526-7A0D-46C3-92EE-CD9CB0D13960.pdf,F641C526-7A0D-46C3-92EE-CD9CB0D13960,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,790,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,NA,NA,90,TUMOR FREE,A,136
ucec_tcga,TCGA-BG-A0MI,TCGA-BG-A0MI-01,83,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1014,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,12/8/10,0.0000,G2,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,2,0,0,0,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,51,NA,TRUE,UEC,23.46,1:DECEASED,NA,b8588e0f-aad6-4ded-845e-3cff67a48d8f,f030dae4-bd6f-4d0d-96e0-12b299057338,NA,NA,NA,TCGA-BG-A0MI.1A0F6DD8-22A2-4A00-8AAD-04710DBBDFED.pdf,1A0F6DD8-22A2-4A00-8AAD-04710DBBDFED,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.666666667,NA,13,TUMOR FREE,A,101
ucec_tcga,TCGA-BG-A0MK,TCGA-BG-A0MK-01,52,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,1399,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,3/29/12,0.0002,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,43.27,1:DECEASED,NA,1F9B1B71-8753-4CD5-A585-708BEA8FF1FA,24678D73-94E1-49B4-A772-BDA6A02D6075,NA,NA,NA,TCGA-BG-A0MK.9D631FCB-78A9-4CA9-A033-D66CB78D8CA3.pdf,9D631FCB-78A9-4CA9-A033-D66CB78D8CA3,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,1100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,NA,NA,NA,WITH TUMOR,A,NA
ucec_tcga,TCGA-BG-A0MO,TCGA-BG-A0MO-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,854,0,NA,43,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/9/10,0.0433,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,36,NA,TRUE,UEC,43,0:LIVING,NA,734ef97f-807c-480e-8df9-feaf041032d2,7582cbb9-42d3-496c-991d-d76bea4c434c,NA,NA,NA,TCGA-BG-A0MO.C120AC98-36D2-49AD-84A1-6EA168D2A2BA.pdf,C120AC98-36D2-49AD-84A1-6EA168D2A2BA,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.2,NA,35.7,TUMOR FREE,A,83
ucec_tcga,TCGA-BG-A0MQ,TCGA-BG-A0MQ-01,71,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,692,0,NA,59.69,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/9/10,0.0493,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,421,NA,TRUE,UEC,59.69,0:LIVING,NA,12d36a1d-9922-4311-bbda-71f32ac2c03b,3d1fa321-d2e8-4460-ae87-356ab1ca6281,NA,NA,NA,TCGA-BG-A0MQ.3252AEB3-3B0D-4066-B18E-31096F928D63.pdf,3252AEB3-3B0D-4066-B18E-31096F928D63,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,14.06666667,NA,25,WITH TUMOR,A,101
ucec_tcga,TCGA-BG-A0MS,TCGA-BG-A0MS-01,53,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,420,0,NA,61.83,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/9/10,0.1663,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,41,NA,TRUE,UEC,61.83,0:LIVING,NA,a798a8cc-4e72-4a8c-9e20-74a14deafd12,ef7f78eb-314b-4cf2-b45b-810c84c6aa7b,NA,NA,NA,TCGA-BG-A0MS.7BE89F2D-74E5-4D9E-8270-A216D79ADCD7.pdf,7BE89F2D-74E5-4D9E-8270-A216D79ADCD7,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,560,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.3,NA,44,TUMOR FREE,A,65
ucec_tcga,TCGA-BG-A0MT,TCGA-BG-A0MT-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,344,0,NA,18.56,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,12/9/10,0.1556,G2,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,41,NA,TRUE,UEC,21.16,0:LIVING,NA,082e32c5-7f82-466a-b52d-a3293a8f8e57,91f629f5-6938-4f5c-ba2e-1f519ce6b255,NA,NA,NA,TCGA-BG-A0MT.89610F48-AC0D-431D-8A9E-FC9E51CF8FC0.pdf,89610F48-AC0D-431D-8A9E-FC9E51CF8FC0,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,820,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,1.366666667,NA,25,TUMOR FREE,A,73
ucec_tcga,TCGA-BG-A0MU,TCGA-BG-A0MU-01,78,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,121,0,NA,20.27,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/9/10,0.0495,G1,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,1,0,0,0,8,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,53,NA,TRUE,UEC,20.27,0:LIVING,NA,a7329910-b1c7-4a18-b28e-8fad79121339,f0af3f30-3d64-4bd8-9a8f-7ff7ab9bb7b0,NA,NA,NA,TCGA-BG-A0MU.7162F7A7-7295-4736-B721-B13DAE006092.pdf,7162F7A7-7295-4736-B721-B13DAE006092,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,860,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.733333333,NA,76.9,TUMOR FREE,A,68
ucec_tcga,TCGA-BG-A0RY,TCGA-BG-A0RY-01,68,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,49,0,NA,15.41,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/9/10,0.3342,G2,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,0,0,0,9,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,43,NA,TRUE,UEC,15.41,0:LIVING,NA,f299ad43-bb16-46ce-9617-48cc6c6f29e7,260692e1-9b2c-4f8b-952d-1b95c042e659,NA,NA,NA,TCGA-BG-A0RY.170B34D7-94B3-4129-9B4D-E36AF7A09897.pdf,170B34D7-94B3-4129-9B4D-E36AF7A09897,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,450,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.466666667,NA,96,TUMOR FREE,A,118
ucec_tcga,TCGA-BG-A0VT,TCGA-BG-A0VT-01,56,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,87,0,NA,51.51,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/16/11,0.0492,G2,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,3,0,NA,NA,3,0,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Dilation and curettage procedure,NA,NA,28,NA,TRUE,UEC,51.51,0:LIVING,NA,cc058b8c-df40-4f9e-88e3-3d1131b22b41,0cfbcb61-c5e2-47f7-beb6-504f3cd4605b,NA,NA,NA,TCGA-BG-A0VT.0BC38740-A7B9-4086-9F03-A139287B33CC.pdf,0BC38740-A7B9-4086-9F03-A139287B33CC,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,0.866666666667,NA,20,TUMOR FREE,A,144
ucec_tcga,TCGA-BG-A0VV,TCGA-BG-A0VV-01,53,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,217,0,NA,51.02,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/16/11,0.0342,G1,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,2,0,NA,NA,6,0,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,35,NA,TRUE,UEC,51.02,0:LIVING,NA,6164588a-d03a-46fc-82fb-a32cbaa54cac,cf919557-13c9-4cf1-982c-a8d8ad3bf4ee,NA,NA,NA,TCGA-BG-A0VV.42E7D5FF-18CD-4DEA-9518-9B9732BCA635.pdf,42E7D5FF-18CD-4DEA-9518-9B9732BCA635,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.166666667,NA,50,TUMOR FREE,A,147
ucec_tcga,TCGA-BG-A0VW,TCGA-BG-A0VW-01,77,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,246,0,NA,51.97,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/16/11,0.0117,G1,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,2,0,NA,NA,10,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,220,NA,TRUE,UEC,51.97,0:LIVING,NA,62d71839-4fba-42e9-9929-8d937f0fe287,e5e61331-4cca-4742-83ab-87e9dddafaca,NA,NA,NA,TCGA-BG-A0VW.7663D410-13EC-4A5B-B655-F7DCCC9C8E8D.pdf,7663D410-13EC-4A5B-B655-F7DCCC9C8E8D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,7.2,NA,50,TUMOR FREE,A,93
ucec_tcga,TCGA-BG-A0VX,TCGA-BG-A0VX-01,58,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,729,0,NA,34.26,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/16/11,0.0000,G1,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Excisional Biopsy,NA,NA,162,NA,TRUE,UEC,34.26,0:LIVING,NA,6c2a0f37-49cd-4fd0-b126-58b35f9121df,5797d32b-e482-4af3-b043-ad84c84e0296,NA,NA,NA,TCGA-BG-A0VX.D0131F13-2BA5-4B20-8D3D-25743A258C06.pdf,D0131F13-2BA5-4B20-8D3D-25743A258C06,NA,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,5.4,NA,15,TUMOR FREE,A,157
ucec_tcga,TCGA-BG-A0VZ,TCGA-BG-A0VZ-01,58,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,876,0,NA,52.6,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/17/11,0.0026,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,234,NA,TRUE,UEC,52.6,0:LIVING,NA,edee2bf5-284c-4d77-823a-d037fe4c4b9e,fa28a6f2-c6d2-4cf1-8026-fed92675bdb9,NA,NA,NA,TCGA-BG-A0VZ.6CCCA758-AB3D-4260-BD25-16716E34B3BB.pdf,6CCCA758-AB3D-4260-BD25-16716E34B3BB,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,7.733333333,NA,52,TUMOR FREE,A,109
ucec_tcga,TCGA-BG-A0W1,TCGA-BG-A0W1-01,89,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,1014,0,NA,52.79,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/18/11,0.1698,G2,130,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,NA,NA,NA,NA,11,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,63,NA,TRUE,UEC,52.79,0:LIVING,NA,2d750c67-24a2-4b12-b4f2-dbd65f2f27f0,13dec3d1-c7f8-4b95-bd54-2d3136cee001,NA,NA,NA,TCGA-BG-A0W1.BE7CC54D-8220-4AC6-9F8D-016DE4167B35.pdf,BE7CC54D-8220-4AC6-9F8D-016DE4167B35,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,2.1,NA,45,TUMOR FREE,A,56
ucec_tcga,TCGA-BG-A0W2,TCGA-BG-A0W2-01,57,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1073,0,NA,56.54,0:DiseaseFree,NA,NA,NA,NA,3/18/11,0.0465,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,34,NA,TRUE,UEC,56.54,0:LIVING,NA,f47df5f9-7c60-4b1a-b574-7036245af341,0945d625-8d4b-4f5a-a863-a61dad5ecd34,NA,NA,NA,TCGA-BG-A0W2.D9BDB0FB-9205-4E41-9D7D-B12C206A608E.pdf,D9BDB0FB-9205-4E41-9D7D-B12C206A608E,NA,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.1,NA,0,TUMOR FREE,A,121
ucec_tcga,TCGA-BG-A0YU,TCGA-BG-A0YU-01,37,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,166,0,NA,14.82,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/16/11,0.0495,G1,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",pelvic wash specimen from PAP,NA,15,NA,TRUE,UEC,14.82,0:LIVING,NA,957ac10a-7365-47b1-bbed-47e5d42fbfdf,61a80dcf-f83b-4b4f-806f-8ad3882ecfe4,NA,NA,NA,TCGA-BG-A0YU.5E3AA4BA-20F6-4241-AD70-8E5DEDA9D129.pdf,5E3AA4BA-20F6-4241-AD70-8E5DEDA9D129,NA,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,310,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,0.5,NA,50,TUMOR FREE,A,107
ucec_tcga,TCGA-BG-A0YV,TCGA-BG-A0YV-01,67,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,62,0,NA,12.55,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/16/11,0.2432,G3,155,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,68,NA,TRUE,USC,12.55,0:LIVING,NA,d8e57746-37a1-482a-a3d3-a11bd00cdc11,13db3af5-5f71-49b8-95f6-d452062c7ea4,NA,NA,NA,TCGA-BG-A0YV.D037EFD1-22CB-43FE-BE0A-F2189C5FB202.pdf,D037EFD1-22CB-43FE-BE0A-F2189C5FB202,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,330,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,2.266666667,NA,NA,TUMOR FREE,A,54
ucec_tcga,TCGA-BG-A186,TCGA-BG-A186-01,61,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,104,0,NA,13.76,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/13/11,0.0496,G2,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,6,0,NA,NA,23,0,NA,NA,NA,Office Endometrial Biopsy,NA,NA,28,NA,TRUE,UEC,13.76,0:LIVING,NA,fe4db898-3a9f-4dff-adcb-7b8c30137350,b1645a83-57b7-4357-b977-63a5b6aee39e,NA,NA,NA,TCGA-BG-A186.76C588F1-ED43-485D-8FFF-32F4C5D92202.pdf,76C588F1-ED43-485D-8FFF-32F4C5D92202,positive,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,RX,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,0.9,NA,28,TUMOR FREE,A,75
ucec_tcga,TCGA-BG-A187,TCGA-BG-A187-01,65,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,97,0,NA,14.72,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/16/11,0.0465,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,3,NA,NA,NA,4,0,NA,NA,NA,Dilation and curettage procedure,NA,NA,80,NA,TRUE,UEC,14.72,0:LIVING,NA,0f59bb0a-135c-4793-b1a7-5ad5172ed82d,1738b7d6-c860-449a-aae9-065ef65a149b,NA,NA,NA,TCGA-BG-A187.CB8E915A-CE5D-4181-9303-22BD8CBCB80D.pdf,CB8E915A-CE5D-4181-9303-22BD8CBCB80D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,360,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,2.633333333,NA,80,NA,A,61
ucec_tcga,TCGA-BG-A18A,TCGA-BG-A18A-01,74,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,146,0,NA,13.99,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/19/11,0.0464,G1,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,2,0,NA,NA,11,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,51,NA,TRUE,UEC,13.99,0:LIVING,NA,feb3e930-3638-44b4-ac0f-a5dcb01fed76,8fd0971d-40ba-46c2-b3c4-8e48a3e6c122,NA,NA,NA,TCGA-BG-A18A.099561AC-A5E7-4CA9-8F07-EEA7B3A96EEA.pdf,099561AC-A5E7-4CA9-8F07-EEA7B3A96EEA,negative,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,1.7,NA,50,TUMOR FREE,A,84
ucec_tcga,TCGA-BG-A18B,TCGA-BG-A18B-01,53,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage I,56,0,NA,15.44,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/19/11,0.0005,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,5,0,NA,NA,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,265,NA,TRUE,UEC,15.44,0:LIVING,NA,62ae3bb1-8102-4693-aee6-4d8d0d2bc515,2a3bc803-54c4-4544-a72d-7077dbb0b93e,NA,NA,NA,TCGA-BG-A18B.E7006FF4-33D9-4369-A4E0-42D124EAE1E0.pdf,E7006FF4-33D9-4369-A4E0-42D124EAE1E0,NA,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,480,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,8.8,NA,NA,TUMOR FREE,A,116
ucec_tcga,TCGA-BG-A18C,TCGA-BG-A18C-01,72,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,52,0,NA,15.44,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/27/11,0.8304,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,5,0,NA,NA,25,0,NA,NA,NA,Dilation and curettage procedure,NA,NA,39,NA,TRUE,UEC,15.44,0:LIVING,NA,66e305ca-8a16-44f0-b837-85e529b7ad55,37f209b1-c738-441c-b205-eaec4e2ade4e,NA,NA,NA,TCGA-BG-A18C.2A6FB6E4-7FBF-45EA-B9B0-C4EDC78C35E2.pdf,2A6FB6E4-7FBF-45EA-B9B0-C4EDC78C35E2,NA,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,340,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,1.3,NA,13,NA,A,96
ucec_tcga,TCGA-BG-A220,TCGA-BG-A220-01,69,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,110,0,NA,14.26,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/28/11,0.0000,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,NA,Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,14.26,0:LIVING,NA,41dcafa0-b196-46dd-ab07-58cb747c9ebc,b88002d7-76cb-4ea7-b894-8572d49411ab,NA,NA,NA,TCGA-BG-A220.59CD459F-FB2B-4B0E-9E16-3E26BDF252E1.pdf,59CD459F-FB2B-4B0E-9E16-3E26BDF252E1,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,NA,NA,NA,TUMOR FREE,A,127
ucec_tcga,TCGA-BG-A221,TCGA-BG-A221-01,84,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,99,0,NA,1.81,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/28/11,0.1407,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,3,0,NA,NA,15,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,1.81,0:LIVING,NA,e7e667be-9b31-4870-9c38-740098f37213,d96882db-9a46-493a-a26b-efb7bddf34ff,NA,NA,NA,TCGA-BG-A221.58D68577-9022-4EF3-82E9-6EE159D41947.pdf,58D68577-9022-4EF3-82E9-6EE159D41947,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,NA,NA,NA,NA,A,62
ucec_tcga,TCGA-BG-A222,TCGA-BG-A222-01,49,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,50,0,NA,9.56,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/28/11,0.0443,G3,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,7,0,NA,NA,25,0,NA,NA,NA,Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,9.56,0:LIVING,NA,397b2672-d014-4b57-88dd-17e66ff8be4d,002eb27d-18c4-49d0-a977-8d2717e7ee42,NA,NA,NA,TCGA-BG-A222.32837D2C-0D2B-4A47-9E42-1A809CB4A25A.pdf,32837D2C-0D2B-4A47-9E42-1A809CB4A25A,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,630,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,NA,NA,NA,NA,A,132
ucec_tcga,TCGA-BG-A2AD,TCGA-BG-A2AD-01,63,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIB,45,0,NA,20.01,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/28/11,0.0016,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,8,0,NA,NA,18,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,20.01,0:LIVING,NA,49adc60f-211b-4547-84f6-094257767409,d07bb656-7b30-4d4c-a804-e3336c881a20,NA,NA,NA,TCGA-BG-A2AD.E3FBF856-C09F-4F3A-975E-A1D07286A0EB.pdf,E3FBF856-C09F-4F3A-975E-A1D07286A0EB,positive,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,770,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,NA,NA,NA,NA,A,80
ucec_tcga,TCGA-BG-A2AE,TCGA-BG-A2AE-01,57,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,50,0,NA,23.69,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,9/28/11,0.2380,G3,179,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,NA,NA,NA,NA,8,1,NA,NA,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,47,NA,TRUE,UEC,23.69,0:LIVING,NA,f384eb3f-92ab-4327-87eb-45b5f72a1580,273a3b52-7613-400e-8ae1-a68c36ab6968,NA,NA,NA,TCGA-BG-A2AE.BA5BC88E-6A6C-425E-84B4-EC33DB9AC146.pdf,BA5BC88E-6A6C-425E-84B4-EC33DB9AC146,NA,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,460,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,1.566666667,NA,NA,NA,A,135
ucec_tcga,TCGA-BG-A2L7,TCGA-BG-A2L7-01,68,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,141,0,NA,20.11,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,1/18/12,0.0004,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,1,0,NA,NA,15,0,NA,NA,NA,Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,20.11,0:LIVING,NA,214A09BB-CE52-4055-B036-065E8CB7AC7D,68328DE4-7DE9-4893-A402-F15C64C7718E,NA,NA,NA,TCGA-BG-A2L7.6A14E5E4-ED0F-415A-B54B-DE16D7DC6E78.pdf,6A14E5E4-ED0F-415A-B54B-DE16D7DC6E78,NA,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BG,NA,NA,NA,TUMOR FREE,A,NA
ucec_tcga,TCGA-BG-A3EW,TCGA-BG-A3EW-01,62,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage III,24,0,NA,11.3,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/28/12,0.0349,G3,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,2,0,NA,NA,9,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,11.3,0:LIVING,NA,A31554AF-D77A-4862-8AED-4581FB2BD877,BE387236-F691-4303-AA47-BE1D67CBDD5E,NA,NA,NA,TCGA-BG-A3EW.0463CA05-339C-4AB9-A236-CEAE733AD5F6.pdf,0463CA05-339C-4AB9-A236-CEAE733AD5F6,NA,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,NA,NA,12,TUMOR FREE,A,126
ucec_tcga,TCGA-BG-A3PP,TCGA-BG-A3PP-01,82,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage II,143,0,NA,21.85,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,7/2/12,0.4180,G3,NA,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,NA,NA,NA,NA,3,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,22.37,0:LIVING,NA,9F92080F-F6E0-42DB-A02B-B3069664F6D0,B3533E99-9A5D-46A5-8D7E-D1B6192D5EDD,NA,NA,NA,TCGA-BG-A3PP.728D12CF-B846-49B7-8B16-463460CAD5C0.pdf,728D12CF-B846-49B7-8B16-463460CAD5C0,positive,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,320,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BG,NA,NA,NA,TUMOR FREE,A,NA
ucec_tcga,TCGA-BK-A0C9,TCGA-BK-A0C9-01,57,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,192,0,NA,35.87,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/8/10,0.5839,G1,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,4,0,0,0,18,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,343,NA,FALSE,UEC,35.87,0:LIVING,NA,92a2cae3-b8ee-4ebb-ac5c-01e58749448f,155181e3-7733-44be-8ef8-7e24cebb59a4,NA,NA,NA,TCGA-BK-A0C9.3E14F5F3-2C40-403F-A499-BE64857E8559.pdf,3E14F5F3-2C40-403F-A499-BE64857E8559,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,490,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BK,11.36666667,NA,40,TUMOR FREE,A,127
ucec_tcga,TCGA-BK-A0CA,TCGA-BK-A0CA-01,61,NA,NA,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IIIC,86,0,NA,34.95,0:DiseaseFree,NA,FPPP,NOT HISPANIC OR LATINO,NA,2/8/11,0.0011,G3,163,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,32,29,NA,29,14,9,NA,9,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,37,NA,FALSE,UCEC,34.95,0:LIVING,NA,51bd85e2-2c60-4654-bfcb-83dccef8964b,d836db96-83fb-4f25-a16c-aaaaf55d7b12,NA,NA,NA,TCGA-BK-A0CA.883D4832-75FB-495C-B93F-904FCA1AB18C.pdf,883D4832-75FB-495C-B93F-904FCA1AB18C,negative,NA,NA,NA,TCGA,YES,WHITE,NA,RX,NO,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BK,1.233333333,NA,NA,TUMOR FREE,A,NA
ucec_tcga,TCGA-BK-A0CB,TCGA-BK-A0CB-01,60,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,64,0,NA,35.87,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/8/10,0.0500,G2,154,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,8,2,0,2,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Incisional Biopsy,NA,NA,56,NA,FALSE,UEC,35.87,0:LIVING,NA,59e9029a-8ddd-4447-b35a-72bc39f82a30,7678c70d-a298-4472-89a0-427af1e93d28,NA,NA,NA,TCGA-BK-A0CB.37923E3D-3CCB-41DB-8F30-C19FDE7407CB.pdf,37923E3D-3CCB-41DB-8F30-C19FDE7407CB,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,450,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BK,1.833333333,NA,76,TUMOR FREE,A,111
ucec_tcga,TCGA-BK-A0CC,TCGA-BK-A0CC-01,69,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,52,0,NA,33.18,1:Recurred/Progressed,NA,FPPP,HISPANIC OR LATINO,NA,10/8/10,0.5281,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,5,0,0,0,12,2,0,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Incisional Biopsy,NA,NA,34,NA,FALSE,USC,35.05,0:LIVING,NA,2b865f8c-539f-4cb2-8f08-41709e9511e5,ed22cb10-ebde-4019-9b6d-e19ab573ca94,NA,NA,NA,TCGA-BK-A0CC.6A2AAC78-98B9-44D4-AF8D-9A132579CC2D.pdf,6A2AAC78-98B9-44D4-AF8D-9A132579CC2D,negative,NA,NA,NA,TCGA,YES,BLACK OR AFRICAN AMERICAN,NA,RX,NO,1,310,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BK,1.1,NA,54,WITH TUMOR,A,72
ucec_tcga,TCGA-BK-A139,TCGA-BK-A139-01,74,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,175,0,NA,22.47,1:Recurred/Progressed,NA,FPPP,NOT HISPANIC OR LATINO,NA,2/23/11,0.4547,G3,154,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,9,0,0,0,24,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,78,NA,FALSE,UEC,30.98,1:DECEASED,NA,8d9e4917-334b-4c76-aee1-1e22be772db0,d777e49b-cb47-44f3-ad42-4d23af7e296c,NA,NA,NA,TCGA-BK-A139.5F8C376B-31F8-4566-8EBF-21E7F4E6499D.pdf,5F8C376B-31F8-4566-8EBF-21E7F4E6499D,NA,NA,NA,NA,TCGA,YES,WHITE,NA,R0,NO,2,770,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BK,2.6,NA,NA,TUMOR FREE,A,59
ucec_tcga,TCGA-BK-A139,TCGA-BK-A139-02,74,NA,NA,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IB,NA,0,NA,22.47,1:Recurred/Progressed,NA,FPPP,NOT HISPANIC OR LATINO,NA,2/23/11,0.6928,G3,154,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NA,NA,9,0,0,0,24,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,NA,UCEC,30.98,1:DECEASED,NA,8d9e4917-334b-4c76-aee1-1e22be772db0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TCGA,YES,WHITE,NA,R0,NO,2,NA,Recurrence,2,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BK,NA,NA,NA,TUMOR FREE,NA,59
ucec_tcga,TCGA-BK-A13B,TCGA-BK-A13B-01,58,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,140,0,NA,25.2,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,2/1/12,0.0344,G3,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,10,NA,NA,0,15,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,31.73,0:LIVING,NA,E71B3CE1-41E0-4CFC-9570-367B8C2124C1,9530BFBB-DFFC-4A16-9444-D51E24F8E843,NA,NA,NA,TCGA-BK-A13B.F8B15B22-27A6-4D7A-BCDC-B46EBCA5888E.pdf,F8B15B22-27A6-4D7A-BCDC-B46EBCA5888E,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,NA,NO,1,830,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,BK,NA,NA,NA,TUMOR FREE,A,131
ucec_tcga,TCGA-BK-A13C,TCGA-BK-A13C-01,47,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,146,0,NA,24.97,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/17/11,0.0343,G2,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,5,0,0,0,25,0,0,0,Peri (6-12 months since last menstrual period),Dilation and curettage procedure,NA,NA,38,NA,FALSE,UEC,24.97,0:LIVING,NA,ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38,7cc1bcb4-63a2-4585-b936-30a9e23caccc,NA,NA,NA,TCGA-BK-A13C.2043D579-6785-4775-8A28-CDE3F1400BA2.pdf,2043D579-6785-4775-8A28-CDE3F1400BA2,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,310,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BK,1.233333333,NA,17,TUMOR FREE,A,93
ucec_tcga,TCGA-BK-A26L,TCGA-BK-A26L-01,71,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC1,131,0,NA,24.11,0:DiseaseFree,NA,FPPP,NOT HISPANIC OR LATINO,NA,8/8/11,0.3822,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,3,0,0,0,10,0,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,24.11,0:LIVING,NA,ab7adf74-6e87-4117-9742-54e323348e06,cfde53b1-a992-4180-b747-b4c1d3ed2e2b,NA,NA,NA,TCGA-BK-A26L.979388A8-CC61-4C03-BADC-BEF9EC50C40A.pdf,979388A8-CC61-4C03-BADC-BEF9EC50C40A,negative,NA,NA,NA,TCGA,YES,WHITE,NA,RX,NO,1,320,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BK,NA,NA,80,NA,A,75
ucec_tcga,TCGA-BK-A4ZD,TCGA-BK-A4ZD-01,42,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,92,0,NA,16.62,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,2/28/13,0.8106,G3,163,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,NA,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,2,0,NA,0,14,0,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,16.62,0:LIVING,NA,1C4D225E-E065-4E26-9413-78F54A7E0CF5,115D93C2-9396-48BD-BA90-4CC4888AB821,NA,NA,NA,TCGA-BK-A4ZD.388C7674-9CA2-446C-A67D-9639A28ADEB4.pdf,388C7674-9CA2-446C-A67D-9639A28ADEB4,negative,NO,3,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,R0,NO,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BK,NA,Complete Remission/Response,25,TUMOR FREE,A,142
ucec_tcga,TCGA-BK-A56F,TCGA-BK-A56F-01,75,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,93,0,NA,13.17,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,4/2/13,0.0024,G1,163,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,NA,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,3,NA,NA,0,10,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,13.17,0:LIVING,NA,2D166DC0-8890-4B00-AB73-9E2DBB6C530D,EF8E84FF-3E1B-4543-99EE-56EE8687795C,NA,NA,NA,TCGA-BK-A56F.2778F3EE-0211-4B51-8FBE-050FC7A4D0FF.pdf,2778F3EE-0211-4B51-8FBE-050FC7A4D0FF,negative,NO,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,360,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,BK,NA,Complete Remission/Response,60,TUMOR FREE,A,84
ucec_tcga,TCGA-BK-A6W3,TCGA-BK-A6W3-01,34,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,94,0,NA,10.02,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,11/29/13,0.0003,G2,167,Endometrioid endometrial adenocarcinoma,NO,NA,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,NO,C54.1,8380/3,C54.1,YES,2013,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,10.02,0:LIVING,NA,119B1761-A5B4-42B6-9971-ECE11FB0E0F6,BB8C1148-9006-4819-920E-827BCFA9ADB5,NA,NA,NA,TCGA-BK-A6W3.15A94B35-48FD-4F94-94E4-25F8084F8B91.pdf,15A94B35-48FD-4F94-94E4-25F8084F8B91,negative,NO,3,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,R0,NO,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,BK,NA,Complete Remission/Response,NA,TUMOR FREE,A,89
ucec_tcga,TCGA-BK-A6W4,TCGA-BK-A6W4-01,62,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,118,0,NA,9.86,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,12/5/13,0.0000,G2,157,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2013,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NO,FALSE,UEC,9.86,0:LIVING,NA,8E7792B3-2B6C-47AC-ACBE-3DA7462A8321,780BB0AC-D5DD-447F-A280-3FF49D7849F2,NA,NA,NA,TCGA-BK-A6W4.5F25185F-4F80-4137-A07C-230FB3ACE3AE.pdf,5F25185F-4F80-4137-A07C-230FB3ACE3AE,NA,NO,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,BK,NA,Complete Remission/Response,32,TUMOR FREE,A,107
ucec_tcga,TCGA-BS-A0T9,TCGA-BS-A0T9-01,39,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,2009,0,NA,20.83,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,11/19/10,0.0504,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,2,0,0,1,2,0,0,2,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Tumor resection,NA,NA,51,NA,FALSE,UEC,46.91,1:DECEASED,NA,4eb95566-0e73-4260-853e-f7df650667a0,3c9ff865-013f-427a-8d4d-c8e60ea346a1,NA,NA,NA,TCGA-BS-A0T9.C9151621-D012-48F9-B7E1-F540567E791C.pdf,C9151621-D012-48F9-B7E1-F540567E791C,positive,NA,NA,NA,NA,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,R2,YES,1,600,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,1.733333333,NA,67,WITH TUMOR,A,109
ucec_tcga,TCGA-BS-A0TA,TCGA-BS-A0TA-01,58,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,1788,0,NA,19.09,1:Recurred/Progressed,NA,NA,HISPANIC OR LATINO,NA,11/19/10,0.0005,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,1,0,0,1,14,0,0,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Fine needle aspiration biopsy,NA,NA,295,NA,FALSE,UEC,24.31,1:DECEASED,NA,ad3d8420-f562-4cbe-ac82-c968bd4f782d,b6a042b6-f94a-4acc-98cb-a1a2fe72b9ad,NA,NA,NA,TCGA-BS-A0TA.5F009A9A-549F-4EEB-BB6D-C67353C7A292.pdf,5F009A9A-549F-4EEB-BB6D-C67353C7A292,negative,NA,NA,NA,NA,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,RX,YES,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,9.7,NA,88,WITH TUMOR,A,90
ucec_tcga,TCGA-BS-A0TC,TCGA-BS-A0TC-01,69,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2227,0,NA,85.48,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/19/10,0.0005,G1,147,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.3,8380/3,C54.3,YES,2004,NO,NA,3,0,0,0,20,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,1204,NA,FALSE,UEC,85.48,0:LIVING,NA,7b7d2d2b-abe6-4f32-add0-3715096995d1,c4c99327-b778-4e29-a111-75569ad38696,NA,NA,NA,TCGA-BS-A0TC.8AA64402-A062-410D-85B8-24DAD320916D.pdf,8AA64402-A062-410D-85B8-24DAD320916D,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,40.03333333,NA,9,TUMOR FREE,A,68
ucec_tcga,TCGA-BS-A0TD,TCGA-BS-A0TD-01,65,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2004,0,NA,78.15,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/19/10,0.0001,G1,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.9,8380/3,C54.9,YES,2005,NO,NA,0,NA,NA,NA,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,28,NA,FALSE,UEC,78.15,0:LIVING,NA,ffaa98a0-2b69-46dc-aee5-c5c3f2abbc38,8bb3a057-8958-4f62-af81-976da2e92df7,NA,NA,NA,TCGA-BS-A0TD.51ABEFF0-EEA1-48CA-9E00-CC57D1A2DEB0.pdf,51ABEFF0-EEA1-48CA-9E00-CC57D1A2DEB0,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,0.933333333333,NA,3,TUMOR FREE,A,85
ucec_tcga,TCGA-BS-A0TE,TCGA-BS-A0TE-01,35,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,1835,0,NA,1.91,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,11/19/10,0.6335,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.9,8380/3,C54.9,YES,2005,NO,NA,0,NA,NA,NA,6,0,4,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",biopsy of cervical tissue,NA,231,NA,FALSE,UEC,4.8,1:DECEASED,NA,09066fbf-6a1d-46c9-a4c5-c53340c3d1ba,2d1226a1-1c88-422b-9a8d-316bebeb65fd,NA,NA,NA,TCGA-BS-A0TE.8FD57BC9-19A1-4427-B68F-3E58639FEA40.pdf,8FD57BC9-19A1-4427-B68F-3E58639FEA40,positive,NA,NA,NA,NA,NO,ASIAN,NA,R2,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,7.666666667,NA,100,WITH TUMOR,A,91
ucec_tcga,TCGA-BS-A0TG,TCGA-BS-A0TG-01,60,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,1996,0,NA,77.89,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/19/10,0.0498,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,1,0,0,0,7,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,34,NA,FALSE,UEC,77.89,0:LIVING,NA,13f31bcb-befd-4ed2-adc0-dc9e9ce52b75,36e44603-a1ee-4a5b-9506-49a9358bf8d0,NA,NA,NA,TCGA-BS-A0TG.7A7B4B4B-5EE2-4D8D-A90A-DDFB96AE49A8.pdf,7A7B4B4B-5EE2-4D8D-A90A-DDFB96AE49A8,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,1.166666667,NA,40,TUMOR FREE,A,64
ucec_tcga,TCGA-BS-A0TI,TCGA-BS-A0TI-01,64,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,1507,0,NA,61.83,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/19/10,0.3669,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,4,0,0,0,14,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,75,NA,FALSE,UEC,61.83,0:LIVING,NA,df857bc6-fd6a-4713-bef9-6ee1301e5fb1,2f52c850-8e70-4eab-88f3-d35dc55e385b,NA,NA,NA,TCGA-BS-A0TI.60212550-2757-4AB0-B778-723AE046F6BE.pdf,60212550-2757-4AB0-B778-723AE046F6BE,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,2.5,NA,92,TUMOR FREE,A,59
ucec_tcga,TCGA-BS-A0TJ,TCGA-BS-A0TJ-01,59,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,1431,0,NA,67.94,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/19/10,0.0002,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,9,0,0,0,34,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,459,NA,FALSE,UEC,67.94,0:LIVING,NA,f74da4c6-4291-46d2-abd4-7d7f6ef03b00,ac35307b-ac7f-49fc-a237-5e03ab2e2276,NA,NA,NA,TCGA-BS-A0TJ.17D921D9-F2ED-4F8E-8C6F-729C9A0FE5B0.pdf,17D921D9-F2ED-4F8E-8C6F-729C9A0FE5B0,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,15.23333333,NA,58,TUMOR FREE,A,88
ucec_tcga,TCGA-BS-A0U5,TCGA-BS-A0U5-01,76,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2525,0,NA,96.42,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.0001,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2003,NO,NA,1,0,0,0,10,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,58,NA,FALSE,UEC,96.42,0:LIVING,NA,c306d7e8-5486-41d3-84dd-9311ce3e2069,48a5e048-b35d-4207-b45b-e72ac51e041d,NA,NA,NA,TCGA-BS-A0U5.8024498D-449C-45C6-B57D-846DDBA3FF30.pdf,8024498D-449C-45C6-B57D-846DDBA3FF30,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,1.933333333,NA,0,TUMOR FREE,A,59
ucec_tcga,TCGA-BS-A0U7,TCGA-BS-A0U7-01,63,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,2466,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.0908,G2,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2003,NO,NA,14,0,0,0,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,121,NA,FALSE,UEC,30.72,1:DECEASED,NA,282ddc43-922d-4f1f-80c7-6ba2de23b7bc,803c6d51-0eba-475a-9c3c-7b3401787907,NA,NA,NA,TCGA-BS-A0U7.BE83021F-D4D5-4ECA-8484-8A37B2FE67C0.pdf,BE83021F-D4D5-4ECA-8484-8A37B2FE67C0,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,4.033333333,NA,51,TUMOR FREE,A,66
ucec_tcga,TCGA-BS-A0U8,TCGA-BS-A0U8-01,55,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,2432,0,NA,97.34,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.0034,G1,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,1,0,0,0,4,0,0,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,281,NA,FALSE,UEC,97.34,0:LIVING,NA,fb7475df-30cc-4316-b9ac-37cbeeb6ba2b,e3e23393-8597-4091-a343-cd544111c63b,NA,NA,NA,TCGA-BS-A0U8.EAE30BBB-B895-42B9-8AAB-937278A3EBB0.pdf,EAE30BBB-B895-42B9-8AAB-937278A3EBB0,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,9.366666667,NA,100,TUMOR FREE,A,82
ucec_tcga,TCGA-BS-A0U9,TCGA-BS-A0U9-01,59,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIA,1637,0,NA,92.81,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/28/11,0.6511,G3,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,3,0,0,0,34,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,38,NA,FALSE,UEC,92.81,0:LIVING,NA,5ffa2ec6-2d94-4b09-8fb9-3591cf38fa4f,99d6d536-af2c-4c9b-9995-5b4032d54479,NA,NA,NA,TCGA-BS-A0U9.029B0BBB-D88D-4492-AC9A-9094E0DD101C.pdf,029B0BBB-D88D-4492-AC9A-9094E0DD101C,negative,NA,NA,NA,NA,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,RX,YES,1,430,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,1.266666667,NA,5,TUMOR FREE,B,99
ucec_tcga,TCGA-BS-A0UA,TCGA-BS-A0UA-01,68,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2361,0,NA,17.08,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.0000,G1,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,241,NA,FALSE,UEC,114.82,0:LIVING,NA,a1a0177d-e670-4f2f-a99d-6f668a2f9e8a,c72da85c-c6dc-4567-9db6-f15b044328dc,NA,NA,NA,TCGA-BS-A0UA.58DC7332-5100-408B-9A1E-F0282B013648.pdf,58DC7332-5100-408B-9A1E-F0282B013648,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,8.0,NA,26,TUMOR FREE,A,64
ucec_tcga,TCGA-BS-A0UF,TCGA-BS-A0UF-01,65,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2285,0,NA,85.78,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/28/11,0.0001,G3,147,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,4,0,0,0,9,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,7422,NA,FALSE,UEC,85.78,0:LIVING,NA,f77d7256-2ccf-42a7-9b30-332ac24ca812,c805f55a-322f-4a11-ae0c-4bbc365d1bd6,NA,NA,NA,TCGA-BS-A0UF.719E2A48-0E04-4EAD-A5CC-6416450FC68F.pdf,719E2A48-0E04-4EAD-A5CC-6416450FC68F,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,246.9666667,NA,30,TUMOR FREE,A,57
ucec_tcga,TCGA-BS-A0UJ,TCGA-BS-A0UJ-01,68,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2180,0,NA,82.33,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.0001,G1,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,1442,NA,FALSE,UEC,82.33,0:LIVING,NA,ff82548a-f1bb-4daa-a8f7-b3831b5843ad,2ea1339f-a5eb-4552-ac13-858fa70e606e,NA,NA,NA,TCGA-BS-A0UJ.DEE9AA2E-DA73-4074-9588-C75DDEC4D29B.pdf,DEE9AA2E-DA73-4074-9588-C75DDEC4D29B,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,48.1,NA,0,TUMOR FREE,A,52
ucec_tcga,TCGA-BS-A0UL,TCGA-BS-A0UL-01,54,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,2155,0,NA,81.5,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.0001,G1,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2004,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Peri (6-12 months since last menstrual period),Dilation and curettage procedure,NA,NA,296,NA,FALSE,UEC,81.5,0:LIVING,NA,5428c4b2-37c2-4f8c-a474-39fe1aacb26b,d9a2756b-472f-4eee-9d76-91f4320f8a1a,NA,NA,NA,TCGA-BS-A0UL.323FC36E-D8E3-4F6B-A8FE-2040F3E44BB9.pdf,323FC36E-D8E3-4F6B-A8FE-2040F3E44BB9,negative,NA,NA,NA,NA,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,9.8,NA,0,TUMOR FREE,A,114
ucec_tcga,TCGA-BS-A0UM,TCGA-BS-A0UM-01,64,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,2072,0,NA,47.77,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,NA,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,4,0,0,0,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,279,NA,FALSE,UEC,86.86,0:LIVING,NA,a7c565fc-c711-4b63-9549-4cd74d1f57c2,6f70f18e-5c53-4f1f-a63d-62bd27039b8d,NA,NA,NA,TCGA-BS-A0UM.97354B28-9E9A-4DBD-B0C7-79C1165AD1CA.pdf,97354B28-9E9A-4DBD-B0C7-79C1165AD1CA,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,9.233333333,NA,22,WITH TUMOR,A,90
ucec_tcga,TCGA-BS-A0UT,TCGA-BS-A0UT-01,62,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,1886,0,NA,72.67,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.1947,G2,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,5,0,0,0,22,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,41,NA,FALSE,UEC,72.67,0:LIVING,NA,e2b1d0de-5221-44a1-8fad-9708a3cada14,824d0dbc-293f-4893-a68c-24dedd437ea5,NA,NA,NA,TCGA-BS-A0UT.326838B8-D069-4F9C-9353-F806B56DCA48.pdf,326838B8-D069-4F9C-9353-F806B56DCA48,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,1.366666667,NA,33,TUMOR FREE,A,65
ucec_tcga,TCGA-BS-A0UV,TCGA-BS-A0UV-01,55,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,1902,0,NA,73.19,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/28/11,0.1249,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2005,NO,NA,8,0,0,0,8,0,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,7845,NA,FALSE,UEC,73.19,0:LIVING,NA,b19425ab-a82f-4c2a-bf58-d1bd30511d74,30945527-528a-448e-8db4-2e0c31c9016d,NA,NA,NA,TCGA-BS-A0UV.9414D0B9-3126-42E9-8189-7C1EC38B2AAB.pdf,9414D0B9-3126-42E9-8189-7C1EC38B2AAB,negative,NA,NA,NA,NA,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,R0,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,260.7333333,NA,65,TUMOR FREE,A,112
ucec_tcga,TCGA-BS-A0V4,TCGA-BS-A0V4-01,56,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1576,0,NA,59.46,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.0307,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,2,0,0,0,33,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,59.46,0:LIVING,NA,e3f515f8-a940-40d1-86b0-baed0f410f2c,dd12111e-9001-4d8d-b8f3-5801b4ab529b,NA,NA,NA,TCGA-BS-A0V4.AA0FFBF8-693C-484E-A29D-02F859E1E4C5.pdf,AA0FFBF8-693C-484E-A29D-02F859E1E4C5,negative,NA,NA,NA,NA,NO,WHITE,NA,NA,YES,1,310,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,NA,NA,4,TUMOR FREE,A,96
ucec_tcga,TCGA-BS-A0V6,TCGA-BS-A0V6-01,55,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1462,0,NA,89.52,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/28/11,0.0002,G1,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,8,0,0,0,22,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,43,NA,FALSE,UEC,89.52,0:LIVING,NA,a9b6cd65-f042-4073-9000-4143a2c55373,1c337d11-f2ac-48cf-9c8f-ec27550876ea,NA,NA,NA,TCGA-BS-A0V6.657466BC-3CA2-4568-BF64-2905571C3666.pdf,657466BC-3CA2-4568-BF64-2905571C3666,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,1.433333333,NA,5.6,TUMOR FREE,A,83
ucec_tcga,TCGA-BS-A0V7,TCGA-BS-A0V7-01,48,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1455,0,NA,63.53,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/28/11,0.0001,G1,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,1,0,0,0,26,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",suction using pipelle,NA,36,NA,FALSE,UEC,63.53,0:LIVING,NA,ca858743-1f06-40e3-accf-395d08375b63,a772ab94-cb06-464c-9a5a-fa4978510f9b,NA,NA,NA,TCGA-BS-A0V7.A4515806-9888-48E8-8F9E-491527FFC29C.pdf,A4515806-9888-48E8-8F9E-491527FFC29C,negative,NA,NA,NA,NA,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,1.2,NA,36.7,TUMOR FREE,A,102
ucec_tcga,TCGA-BS-A0V8,TCGA-BS-A0V8-01,68,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,1410,0,NA,83.57,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/28/11,0.5415,G2,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,5,0,0,0,13,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,66,NA,FALSE,UEC,83.57,0:LIVING,NA,2b76cc9c-c379-43e4-9c3f-56197a3353be,cf369a2c-d3c3-4fa3-b004-e4269530ceff,NA,NA,NA,TCGA-BS-A0V8.A024F121-F6C9-4CDF-B0ED-B58708DB6DFE.pdf,A024F121-F6C9-4CDF-B0ED-B58708DB6DFE,negative,NA,NA,NA,NA,NO,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NA,R1,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,2.2,NA,75,TUMOR FREE,A,85
ucec_tcga,TCGA-BS-A0VI,TCGA-BS-A0VI-01,58,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,1514,0,NA,86.93,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/28/11,0.0440,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,1,0,0,0,23,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,86.93,0:LIVING,NA,3405c549-7da5-48ee-ba48-177a67bbcc5d,698a5085-0137-4bd8-a8c0-f749d03fbd95,NA,NA,NA,TCGA-BS-A0VI.EC10AA0B-A597-4224-8807-52F7228C6D07.pdf,EC10AA0B-A597-4224-8807-52F7228C6D07,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,340,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,NA,NA,93,TUMOR FREE,A,91
ucec_tcga,TCGA-BS-A0WQ,TCGA-BS-A0WQ-01,55,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,1696,0,NA,66.43,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/25/11,0.0471,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,11,0,0,0,14,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,41,NA,FALSE,UEC,66.43,0:LIVING,NA,e095a927-d985-4fbd-8093-46c1c6ace4de,b19275ba-cff5-4ec7-ac23-d6be497adef2,NA,NA,NA,TCGA-BS-A0WQ.207B2565-ABB2-4F05-8B54-2280DAC57AD3.pdf,207B2565-ABB2-4F05-8B54-2280DAC57AD3,negative,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,BS,1.366666667,NA,0,TUMOR FREE,A,93
ucec_tcga,TCGA-D1-A0ZN,TCGA-D1-A0ZN-01,60,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,567,0,NA,14.72,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,3/4/11,0.0767,G1,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,0,0,0,0,Peri (6-12 months since last menstrual period),Tumor resection,NA,NA,38,NA,FALSE,UEC,16.82,0:LIVING,NA,916ccf0d-02ef-4ccb-824b-6b4294095a08,87d4a16c-1a19-4234-b946-aea11d70169b,NA,NA,NA,TCGA-D1-A0ZN.53DB2270-9308-47F5-BD1F-4D4C737F98AC.pdf,53DB2270-9308-47F5-BD1F-4D4C737F98AC,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.266666667,NA,0,TUMOR FREE,A,82
ucec_tcga,TCGA-D1-A0ZO,TCGA-D1-A0ZO-01,75,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,586,0,NA,19.78,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/4/11,0.0834,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,18,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,419,NA,FALSE,UEC,19.78,0:LIVING,NA,b3d635b3-d7ac-4cf8-a318-0a9dd0073e89,9c617822-c9a8-42c5-aab7-d6f22887c325,NA,NA,NA,TCGA-D1-A0ZO.13826E23-2184-4D03-B67C-B312BF4FA87E.pdf,13826E23-2184-4D03-B67C-B312BF4FA87E,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,13.96666667,NA,30,TUMOR FREE,A,110
ucec_tcga,TCGA-D1-A0ZP,TCGA-D1-A0ZP-01,59,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVA,552,0,NA,20.66,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,3/7/11,0.1861,G3,161,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,19,0,0,0,51,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,30,NA,FALSE,USC,29.93,0:LIVING,NA,ac216bb5-15e4-4462-955e-8a522380690e,41a4ef51-9560-4089-a08a-624a64a168d5,NA,NA,NA,TCGA-D1-A0ZP.FD46BB74-914F-4B4E-819A-5AD5F4548672.pdf,FD46BB74-914F-4B4E-819A-5AD5F4548672,positive,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.0,NA,30,WITH TUMOR,A,58
ucec_tcga,TCGA-D1-A0ZQ,TCGA-D1-A0ZQ-01,90,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,540,0,NA,8.54,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/7/11,0.1772,G2,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,73,NA,FALSE,UEC,8.54,0:LIVING,NA,38243a33-073a-479b-8cf6-c8847aeb5a48,e20471d5-a261-448b-9a6f-fd3be8ed5c04,NA,NA,NA,TCGA-D1-A0ZQ.BAC6E925-0499-41AD-9F58-2CB8E3EE058E.pdf,BAC6E925-0499-41AD-9F58-2CB8E3EE058E,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,2.433333333,NA,60,TUMOR FREE,A,69
ucec_tcga,TCGA-D1-A0ZR,TCGA-D1-A0ZR-01,57,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,537,0,NA,0.56,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/8/11,0.0341,G2,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,10,0,0,0,48,0,0,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,46,NA,FALSE,UEC,0.56,0:LIVING,NA,0ce940f2-9eb1-4757-8f8f-147a4f3a1e67,6647e6db-bba8-4e27-b24f-fc886d777906,NA,NA,NA,TCGA-D1-A0ZR.ECC5B77F-7B6C-4C4A-A32C-1346DC3AF24D.pdf,ECC5B77F-7B6C-4C4A-A32C-1346DC3AF24D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.5,NA,12,TUMOR FREE,A,117
ucec_tcga,TCGA-D1-A0ZS,TCGA-D1-A0ZS-01,54,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,308,0,NA,4.86,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/8/11,0.0000,G3,164,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,19,0,0,0,27,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,292,NA,FALSE,UEC,4.86,0:LIVING,NA,80105773-372e-4552-a10b-5df188b15b16,e914e3db-e907-495a-9b59-43e07132052a,NA,NA,NA,TCGA-D1-A0ZS.313BCAEC-965D-4FF4-BAAA-3CAF48C739C6.pdf,313BCAEC-965D-4FF4-BAAA-3CAF48C739C6,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,9.633333333,NA,40,TUMOR FREE,A,62
ucec_tcga,TCGA-D1-A0ZU,TCGA-D1-A0ZU-01,34,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,508,0,NA,28.65,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/8/11,0.0964,G2,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8382/3,C54.1,YES,2009,NO,NA,0,0,0,0,0,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,31,NA,FALSE,UEC,28.65,0:LIVING,NA,d74bc72e-8103-4aed-8958-5f40953d48eb,7b90b0fe-1088-48e9-8903-6102f27e4485,NA,NA,NA,TCGA-D1-A0ZU.D0BC0903-390B-4344-A613-48ABF71CF08D.pdf,D0BC0903-390B-4344-A613-48ABF71CF08D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.033333333,NA,5,TUMOR FREE,A,94
ucec_tcga,TCGA-D1-A0ZV,TCGA-D1-A0ZV-01,58,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,324,0,NA,23.92,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/8/11,0.0000,G2,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,23,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,36,NA,FALSE,UEC,23.92,0:LIVING,NA,0c01c673-e396-47b2-9562-4144d7705ebf,a1cb5589-26dd-4d0e-9447-375ebeca6b78,NA,NA,NA,TCGA-D1-A0ZV.C9AE2762-705F-4061-B3B6-325426D0C0C8.pdf,C9AE2762-705F-4061-B3B6-325426D0C0C8,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.166666667,NA,30,TUMOR FREE,A,77
ucec_tcga,TCGA-D1-A0ZZ,TCGA-D1-A0ZZ-01,80,NA,NA,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IB,349,0,NA,22.54,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/8/11,0.5039,G3,154,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,12,0,0,0,26,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,57,NA,FALSE,UCEC,22.54,0:LIVING,NA,4d3af3af-24f4-415a-9677-20b0f366a102,c797e9d4-3f3e-48d9-870f-e8ea6bddfd91,NA,NA,NA,TCGA-D1-A0ZZ.4339EAC6-F56E-49E6-8EF9-2256165CADB5.pdf,4339EAC6-F56E-49E6-8EF9-2256165CADB5,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.866666667,NA,11,TUMOR FREE,A,51
ucec_tcga,TCGA-D1-A101,TCGA-D1-A101-01,60,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,349,0,NA,1.74,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/8/11,0.0002,G2,150,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,195,NA,FALSE,UEC,1.74,0:LIVING,NA,9da5ecd0-a287-4e67-84b6-af9077a98009,34fcec04-7c8f-4964-83eb-c7f81c475c79,NA,NA,NA,TCGA-D1-A101.2D6287C8-9C22-4046-8F14-3886DDE62695.pdf,2D6287C8-9C22-4046-8F14-3886DDE62695,negative,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,6.4,NA,10,TUMOR FREE,A,82
ucec_tcga,TCGA-D1-A102,TCGA-D1-A102-01,49,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,380,0,NA,4.43,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/8/11,0.1758,G2,178,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,45,0,0,0,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,37,NA,FALSE,UEC,4.43,0:LIVING,NA,f9cf4125-0db3-4b66-b51b-bc2f0240c9ef,eef5bd16-dc47-47da-baa9-295b8c28361b,NA,NA,NA,TCGA-D1-A102.9983D576-706A-48D2-93EE-70EABB3BD77C.pdf,9983D576-706A-48D2-93EE-70EABB3BD77C,negative,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.233333333,NA,13,TUMOR FREE,A,122
ucec_tcga,TCGA-D1-A103,TCGA-D1-A103-01,87,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,376,0,NA,21.98,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/8/11,0.0001,G1,150,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,5998,NA,FALSE,UEC,21.98,0:LIVING,NA,7427f9e8-1140-45fd-9613-78b72b13a7ba,7430a6c2-758a-4a56-8168-865b3463c2db,NA,NA,NA,TCGA-D1-A103.AE2FAD3D-FA6A-4648-90A5-2D2C442796AF.pdf,AE2FAD3D-FA6A-4648-90A5-2D2C442796AF,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,199.5333333,NA,0,TUMOR FREE,A,60
ucec_tcga,TCGA-D1-A15V,TCGA-D1-A15V-01,68,NA,1995,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,895,0,NA,39.45,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/8/11,0.3738,G3,160,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,16,0,0,0,38,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,36,NA,FALSE,USC,39.45,0:LIVING,NA,f7010b87-a559-4501-99f9-0fcca1e986e1,8bf1146c-8442-47b5-83af-f7899d4a94a6,NA,NA,NA,TCGA-D1-A15V.597F20F2-AE36-4A9F-A7AF-1647CB56B453.pdf,597F20F2-AE36-4A9F-A7AF-1647CB56B453,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.2,NA,20,TUMOR FREE,A,69
ucec_tcga,TCGA-D1-A15W,TCGA-D1-A15W-01,58,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,906,0,NA,30.06,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0024,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,8,0,0,0,34,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,62,NA,FALSE,UEC,30.06,0:LIVING,NA,d6562acf-6d82-4f08-a779-82cdc5df16f9,1ac48153-0577-4bc0-ab8c-f77453ebfbb0,NA,NA,NA,TCGA-D1-A15W.1C938760-9492-4F4E-87CE-85CE3C15BBCA.pdf,1C938760-9492-4F4E-87CE-85CE3C15BBCA,negative,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,2.033333333,NA,38,TUMOR FREE,A,126
ucec_tcga,TCGA-D1-A15X,TCGA-D1-A15X-01,45,NA,1995,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,897,0,NA,29.86,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0006,High Grade,169,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,16,0,0,0,29,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,1333,NA,FALSE,USC,29.86,0:LIVING,NA,14c03068-8930-472a-9fd1-49c9fd4db47d,c81d521c-70f9-4299-87d2-02173751efc8,NA,NA,NA,TCGA-D1-A15X.F32EB1C9-4802-4873-8F0E-E10724DA9C15.pdf,F32EB1C9-4802-4873-8F0E-E10724DA9C15,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,44.43333333,NA,0,TUMOR FREE,A,72
ucec_tcga,TCGA-D1-A15Z,TCGA-D1-A15Z-01,72,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,884,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0465,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,5,0,0,0,28,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,69,NA,FALSE,UEC,1.91,1:DECEASED,NA,c5df9142-27f6-4d97-933e-c79ea9199362,7a961c2f-2e7f-4eb0-945b-9f0d59923962,NA,NA,NA,TCGA-D1-A15Z.280F86BF-4834-4FA9-B153-DE7BE312E619.pdf,280F86BF-4834-4FA9-B153-DE7BE312E619,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,2.266666667,NA,30,TUMOR FREE,A,125
ucec_tcga,TCGA-D1-A160,TCGA-D1-A160-01,70,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,895,0,NA,3.68,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0341,G2,172,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,13,0,0,0,29,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,361,NA,FALSE,UEC,3.68,0:LIVING,NA,170bbbac-940f-4e1b-b0b8-60fa36d0fa23,b36ecf21-9d51-43dc-b2fb-6f6156e85875,NA,NA,NA,TCGA-D1-A160.F349C87E-F324-4A8E-81E1-153C99173E21.pdf,F349C87E-F324-4A8E-81E1-153C99173E21,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,12.06666667,NA,20,TUMOR FREE,A,122
ucec_tcga,TCGA-D1-A161,TCGA-D1-A161-01,78,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,864,0,NA,29.3,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0468,G1,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,9,0,0,0,21,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,71,NA,FALSE,UEC,29.3,0:LIVING,NA,0305db4a-62ee-4ecb-bede-032981298732,94ad0779-7342-4f52-a6da-aed090129cd1,NA,NA,NA,TCGA-D1-A161.E68A0ED2-CBE3-40A9-8DBF-A3BBC49204DD.pdf,E68A0ED2-CBE3-40A9-8DBF-A3BBC49204DD,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,2.366666667,NA,70,TUMOR FREE,A,71
ucec_tcga,TCGA-D1-A162,TCGA-D1-A162-01,69,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,874,0,NA,37.61,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,NA,G1,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,16,0,0,0,45,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,37.61,0:LIVING,NA,3f96b142-77b6-40a1-8e16-6581b964583b,4357a0dc-7d05-4c36-949f-8b30e91e208a,NA,NA,NA,TCGA-D1-A162.CB5E7FA1-33EE-492F-B2B0-F4C9332640A9.pdf,CB5E7FA1-33EE-492F-B2B0-F4C9332640A9,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,50,TUMOR FREE,A,100
ucec_tcga,TCGA-D1-A163,TCGA-D1-A163-01,50,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,854,0,NA,7.33,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0001,G2,169,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,38,0,0,0,53,2,0,2,Peri (6-12 months since last menstrual period),Dilation and curettage procedure,NA,NA,380,NA,FALSE,UEC,32.56,0:LIVING,NA,a438dce7-6592-4ea6-a401-57f5a8fe8ba6,8e3afec6-eb01-404f-ae76-08590b3c0ad0,NA,NA,NA,TCGA-D1-A163.993B9CE9-7D25-4B2B-B246-F642550C70CD.pdf,993B9CE9-7D25-4B2B-B246-F642550C70CD,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,12.73333333,NA,12,TUMOR FREE,A,109
ucec_tcga,TCGA-D1-A165,TCGA-D1-A165-01,64,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,848,0,NA,0.66,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.1588,G1,181,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,13,0,0,0,30,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,51,NA,FALSE,UEC,0.66,0:LIVING,NA,9bc2f33f-3067-4000-bc8a-1c5bb671d101,ba3d9cb2-0d1c-4f3b-b1b8-a6dd4ac9adef,NA,NA,NA,TCGA-D1-A165.476F8219-DAAE-4DB3-BA31-C64AC24ACF65.pdf,476F8219-DAAE-4DB3-BA31-C64AC24ACF65,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.7,NA,25,TUMOR FREE,A,87
ucec_tcga,TCGA-D1-A167,TCGA-D1-A167-01,70,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,841,0,NA,15.7,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0001,G2,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,20,0,0,0,52,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,1362,NA,FALSE,UEC,15.7,0:LIVING,NA,3d215e20-9eea-47e0-849e-cff1fee5634d,96112beb-64c2-40bc-b1f9-784581cc88e3,NA,NA,NA,TCGA-D1-A167.4E67EAA4-3069-4B62-A403-9300A9FA494C.pdf,4E67EAA4-3069-4B62-A403-9300A9FA494C,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,45.33333333,NA,60,TUMOR FREE,A,72
ucec_tcga,TCGA-D1-A168,TCGA-D1-A168-01,67,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,821,0,NA,36.07,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.2320,G3,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,19,0,0,0,49,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,50,NA,FALSE,UEC,36.07,0:LIVING,NA,41893e97-7e90-4b03-b738-260f288ade4c,b44c673e-9560-4b59-9ff3-34ce230cad1c,NA,NA,NA,TCGA-D1-A168.B9D9D808-17B1-415F-9E58-4FDBC1BF30C0.pdf,B9D9D808-17B1-415F-9E58-4FDBC1BF30C0,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.566666667,NA,35,TUMOR FREE,A,76
ucec_tcga,TCGA-D1-A169,TCGA-D1-A169-01,63,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IV,800,0,NA,17.05,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.2083,G2,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,23,0,0,0,29,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,40,NA,FALSE,UEC,37.29,0:LIVING,NA,9a599f57-0e8d-4e1f-a181-791f5fdeadb7,9b36f264-55c3-4e08-a151-4b356871520c,NA,NA,NA,TCGA-D1-A169.F7B4C0DC-2259-4A0A-81D3-E145EFA91279.pdf,F7B4C0DC-2259-4A0A-81D3-E145EFA91279,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.333333333,NA,45,WITH TUMOR,A,102
ucec_tcga,TCGA-D1-A16B,TCGA-D1-A16B-01,64,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,793,0,NA,36.33,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0001,G2,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,12,0,0,0,18,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,47,NA,FALSE,UEC,36.33,0:LIVING,NA,bca1057a-1e96-404d-8a37-5a8dc1944ee7,6a59ff6e-7cc6-4d46-8983-7d9e6a48cc19,NA,NA,NA,TCGA-D1-A16B.1B9ED459-4046-4DD9-ABA5-E815A90601A3.pdf,1B9ED459-4046-4DD9-ABA5-E815A90601A3,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.566666667,NA,56,TUMOR FREE,A,86
ucec_tcga,TCGA-D1-A16D,TCGA-D1-A16D-01,49,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,799,0,NA,37.48,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0003,G2,164,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,0,0,0,34,0,0,0,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,38,NA,FALSE,UEC,37.48,0:LIVING,NA,5693302a-4548-4c0b-8725-0cb7c67bc4f8,007bdfd3-81b6-42c3-a4a6-c4ddaf1be0ae,NA,NA,NA,TCGA-D1-A16D.795A5264-493A-498D-A731-87ECB0A7F612.pdf,795A5264-493A-498D-A731-87ECB0A7F612,negative,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.266666667,NA,86,TUMOR FREE,A,151
ucec_tcga,TCGA-D1-A16E,TCGA-D1-A16E-01,73,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,790,0,NA,36.76,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0001,G1,154,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,47,NA,FALSE,UEC,36.76,0:LIVING,NA,e70465f6-1922-4eb7-b646-8b01ad3ce77b,58fc1e66-39c4-44d1-bdd3-338e0d833792,NA,NA,NA,TCGA-D1-A16E.DF926973-D344-48AE-A6F6-5901A4A8C846.pdf,DF926973-D344-48AE-A6F6-5901A4A8C846,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.6,NA,25,TUMOR FREE,A,60
ucec_tcga,TCGA-D1-A16F,TCGA-D1-A16F-01,60,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,783,0,NA,2.63,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,NA,G2,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,6,0,0,0,15,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,275,NA,FALSE,UEC,2.63,0:LIVING,NA,60c65e5e-57a4-4f15-8b95-30bd2dbd9010,25b73036-0cd7-43e1-b40e-b2e01c1b7247,NA,NA,NA,TCGA-D1-A16F.E89C4CBF-45D5-405D-A673-F67186C206B3.pdf,E89C4CBF-45D5-405D-A673-F67186C206B3,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,9.066666667,NA,25,TUMOR FREE,A,90
ucec_tcga,TCGA-D1-A16G,TCGA-D1-A16G-01,74,NA,1995,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IV,769,0,NA,21.09,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.1014,High Grade,173,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,15,0,0,0,30,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,27,NA,FALSE,USC,27.4,1:DECEASED,NA,16e69011-c295-479f-b521-86e66fba498d,4c34ecb0-9351-4a55-9ff5-2062b7cb391a,NA,NA,NA,TCGA-D1-A16G.778F9F58-841E-48F3-B6EA-7CF58463808B.pdf,778F9F58-841E-48F3-B6EA-7CF58463808B,positive,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,0.933333333333,NA,100,WITH TUMOR,A,75
ucec_tcga,TCGA-D1-A16I,TCGA-D1-A16I-01,62,NA,1995,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IC,763,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.3811,High Grade,163,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,22,0,0,0,29,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,31,NA,FALSE,USC,11.5,1:DECEASED,NA,548ec160-4183-459f-8393-f4b4672a3251,62a1ff9f-f730-4703-8271-89e1a123da65,NA,NA,NA,TCGA-D1-A16I.3D30B053-444A-4F4D-B451-EB8746A157A2.pdf,3D30B053-444A-4F4D-B451-EB8746A157A2,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.033333333,NA,66,TUMOR FREE,A,84
ucec_tcga,TCGA-D1-A16J,TCGA-D1-A16J-01,61,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,735,0,NA,29.89,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.1060,G2,174,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,13,0,0,0,50,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,167,NA,FALSE,UEC,29.89,0:LIVING,NA,4db4d048-016a-4186-a519-bfbad237762f,535b69fc-e529-4615-b789-3756eddda1cd,NA,NA,NA,TCGA-D1-A16J.7A1F7567-5D17-4074-B099-1E60C8069FA1.pdf,7A1F7567-5D17-4074-B099-1E60C8069FA1,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,5.533333333,NA,100,TUMOR FREE,A,130
ucec_tcga,TCGA-D1-A16N,TCGA-D1-A16N-01,51,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,629,0,NA,31.04,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.5101,G3,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,10,0,0,0,49,0,0,0,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,94,NA,FALSE,UEC,31.04,0:LIVING,NA,dbbbddae-d711-40f5-bd10-863735885b1f,6d916a47-dcff-4c98-9e88-348aaa353f98,NA,NA,NA,TCGA-D1-A16N.81CFA07C-5FCE-41F3-88D1-FFD17840B293.pdf,81CFA07C-5FCE-41F3-88D1-FFD17840B293,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,3.133333333,NA,42,TUMOR FREE,A,89
ucec_tcga,TCGA-D1-A16O,TCGA-D1-A16O-01,44,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,756,0,NA,33.61,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0635,G1,169,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,32,NA,FALSE,UEC,33.61,0:LIVING,NA,8f508b78-cdc6-4a3d-b86e-520746d78653,a2befa03-27ec-4d5a-bf12-6ded95a4dd18,NA,NA,NA,TCGA-D1-A16O.B4EFFDB8-CB4C-46D7-96AD-9D33DF7163C0.pdf,B4EFFDB8-CB4C-46D7-96AD-9D33DF7163C0,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.066666667,NA,12,TUMOR FREE,A,102
ucec_tcga,TCGA-D1-A16Q,TCGA-D1-A16Q-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,136,0,NA,10.64,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0061,G2,172,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,19,0,0,0,74,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,28,NA,FALSE,UEC,10.64,0:LIVING,NA,7f4f3aed-69af-421e-817b-b258dcc0bac5,bfe3da05-506e-4837-ac72-a285fe079c58,NA,NA,NA,TCGA-D1-A16Q.60635568-D27E-4C72-BFF2-238CF2992925.pdf,60635568-D27E-4C72-BFF2-238CF2992925,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,0.966666666667,NA,77,TUMOR FREE,A,117
ucec_tcga,TCGA-D1-A16R,TCGA-D1-A16R-01,39,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,161,0,NA,0.69,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0525,G1,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,0,0,0,49,0,0,0,Indeterminate (neither Pre or Postmenopausal),Dilation and curettage procedure,NA,NA,38,NA,FALSE,UEC,0.69,0:LIVING,NA,40f43483-b504-4ea7-ad24-40682b10caac,f57eb4ed-4393-4dc3-9362-a4757ef8b21d,NA,NA,NA,TCGA-D1-A16R.D9641375-D204-4469-989A-ED08DDE66408.pdf,D9641375-D204-4469-989A-ED08DDE66408,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,290,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.266666667,NA,19,TUMOR FREE,A,105
ucec_tcga,TCGA-D1-A16S,TCGA-D1-A16S-01,70,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,177,0,NA,18.66,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.4270,High Grade,162,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,20,0,0,0,35,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,43,NA,FALSE,USC,18.66,0:LIVING,NA,0b670df6-c487-4ed6-9b48-ef4b01a1aec3,8e157714-099f-4496-ad37-0b83c76797bc,NA,NA,NA,TCGA-D1-A16S.D69D2E09-B195-4F3F-B5A1-821A87852266.pdf,D69D2E09-B195-4F3F-B5A1-821A87852266,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,290,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.433333333,NA,100,TUMOR FREE,A,59
ucec_tcga,TCGA-D1-A16V,TCGA-D1-A16V-01,78,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,609,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.3077,G3,173,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,30,7,0,7,35,15,0,15,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,FALSE,UEC,3.94,1:DECEASED,NA,8b19c8ac-68e6-4dc8-aec9-1556e62ca20f,67d0886e-54be-4771-aee7-63adf4a475b7,NA,NA,NA,TCGA-D1-A16V.92EA83B6-8041-4449-BAE6-5060C32966D0.pdf,92EA83B6-8041-4449-BAE6-5060C32966D0,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,410,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,73,TUMOR FREE,A,105
ucec_tcga,TCGA-D1-A16X,TCGA-D1-A16X-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,618,0,NA,3.65,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0001,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,26,0,0,0,46,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,1774,NA,FALSE,UEC,3.65,0:LIVING,NA,22618073-4ef0-4c3a-97b9-90ba1caa1d72,6421d807-9bec-4ad4-8b75-8f9dd594a977,NA,NA,NA,TCGA-D1-A16X.0C395D2C-1864-448E-8FB7-09BFE5FF4C50.pdf,0C395D2C-1864-448E-8FB7-09BFE5FF4C50,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,58.96666667,NA,18,TUMOR FREE,A,101
ucec_tcga,TCGA-D1-A16Y,TCGA-D1-A16Y-01,56,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,610,0,NA,17.48,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0000,G1,156,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,6,0,0,0,20,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,961,NA,FALSE,UEC,17.48,0:LIVING,NA,0e9c36fd-2d5d-48da-8364-f8c5edc3d873,56b2dbc4-9ab6-43ef-9d86-a39d4a60a18d,NA,NA,NA,TCGA-D1-A16Y.0A0451C4-2A58-4404-934E-3517443E4CEE.pdf,0A0451C4-2A58-4404-934E-3517443E4CEE,negative,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,32.03333333,NA,8,TUMOR FREE,A,87
ucec_tcga,TCGA-D1-A174,TCGA-D1-A174-01,51,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,219,0,NA,19.51,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0006,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,9,0,0,0,19,0,0,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,525,NA,FALSE,UEC,19.51,0:LIVING,NA,fc7315b0-9f48-4206-b197-2268c0518eb4,ad5a9cb6-b3f9-4651-b6d1-13c78010bd88,NA,NA,NA,TCGA-D1-A174.E45B2436-C0B2-44C3-B400-49C668114B01.pdf,E45B2436-C0B2-44C3-B400-49C668114B01,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,17.5,NA,8,TUMOR FREE,A,65
ucec_tcga,TCGA-D1-A175,TCGA-D1-A175-01,48,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,566,0,NA,6.64,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/13/11,0.0001,G3,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,17,0,0,0,23,0,0,0,Indeterminate (neither Pre or Postmenopausal),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,6.64,0:LIVING,NA,f0b3ab10-43f8-48a8-b460-66ceaaf637db,07bfbb0c-b58b-4364-b12e-dca462c5b43e,NA,NA,NA,TCGA-D1-A175.4A0D74F3-74A0-4CAE-960B-71D37DF4F4DE.pdf,4A0D74F3-74A0-4CAE-960B-71D37DF4F4DE,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,90,TUMOR FREE,A,64
ucec_tcga,TCGA-D1-A176,TCGA-D1-A176-01,67,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,555,0,NA,30.12,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0392,G2,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,33,0,NA,0,57,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,279,NA,FALSE,UEC,30.12,0:LIVING,NA,6d061ca9-ba7e-4b82-ab3c-34e33f244a54,b66b5979-62a1-4938-a655-aeff90d2d472,NA,NA,NA,TCGA-D1-A176.6F361A45-F13E-44F7-8F3C-00C8B30ACB7A.pdf,6F361A45-F13E-44F7-8F3C-00C8B30ACB7A,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,9.266666667,NA,13,TUMOR FREE,A,94
ucec_tcga,TCGA-D1-A177,TCGA-D1-A177-01,70,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,227,0,NA,11.4,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0342,G2,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,15,0,NA,0,45,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,558,NA,FALSE,UEC,18,0:LIVING,NA,e8c58d8b-51d7-4599-af79-469ee6f269db,97587fd4-0f6f-4af5-ac0a-7328abb40e9c,NA,NA,NA,TCGA-D1-A177.28FF1BEE-6F93-4BCA-A6DC-56A1EA8EA337.pdf,28FF1BEE-6F93-4BCA-A6DC-56A1EA8EA337,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,18.6,NA,93,TUMOR FREE,A,53
ucec_tcga,TCGA-D1-A179,TCGA-D1-A179-01,76,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,230,0,NA,14.03,1:Recurred/Progressed,NA,NA,HISPANIC OR LATINO,NA,4/14/11,0.8540,High Grade,162,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,9,6,NA,6,21,2,NA,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,14.72,1:DECEASED,NA,37d5c1d9-3ff5-44fe-afdc-ff430a0f3510,ba812542-9161-4060-93cd-8b730adb4d40,NA,NA,NA,TCGA-D1-A179.F8F4C024-B723-424C-B98D-AA885C38CDFB.pdf,F8F4C024-B723-424C-B98D-AA885C38CDFB,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,250,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,NA,NA,25,TUMOR FREE,A,95
ucec_tcga,TCGA-D1-A17A,TCGA-D1-A17A-01,59,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIA,553,0,NA,1.58,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0350,G3,176,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,23,0,NA,0,40,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,170,NA,FALSE,UEC,1.58,0:LIVING,NA,c68dd983-b199-4f53-ac0c-b2d8dd6a7931,a0083336-5187-4969-85bb-993fa72fbd75,NA,NA,NA,TCGA-D1-A17A.9E0E5CDA-AE46-4ABC-8AF7-C89FE86B7472.pdf,9E0E5CDA-AE46-4ABC-8AF7-C89FE86B7472,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,60,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,5.7,NA,41,TUMOR FREE,A,102
ucec_tcga,TCGA-D1-A17B,TCGA-D1-A17B-01,69,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,685,0,NA,7,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0341,G2,162,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,NA,NA,NA,NA,42,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,204,NA,FALSE,UEC,7,0:LIVING,NA,e55dd65a-c75e-4a3c-bb24-8b3af4d65321,37c92c44-320d-4881-8cb3-357cc8bace5c,NA,NA,NA,TCGA-D1-A17B.FBE330EA-52BC-4B16-A046-3858318348F5.pdf,FBE330EA-52BC-4B16-A046-3858318348F5,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,6.8,NA,8,TUMOR FREE,A,110
ucec_tcga,TCGA-D1-A17C,TCGA-D1-A17C-01,78,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,249,0,NA,0.99,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0001,G1,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,43,NA,FALSE,UEC,0.99,0:LIVING,NA,6f4f0cdd-8387-45d0-a9e8-efce6260159d,2d5ac7fc-bed4-4c7f-927d-9b44846324c4,NA,NA,NA,TCGA-D1-A17C.213A073E-C5E1-4BA8-B4D5-23C92E539FA5.pdf,213A073E-C5E1-4BA8-B4D5-23C92E539FA5,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.433333333,NA,14,TUMOR FREE,A,81
ucec_tcga,TCGA-D1-A17D,TCGA-D1-A17D-01,58,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,541,0,NA,30.42,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0000,G3,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,36,0,NA,0,23,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,357,NA,FALSE,UEC,30.42,0:LIVING,NA,7ddeddd1-b2ad-425f-94a2-9c476b959f2a,9ec5a25b-9ce1-4fde-9341-13da39bc74b0,NA,NA,NA,TCGA-D1-A17D.1042404C-E963-4620-BC02-E33751FDB96C.pdf,1042404C-E963-4620-BC02-E33751FDB96C,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,11.86666667,NA,67,TUMOR FREE,A,68
ucec_tcga,TCGA-D1-A17F,TCGA-D1-A17F-01,68,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,269,0,NA,1.28,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0000,G2,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,42,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,159,NA,FALSE,UEC,1.28,0:LIVING,NA,129a49d4-edb8-4a1d-aabb-51b9ad5a8dd1,9592e87f-f3e4-49e9-919c-6f679a4b9110,NA,NA,NA,TCGA-D1-A17F.62F464EA-9410-4511-8DE8-F0E62AB1E482.pdf,62F464EA-9410-4511-8DE8-F0E62AB1E482,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,5.3,NA,21,TUMOR FREE,A,79
ucec_tcga,TCGA-D1-A17H,TCGA-D1-A17H-01,61,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,531,0,NA,27.99,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0052,G1,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,28,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,438,NA,FALSE,UEC,27.99,0:LIVING,NA,6c526c42-2fb2-4dfa-8a3d-5651dd600ac7,bf526d65-b323-418f-926a-6a0acd8f68e3,NA,NA,NA,TCGA-D1-A17H.E2EBC803-BE77-4936-9B6A-9E6E7E6B8FA4.pdf,E2EBC803-BE77-4936-9B6A-9E6E7E6B8FA4,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,14.53333333,NA,57,TUMOR FREE,A,96
ucec_tcga,TCGA-D1-A17K,TCGA-D1-A17K-01,74,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,513,0,NA,26.77,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.2631,G2,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,43,NA,FALSE,UEC,28.06,0:LIVING,NA,5c22c8d6-5805-455c-8e1c-e6b8006738e4,ca213835-efc5-4216-a762-a6b320b516bf,NA,NA,NA,TCGA-D1-A17K.C9E1B85A-8637-4421-A8CD-2E4BB28B3A73.pdf,C9E1B85A-8637-4421-A8CD-2E4BB28B3A73,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.466666667,NA,0,TUMOR FREE,A,97
ucec_tcga,TCGA-D1-A17L,TCGA-D1-A17L-01,81,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,493,0,NA,26.35,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0341,G1,172,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,34,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,58,NA,FALSE,UEC,26.35,0:LIVING,NA,67ccb182-3021-4621-bffb-6565574dbc58,5507cf56-068f-406e-aafd-8231f5943cbf,NA,NA,NA,TCGA-D1-A17L.BCF17C02-8F6E-419F-AEDF-3AC03AA883E7.pdf,BCF17C02-8F6E-419F-AEDF-3AC03AA883E7,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.9,NA,22,TUMOR FREE,A,123
ucec_tcga,TCGA-D1-A17M,TCGA-D1-A17M-01,56,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,454,0,NA,10.22,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0454,G1,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,14,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,305,NA,FALSE,UEC,10.22,0:LIVING,NA,02b2cd50-221f-437c-a1ce-6da1467ec809,027f53c8-0687-495f-917a-4dc6894216a6,NA,NA,NA,TCGA-D1-A17M.E69EF984-AF58-4EB0-93D2-CADE53DF0A6D.pdf,E69EF984-AF58-4EB0-93D2-CADE53DF0A6D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,10.16666667,NA,24,TUMOR FREE,A,142
ucec_tcga,TCGA-D1-A17N,TCGA-D1-A17N-01,46,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,451,0,NA,1.51,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0000,G2,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,26,NA,FALSE,UEC,1.51,0:LIVING,NA,001e0309-9c50-42b0-9e38-347883ee2cd3,f93931ba-8333-4e22-a430-ca02d9da3ffc,NA,NA,NA,TCGA-D1-A17N.AD892375-1A50-4D9E-8235-A9A495C35B97.pdf,AD892375-1A50-4D9E-8235-A9A495C35B97,negative,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,0.866666666667,NA,0,TUMOR FREE,A,134
ucec_tcga,TCGA-D1-A17Q,TCGA-D1-A17Q-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,434,0,NA,1.77,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0000,G2,169,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,29,0,NA,0,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,5165,NA,FALSE,UEC,1.77,0:LIVING,NA,ca8dbbfd-8928-4e25-94c6-b875de631bbd,b6abeb01-b6ea-4ab4-aa00-ae16cfc88b7c,NA,NA,NA,TCGA-D1-A17Q.698079B6-EB07-4491-9672-4BDE4E5DAC49.pdf,698079B6-EB07-4491-9672-4BDE4E5DAC49,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,171.9666667,NA,12,TUMOR FREE,A,68
ucec_tcga,TCGA-D1-A17R,TCGA-D1-A17R-01,58,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,443,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.2392,G2,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,11,0,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,133,NA,FALSE,UEC,11.14,1:DECEASED,NA,73a0dd38-115d-48fb-b683-04aa5d612f2a,205de3e7-b078-4904-82c3-3d0f757d94a8,NA,NA,NA,TCGA-D1-A17R.51598364-A609-4EBC-8500-53042C9E79E9.pdf,51598364-A609-4EBC-8500-53042C9E79E9,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,4.5,NA,5,TUMOR FREE,A,126
ucec_tcga,TCGA-D1-A17S,TCGA-D1-A17S-01,59,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,419,0,NA,24.28,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0000,G1,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,52,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,37,NA,FALSE,UEC,24.28,0:LIVING,NA,24434832-46fc-485a-9ff4-2aa95c3d3936,5f4de8f1-b75f-4a53-9b4d-6a2f5422d6ca,NA,NA,NA,TCGA-D1-A17S.54337BED-9366-4CB6-BA95-BB5999CBF342.pdf,54337BED-9366-4CB6-BA95-BB5999CBF342,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.233333333,NA,18,TUMOR FREE,A,109
ucec_tcga,TCGA-D1-A17T,TCGA-D1-A17T-01,67,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,318,0,NA,2.33,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0464,G2,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,24,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,52,NA,FALSE,UEC,2.33,0:LIVING,NA,efa4c675-e35e-4f48-8d12-a40f30b63ddb,179bdb8c-c4fd-4949-8aca-eca735a5320f,NA,NA,NA,TCGA-D1-A17T.D5927418-5A2B-477D-9917-7CE912628CA4.pdf,D5927418-5A2B-477D-9917-7CE912628CA4,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,1.666666667,NA,25,TUMOR FREE,A,83
ucec_tcga,TCGA-D1-A17U,TCGA-D1-A17U-01,53,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC2,314,0,NA,22.9,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/14/11,0.0009,G2,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,9,4,NA,4,3,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,249,NA,FALSE,UEC,22.9,0:LIVING,NA,6397c4a1-0a29-4c2c-b8cb-ce73af93dd0b,1f1945ee-4cf3-43a3-9998-1c4528c7a511,NA,NA,NA,TCGA-D1-A17U.A0A4164D-FD8D-4472-BAFA-A036469E22CC.pdf,A0A4164D-FD8D-4472-BAFA-A036469E22CC,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,8.3,NA,100,TUMOR FREE,A,87
ucec_tcga,TCGA-D1-A1NS,TCGA-D1-A1NS-01,53,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,92,0,NA,1.41,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.0002,G1,178,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,41,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,1.41,0:LIVING,NA,a79a4e56-09bf-4691-b7e0-81a9c2620d0f,88b09e18-049d-4cbe-b7cb-42f0add220bb,NA,NA,NA,TCGA-D1-A1NS.FE397385-B600-4450-AE73-3CB62D5FEA3B.pdf,FE397385-B600-4450-AE73-3CB62D5FEA3B,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,17,TUMOR FREE,A,126
ucec_tcga,TCGA-D1-A1NU,TCGA-D1-A1NU-01,74,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,87,0,NA,13.21,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.4092,G3,151,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,8,0,0,0,37,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,68,NA,FALSE,USC,13.21,0:LIVING,NA,e56491af-718f-4ca1-b3cd-0e5b3154697b,7901f084-c220-4865-a034-da0144d63a28,NA,NA,NA,TCGA-D1-A1NU.08AE92E6-EDAB-4059-AF51-4A8522EDD463.pdf,08AE92E6-EDAB-4059-AF51-4A8522EDD463,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,2.266666667,NA,16,TUMOR FREE,A,93
ucec_tcga,TCGA-D1-A1NW,TCGA-D1-A1NW-01,72,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IVB,199,0,NA,0.72,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.2859,G3,160,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,26,2,0,2,36,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UCEC,0.72,0:LIVING,NA,d7258a64-3ea0-40fc-b3f4-b581a1725fff,b79a1d9c-02ef-4192-beb3-bca8b362eb2e,NA,NA,NA,TCGA-D1-A1NW.10E1E872-408C-458D-9438-00F5ECA3083A.pdf,10E1E872-408C-458D-9438-00F5ECA3083A,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,0,TUMOR FREE,A,98
ucec_tcga,TCGA-D1-A1NX,TCGA-D1-A1NX-01,66,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,204,0,NA,15.64,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.1787,G3,159,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,23,13,0,13,39,8,0,8,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,44,NA,FALSE,USC,18.23,0:LIVING,NA,df01a5ee-e8b5-40b0-8a6a-b6b3faed9df9,1e016d9f-9fab-4191-8209-bc0a8ff0bacf,NA,NA,NA,TCGA-D1-A1NX.C2A3FA63-63A1-4424-BD92-FAEC1C377C62.pdf,C2A3FA63-63A1-4424-BD92-FAEC1C377C62,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,1.466666667,NA,95,TUMOR FREE,A,87
ucec_tcga,TCGA-D1-A1NY,TCGA-D1-A1NY-01,67,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,199,0,NA,16.85,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.0562,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,10,0,0,0,17,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,16.85,0:LIVING,NA,0a9faff7-ec4d-4b5a-aa83-6fa358f72074,4d1fc186-32c8-4f12-a4c3-f683cee53737,NA,NA,NA,TCGA-D1-A1NY.8F963009-F6C3-4F45-B714-0E96F5D5E526.pdf,8F963009-F6C3-4F45-B714-0E96F5D5E526,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,85,TUMOR FREE,A,97
ucec_tcga,TCGA-D1-A1NZ,TCGA-D1-A1NZ-01,60,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,191,0,NA,18,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.0341,G1,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,34,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,18,0:LIVING,NA,e49f545f-3268-4d25-b7a3-4da8e6ab2578,7239e42a-f0ef-43dd-9d1f-a5a507e0e66c,NA,NA,NA,TCGA-D1-A1NZ.0AFDCBC0-FA0A-4138-A0BE-E374AEB3CB25.pdf,0AFDCBC0-FA0A-4138-A0BE-E374AEB3CB25,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,33,TUMOR FREE,A,90
ucec_tcga,TCGA-D1-A1O0,TCGA-D1-A1O0-01,77,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,195,0,NA,2.07,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.4475,G3,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,5,0,0,0,38,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,2.07,0:LIVING,NA,A98BBE29-8817-4380-A738-3C1BF9F8E0CC,E113E0F0-3AE5-48A3-A226-AD920F41259E,NA,NA,NA,TCGA-D1-A1O0.2F5CADA5-176C-4B9D-9660-53BE86B1CD39.pdf,2F5CADA5-176C-4B9D-9660-53BE86B1CD39,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,5,TUMOR FREE,A,117
ucec_tcga,TCGA-D1-A1O5,TCGA-D1-A1O5-01,61,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,174,0,NA,15.05,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.0002,G1,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,20,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,15.05,0:LIVING,NA,f054a123-322f-444a-9971-53d3df371753,a2a2d119-29a0-4cdb-bbed-44219adddfcf,NA,NA,NA,TCGA-D1-A1O5.F8BEE46E-D0C9-4977-B1C3-DA87AF089B6D.pdf,F8BEE46E-D0C9-4977-B1C3-DA87AF089B6D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,8,TUMOR FREE,A,80
ucec_tcga,TCGA-D1-A1O7,TCGA-D1-A1O7-01,60,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,154,0,NA,1.05,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.0000,G1,148,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,1.05,0:LIVING,NA,01ed791e-3187-4e24-a5ff-afff0778c152,c38210f9-bb16-471c-91e1-2cdebfe23345,NA,NA,NA,TCGA-D1-A1O7.37C25226-AD56-487E-969B-1538E6E00A5D.pdf,37C25226-AD56-487E-969B-1538E6E00A5D,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,D1,NA,NA,5,TUMOR FREE,A,96
ucec_tcga,TCGA-D1-A1O8,TCGA-D1-A1O8-01,70,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,147,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.0000,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,3,3,0,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,3.94,1:DECEASED,NA,21faf1a4-f6d3-4cc6-a49a-04b8541ef598,1efc3a5a-d36d-4973-a725-2eeb73cce08e,NA,NA,NA,TCGA-D1-A1O8.8E7FDFD5-892F-4671-8172-FC2BFB800AE9.pdf,8E7FDFD5-892F-4671-8172-FC2BFB800AE9,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,85,TUMOR FREE,A,85
ucec_tcga,TCGA-D1-A2G0,TCGA-D1-A2G0-01,70,NA,1995,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IB,1416,0,NA,48.75,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,6/2/11,0.0916,G3,171,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2007,NO,NA,13,0,0,0,37,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UCEC,48.75,0:LIVING,NA,6F661F0D-F08B-486E-8BD7-4306E1593EB9,134CD317-CBEB-4633-B540-B639454615F7,NA,NA,NA,TCGA-D1-A2G0.02872006-6F7E-4FB7-B1C2-1C5DD3199FE3.pdf,02872006-6F7E-4FB7-B1C2-1C5DD3199FE3,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,17,TUMOR FREE,A,73
ucec_tcga,TCGA-D1-A2G5,TCGA-D1-A2G5-01,50,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1354,0,NA,36.86,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.9268,G3,173,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,15,0,0,0,37,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,47.8,0:LIVING,NA,016E515E-7F78-4997-9B97-3628464D9222,7AAFAD6C-6329-41E5-BA2E-74AE104DDCB1,NA,NA,NA,TCGA-D1-A2G5.741AB1D9-493E-4659-BC2E-BF77A7E1CC14.pdf,741AB1D9-493E-4659-BC2E-BF77A7E1CC14,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,20,WITH TUMOR,A,143
ucec_tcga,TCGA-D1-A2G6,TCGA-D1-A2G6-01,53,NA,1995,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,1350,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,6/2/11,0.2916,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2007,NO,NA,20,0,0,0,30,2,0,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,8.48,1:DECEASED,NA,46CD8DED-F8A1-4F8C-A4C2-2D5B51C04F18,2127E58B-BD7B-490E-B34B-4F626B2A4053,NA,NA,NA,TCGA-D1-A2G6.3375E2AF-173B-4263-84A8-8535DF33BA69.pdf,3375E2AF-173B-4263-84A8-8535DF33BA69,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,94,WITH TUMOR,A,80
ucec_tcga,TCGA-D1-A2G7,TCGA-D1-A2G7-01,65,NA,1995,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,1339,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,10/11/11,0.2241,G3,164,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2007,NO,NA,23,0,0,0,48,0,0,0,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,58.9,1:DECEASED,NA,32B5D0E4-A242-44D1-AC20-6E5CA2F35B71,9C10D27C-4372-4C1F-8A92-F84A387A1161,NA,NA,NA,TCGA-D1-A2G7.5D25FD0B-EEE9-435C-82C7-BC44B0758A14.pdf,5D25FD0B-EEE9-435C-82C7-BC44B0758A14,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,8,TUMOR FREE,A,133
ucec_tcga,TCGA-D1-A3DA,TCGA-D1-A3DA-01,77,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,128,0,NA,15.87,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/15/12,0.0399,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,19,NA,NA,0,34,NA,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Excisional Biopsy,NA,NA,NA,NA,TRUE,UEC,15.87,0:LIVING,NA,E17A5FCA-616C-4A74-ABE7-778539ECDC0B,24BE1526-B1CA-4206-BC2F-533D51548565,NA,NA,NA,TCGA-D1-A3DA.8F3D4AFC-2E70-4633-A58F-C98ED00A8964.pdf,8F3D4AFC-2E70-4633-A58F-C98ED00A8964,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,17,TUMOR FREE,A,57
ucec_tcga,TCGA-D1-A3DG,TCGA-D1-A3DG-01,81,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,49,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,2/15/12,0.9290,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Excisional Biopsy,NA,NA,NA,NA,TRUE,UEC,4.27,1:DECEASED,NA,7890628D-7120-4DBC-85AE-1F895B6660C2,AD26154D-5587-4AF9-975F-367D712A5749,NA,NA,NA,TCGA-D1-A3DG.97C44FFC-8D88-43DC-BCC9-F634151C7098.pdf,97C44FFC-8D88-43DC-BCC9-F634151C7098,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,41,TUMOR FREE,A,86
ucec_tcga,TCGA-D1-A3DH,TCGA-D1-A3DH-01,71,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,43,0,NA,18.82,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,2/15/12,0.7039,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,14,NA,NA,0,48,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Excisional Biopsy,NA,NA,NA,NA,TRUE,UEC,18.82,0:LIVING,NA,7D22FF96-9249-46B3-9CFA-E40DC4ECEBD6,5D130578-DE0C-4336-92E6-02C6F11ADD92,NA,NA,NA,TCGA-D1-A3DH.C63CF985-CF78-42EE-A7A2-22083FED571D.pdf,C63CF985-CF78-42EE-A7A2-22083FED571D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,NA,11,TUMOR FREE,A,76
ucec_tcga,TCGA-D1-A3JP,TCGA-D1-A3JP-01,61,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,101,0,NA,16.92,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,3/20/13,0.5437,G3,159,Serous endometrial adenocarcinoma,NO,NA,"No, I have never taken menopausal hormone therapy.",No,Yes,Never Used,NO,C54.1,8441/3,C54.1,YES,2011,NO,NA,18,NA,NA,0,56,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,USC,16.92,0:LIVING,NA,4846CB23-D7E7-47F4-972F-3ABE229F7BDB,29A581ED-3DCA-4A65-AB6B-5A9656674F92,NA,NA,NA,TCGA-D1-A3JP.62290E86-409F-4590-AA2C-D3D2F77148FF.pdf,62290E86-409F-4590-AA2C-D3D2F77148FF,negative,NO,2,NA,NA,NO,WHITE,YES,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,Partial Remission/Response,0,TUMOR FREE,A,59
ucec_tcga,TCGA-D1-A3JQ,TCGA-D1-A3JQ-01,61,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,77,0,NA,17.28,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,3/19/13,0.2228,G3,161,Serous endometrial adenocarcinoma,NO,NA,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8441/3,C54.1,YES,2011,NO,NA,20,NA,NA,0,28,NA,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,USC,17.28,0:LIVING,NA,07C805C2-FF09-4D5A-95F8-1D7D9F84C33C,720B03F2-B46F-43A0-9AB0-FB0734E691F1,NA,NA,NA,TCGA-D1-A3JQ.2001A1EC-1385-4EB3-BC9E-7E48143FD663.pdf,2001A1EC-1385-4EB3-BC9E-7E48143FD663,negative,YES,4+,NA,NA,NO,WHITE,YES,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,D1,NA,Complete Remission/Response,32,TUMOR FREE,A,121
ucec_tcga,TCGA-DF-A2KN,TCGA-DF-A2KN-01,NA,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,NA,NA,NA,2.2,0:DiseaseFree,NA,NA,NA,NA,11/7/13,0.0008,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,NA,NO,NA,0,NA,NA,NA,20,NA,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,FALSE,UEC,2.2,0:LIVING,NA,D438C58E-F038-47A3-8E62-485A5ACA9695,4AD23A52-BCEB-4B12-88AA-272153E01B01,NA,NA,NA,TCGA-DF-A2KN.A61CE064-B18B-429E-93F1-BA0FC06AB310.pdf,A61CE064-B18B-429E-93F1-BA0FC06AB310,NA,NA,NA,NA,NA,NO,NA,NA,RX,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,DF,NA,NA,NA,TUMOR FREE,A,77
ucec_tcga,TCGA-DF-A2KR,TCGA-DF-A2KR-01,84,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,NA,NA,NA,69.42,1:Recurred/Progressed,NA,NA,NA,NA,10/14/13,0.7258,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,NA,NO,NA,NA,NA,NA,NA,7,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:","endometrial biopsy, not otherwise specified",NA,NA,NO,FALSE,UEC,71.55,0:LIVING,NA,30B62630-FC6D-4620-874A-1E15FD4F40EA,ACDC8A17-C1B8-4F45-A1AF-7C7953C346A4,NA,NA,NA,TCGA-DF-A2KR.7252DF0D-0D16-48DD-9484-9C4B83012927.pdf,7252DF0D-0D16-48DD-9484-9C4B83012927,NA,NO,NA,NA,NA,NO,NA,YES,RX,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,DF,NA,NA,70,TUMOR FREE,A,NA
ucec_tcga,TCGA-DF-A2KS,TCGA-DF-A2KS-01,69,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,NA,NA,NA,74.8,1:Recurred/Progressed,NA,NA,NA,NA,10/15/13,0.6253,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,NA,NO,NA,0,NA,NA,NA,18,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",endometrial biopsy not otherwise specified,NA,NA,NA,FALSE,UEC,109,0:LIVING,NA,46E064CC-933B-444B-9E15-80FADBC53487,0E438D6A-52A7-473F-BB85-7805D63DF150,NA,NA,NA,TCGA-DF-A2KS.C6638C17-4F05-491F-86ED-6D7DDB1B8FDE.pdf,C6638C17-4F05-491F-86ED-6D7DDB1B8FDE,negative,NO,NA,NA,NA,NO,NA,YES,RX,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,DF,NA,NA,31,TUMOR FREE,A,66
ucec_tcga,TCGA-DF-A2KU,TCGA-DF-A2KU-01,NA,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,NA,NA,NA,100.76,0:DiseaseFree,NA,NA,NA,NA,10/15/13,0.0048,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,NA,NO,NA,0,NA,NA,NA,9,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,100.76,0:LIVING,NA,95EEFB47-3F96-4A6D-8773-4D22843F0A6A,341B9AD3-2AA4-4E8C-9A41-1915AB6CDBA8,NA,NA,NA,TCGA-DF-A2KU.6F425E9F-E02A-4EFB-A0DE-00BF09D9BB98.pdf,6F425E9F-E02A-4EFB-A0DE-00BF09D9BB98,negative,NO,NA,NA,NA,NO,NA,YES,RX,YES,1,380,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,DF,NA,Complete Remission/Response,8,TUMOR FREE,A,NA
ucec_tcga,TCGA-DF-A2KV,TCGA-DF-A2KV-01,55,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,NA,0,NA,89.26,0:DiseaseFree,NA,NA,NA,NA,10/14/13,0.0003,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,NA,NO,NA,0,NA,NA,NA,21,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,NA,NO,FALSE,UEC,89.26,0:LIVING,NA,59CEBAE6-632D-4632-B695-C48AE46B2E67,0C713392-8713-40F2-93CF-4272BE99427F,NA,NA,NA,TCGA-DF-A2KV.5717937B-AC81-452E-9B4D-3301FDA7CD0B.pdf,5717937B-AC81-452E-9B4D-3301FDA7CD0B,negative,NA,NA,NA,NA,NO,NA,NA,RX,YES,1,580,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,DF,NA,NA,21,TUMOR FREE,A,NA
ucec_tcga,TCGA-DF-A2KY,TCGA-DF-A2KY-01,49,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVA,NA,0,NA,10.91,0:DiseaseFree,NA,NA,NA,NA,6/20/14,0.0120,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,NA,NO,NA,0,0,0,0,12,1,0,1,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),"Other method, specify:",Hysteroscopy and endometrial ablation,NA,NA,NA,FALSE,UEC,10.91,0:LIVING,NA,5BF97D66-CDC6-47D0-AC74-5C6280B31072,5C46962C-67DC-45CD-842A-D0F71C747BBD,NA,NA,NA,TCGA-DF-A2KY.8A35F74A-AFA4-4B2D-931B-FA2DE895F010.pdf,8A35F74A-AFA4-4B2D-931B-FA2DE895F010,NA,YES,NA,NA,NA,NO,NA,NO,R1,YES,1,960,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,DF,NA,NA,73.3,WITH TUMOR,A,NA
ucec_tcga,TCGA-DF-A2KZ,TCGA-DF-A2KZ-01,87,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,NA,0,NA,27.14,0:DiseaseFree,NA,NA,NA,NA,6/11/14,0.0341,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,NA,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NO,FALSE,UEC,27.14,0:LIVING,NA,3B218AB7-5C2E-4458-A0AC-5152EC3D2B94,76D43B40-612E-4580-ABD7-D1837D8FD5D0,NA,NA,NA,TCGA-DF-A2KZ.D69C73D1-1CEB-4AF5-AAF2-8E707EF4CA38.pdf,D69C73D1-1CEB-4AF5-AAF2-8E707EF4CA38,negative,NO,NA,NA,NA,NO,NA,YES,RX,YES,1,450,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,DF,NA,NA,25,TUMOR FREE,A,NA
ucec_tcga,TCGA-DF-A2L0,TCGA-DF-A2L0-01,60,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,NA,NA,NA,17.18,1:Recurred/Progressed,NA,NA,NA,NA,10/11/13,0.5377,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,NA,NO,NA,0,NA,NA,NA,17,5,0,5,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",endometrial biopsy not otherwise specified,NA,NA,NA,FALSE,UEC,25.89,1:DECEASED,NA,7ADAF608-19A5-4184-8B79-BBC6F9CF24AE,E3F9C326-544D-46E2-A58E-FC95E5ECD702,NA,NA,NA,TCGA-DF-A2L0.1679CA2C-86BF-41D1-96E1-62FC89D9AAA7.pdf,1679CA2C-86BF-41D1-96E1-62FC89D9AAA7,NA,NA,NA,NA,NA,NO,NA,NA,RX,YES,1,520,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,DF,NA,NA,86,WITH TUMOR,A,95
ucec_tcga,TCGA-DI-A0WH,TCGA-DI-A0WH-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,244,0,NA,16.29,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/12/11,0.0346,G3,173,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,2,0,0,0,18,0,0,0,NA,Dilation and curettage procedure,NA,NA,358,NA,FALSE,UEC,16.29,0:LIVING,NA,3dab68d3-232c-4b4f-81a4-ca8f72d69a43,89f499fb-e061-4002-a8e8-dc3366e14a12,NA,NA,NA,TCGA-DI-A0WH.3D6B2D82-2F6D-40E6-8138-4DBF33DE8BEF.pdf,3D6B2D82-2F6D-40E6-8138-4DBF33DE8BEF,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,180,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,DI,11.9,NA,15.6,TUMOR FREE,A,107
ucec_tcga,TCGA-DI-A1BU,TCGA-DI-A1BU-01,55,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IIB,903,0,NA,39.26,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/13/11,0.0001,G3,171,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,6,0,0,0,25,0,0,0,NA,"Other method, specify:",endometrial biopsy,NA,NA,NA,FALSE,UCEC,39.26,0:LIVING,NA,53245616-e095-4616-89bb-6062669122da,241bfb1f-5cf8-458d-b335-18babf507e85,NA,NA,NA,TCGA-DI-A1BU.18A286FD-E85B-48FC-B193-456AB10D24B9.pdf,18A286FD-E85B-48FC-B193-456AB10D24B9,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,DI,NA,NA,15.8,TUMOR FREE,A,93
ucec_tcga,TCGA-DI-A1BY,TCGA-DI-A1BY-01,63,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIB,989,0,NA,36.6,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/13/11,0.0005,G2,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,6,0,0,0,NA,"Other method, specify:",Uterine scrapings,NA,NA,NA,FALSE,UEC,36.6,0:LIVING,NA,e46b6434-ee88-4630-9fc3-441afc431745,7a5cf7c9-1b05-4de9-af5d-a859171049d6,NA,NA,NA,TCGA-DI-A1BY.8B96371D-5E42-461B-B7A2-AB9641D842CD.pdf,8B96371D-5E42-461B-B7A2-AB9641D842CD,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,DI,NA,NA,17,TUMOR FREE,A,125
ucec_tcga,TCGA-DI-A1C3,TCGA-DI-A1C3-01,38,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,755,0,NA,24.28,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/12/11,0.0000,G2,171,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,0,NA,NA,NA,NA,"Other method, specify:",polyp removal,NA,NA,NA,FALSE,UEC,24.28,0:LIVING,NA,3f305a1f-1020-4ebb-82ab-fd132bcaea02,d4ab43b5-5ff7-4a06-8efb-f05eba3b2a7f,NA,NA,NA,TCGA-DI-A1C3.63A6706E-823B-456E-A3BC-65755C07CF62.pdf,63A6706E-823B-456E-A3BC-65755C07CF62,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,DI,NA,NA,8.6,TUMOR FREE,A,144
ucec_tcga,TCGA-DI-A1NN,TCGA-DI-A1NN-01,63,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,813,0,NA,33.61,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,8/1/11,0.1974,G3,173,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,9,2,0,2,10,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,38,NA,FALSE,USC,35.35,0:LIVING,NA,944a102f-3475-45aa-9e30-4b92d1449f00,5fabce9c-0dfb-4b0d-8478-599fd181a84f,NA,NA,NA,TCGA-DI-A1NN.EBBDE504-29C9-4662-8D06-44E8CBAD0741.pdf,EBBDE504-29C9-4662-8D06-44E8CBAD0741,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,DI,1.3,NA,3,TUMOR FREE,A,71
ucec_tcga,TCGA-DI-A1NO,TCGA-DI-A1NO-01,68,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,688,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,8/1/11,0.5988,G3,166,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,0,0,0,2,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,9.36,1:DECEASED,NA,d3e93d76-6565-454a-a085-4492024350e9,002a3a28-71c7-4a8c-960a-14a239ffb433,NA,NA,NA,TCGA-DI-A1NO.11CEAAB6-3853-48EB-94CE-1B11FEF45B4C.pdf,11CEAAB6-3853-48EB-94CE-1B11FEF45B4C,NA,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,RX,YES,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,DI,NA,NA,1.03,WITH TUMOR,A,122
ucec_tcga,TCGA-DI-A2QT,TCGA-DI-A2QT-01,51,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC,1186,0,NA,NA,NA,NA,NA,HISPANIC OR LATINO,NA,8/26/11,0.3625,G3,156,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,10,10,0,10,15,7,0,7,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,USC,12.39,1:DECEASED,NA,EE932B34-0114-41DC-B119-210C0ED84BCB,41EE0D15-A55B-47A4-9F5A-02A29E89E8DD,NA,NA,NA,TCGA-DI-A2QT.416DF035-67B0-4461-9523-EB4A4A1FBA5B.pdf,416DF035-67B0-4461-9523-EB4A4A1FBA5B,NA,NA,NA,NA,NA,NO,AMERICAN INDIAN OR ALASKA NATIVE,NA,R2,YES,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,DI,NA,NA,96,WITH TUMOR,A,62
ucec_tcga,TCGA-DI-A2QU,TCGA-DI-A2QU-01,67,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,2296,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,8/26/11,0.3324,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2005,NO,NA,0,NA,NA,NA,6,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,31.08,1:DECEASED,NA,E9FA66F5-282C-416A-9DCF-46714EA12FCF,E319E562-6AF4-4A5A-B82B-94DDFB325AE8,NA,NA,NA,TCGA-DI-A2QU.43F1EE09-6F10-4BCE-A55C-147084A26999.pdf,43F1EE09-6F10-4BCE-A55C-147084A26999,NA,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,240,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,DI,NA,NA,0,WITH TUMOR,A,93
ucec_tcga,TCGA-DI-A2QY,TCGA-DI-A2QY-01,64,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIB,2957,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,8/29/11,0.6407,G3,160,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2003,NO,NA,3,0,0,0,6,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",endocervical smear,NA,NA,NA,FALSE,USC,110.02,1:DECEASED,NA,6524A6D3-A9F0-4A46-AC0B-7BEB0CD1B915,E86DF94D-784D-41E0-8610-46DED1032F00,NA,NA,NA,TCGA-DI-A2QY.C78D0C27-34C3-44C4-9814-94EEE8A8AB95.pdf,C78D0C27-34C3-44C4-9814-94EEE8A8AB95,positive,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,DI,NA,NA,50,TUMOR FREE,A,85
ucec_tcga,TCGA-E6-A1LX,TCGA-E6-A1LX-01,40,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1539,0,NA,23.36,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,6/7/11,0.0112,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,3,0,NA,0,0,NA,NA,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Tumor resection,NA,NA,NA,NA,FALSE,UEC,23.36,0:LIVING,NA,435b57e7-5cd4-486a-b3d4-ccb1ef160d52,840ff7bf-7acc-400b-8395-d048e38674ee,NA,NA,NA,TCGA-E6-A1LX.73CEBF93-0E7C-4EF9-A695-AF489AF3F0F0.pdf,73CEBF93-0E7C-4EF9-A695-AF489AF3F0F0,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,190,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,E6,NA,NA,14,TUMOR FREE,A,NA
ucec_tcga,TCGA-E6-A1LZ,TCGA-E6-A1LZ-01,76,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,1233,0,NA,79.04,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,6/7/11,0.5552,G3,NA,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2007,NO,NA,5,0,NA,0,26,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,171,NA,FALSE,USC,79.04,0:LIVING,NA,9205c164-7975-421a-90c3-edfe8def595c,62bff77e-4fe6-4a9f-a867-345584608e7d,NA,NA,NA,TCGA-E6-A1LZ.55F7B7D0-D30A-4E78-B91A-CE794784CA3C.pdf,55F7B7D0-D30A-4E78-B91A-CE794784CA3C,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,350,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,E6,5.666666667,NA,NA,TUMOR FREE,A,65
ucec_tcga,TCGA-E6-A1M0,TCGA-E6-A1M0-01,56,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,360,0,NA,58.9,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,6/7/11,0.2016,G3,174,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,5,0,NA,0,13,2,NA,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,FALSE,UEC,58.9,0:LIVING,NA,e3dcde4e-5def-4b89-97b4-047b8288919b,7e75ca29-183d-4bad-9ddc-527871bd7554,NA,NA,NA,TCGA-E6-A1M0.F1AF61FE-BF05-49E2-85DA-F4CE37596DEA.pdf,F1AF61FE-BF05-49E2-85DA-F4CE37596DEA,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,E6,NA,NA,90,TUMOR FREE,A,114
ucec_tcga,TCGA-E6-A2P8,TCGA-E6-A2P8-01,53,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IV,254,0,NA,1.97,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,12/22/11,0.0002,G3,156,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,0,NA,0,1,1,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UCEC,2.37,1:DECEASED,NA,D213DA3A-FF1C-4FBD-8D4E-7F9E6A2318D0,04DEA046-32C8-4BD8-A5B2-944957072BDC,NA,NA,NA,TCGA-E6-A2P8.B67CD692-73B4-4A61-A65B-65964AA3ACF4.pdf,B67CD692-73B4-4A61-A65B-65964AA3ACF4,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,NA,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,E6,NA,NA,89.1,WITH TUMOR,A,76
ucec_tcga,TCGA-E6-A2P9,TCGA-E6-A2P9-01,65,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,189,0,NA,45.53,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,12/21/11,0.0810,G3,173,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,1,0,NA,0,7,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,45.53,0:LIVING,NA,077BDC90-1BBD-49EC-93A5-729B1AC1BA8D,9C35E13B-87FC-4DC4-A847-DBA192079EC1,NA,NA,NA,TCGA-E6-A2P9.EF7B01C4-0952-4FE8-B128-2A43FA31E6F5.pdf,EF7B01C4-0952-4FE8-B128-2A43FA31E6F5,negative,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,E6,NA,NA,20,TUMOR FREE,A,125
ucec_tcga,TCGA-E6-A8L9,TCGA-E6-A8L9-01,61,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,657,0,NA,33.28,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,4/3/14,0.6129,G3,162,Serous endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,Yes,Never Used,NO,C54.1,8441/3,C54.1,YES,2012,NO,NA,5,0,NA,0,15,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,USC,33.28,0:LIVING,NA,EB642568-30D4-4805-A295-BDA314CCAAAF,04225AB6-5A39-4694-BAB3-423F95D60421,NA,NA,NA,TCGA-E6-A8L9.40CB57C1-7E8C-45B0-BEDD-DFE531C9201E.pdf,40CB57C1-7E8C-45B0-BEDD-DFE531C9201E,negative,YES,4+,NA,NA,NO,BLACK OR AFRICAN AMERICAN,YES,R0,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,E6,NA,Complete Remission/Response,1.92,TUMOR FREE,A,78
ucec_tcga,TCGA-EC-A1NJ,TCGA-EC-A1NJ-01,73,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,60,0,NA,16.03,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,6/23/11,0.0530,G2,153,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,TRUE,UEC,16.03,0:LIVING,NA,b3aa16d6-1677-445d-a8d3-46657d4f8b43,0a6212d0-cb90-4e24-add2-6ef723d2a701,NA,NA,NA,TCGA-EC-A1NJ.8E02F7D6-EBE4-46CB-B05C-B41FDCDC1141.pdf,8E02F7D6-EBE4-46CB-B05C-B41FDCDC1141,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,620,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EC,NA,NA,33,TUMOR FREE,A,62
ucec_tcga,TCGA-EC-A1QX,TCGA-EC-A1QX-01,71,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,81,0,NA,7.19,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,8/3/11,0.0796,G3,161,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,7.36,0:LIVING,NA,f17bb238-2651-48a5-9a47-5077218efe08,a86cd958-656b-45d1-ab59-453896a9e839,NA,NA,NA,TCGA-EC-A1QX.0C3EABFA-0F72-47C9-9A8B-6B14F2CD2D12.pdf,0C3EABFA-0F72-47C9-9A8B-6B14F2CD2D12,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,560,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,EC,NA,NA,NA,TUMOR FREE,A,90
ucec_tcga,TCGA-EC-A24G,TCGA-EC-A24G-01,57,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,78,0,NA,16.79,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,3/21/11,0.0005,G3,148,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,0,0,0,15,0,0,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,16.79,0:LIVING,NA,b5c1e511-baf2-45b3-9919-110e8941e3c2,2fea9b96-3434-4a38-bd69-a5fec3d8f960,NA,NA,NA,TCGA-EC-A24G.5DE142C5-7A0D-4C5E-8EF6-2809B10378C4.pdf,5DE142C5-7A0D-4C5E-8EF6-2809B10378C4,NA,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,410,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,EC,NA,NA,50,TUMOR FREE,A,93
ucec_tcga,TCGA-EO-A1Y5,TCGA-EO-A1Y5-01,63,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,223,0,NA,10.91,0:DiseaseFree,NA,NA,NA,NA,7/26/11,0.4065,G3,161,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,1,1,NA,1,17,8,NA,8,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,63,NA,FALSE,USC,10.91,0:LIVING,NA,5f2f2e7a-8aec-4011-b261-0c5bc68da840,9bed3aea-1f78-4567-bb7b-016753a9bd0b,NA,NA,NA,TCGA-EO-A1Y5.B3A96371-1CD6-4B08-BDA5-C8CD7C7DE81F.pdf,B3A96371-1CD6-4B08-BDA5-C8CD7C7DE81F,NA,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,2.066666667,NA,100,TUMOR FREE,A,79
ucec_tcga,TCGA-EO-A1Y7,TCGA-EO-A1Y7-01,65,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,196,0,NA,28.91,1:Recurred/Progressed,NA,NA,NA,NA,7/26/11,0.2798,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,8,0,NA,0,3,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,49.11,0:LIVING,NA,71ed2681-79bb-4ffb-985c-6d3cf18e9168,c27f13ab-69dd-403c-b81e-fc4bc4bfa329,NA,NA,NA,TCGA-EO-A1Y7.88AABD4B-ECB4-4748-B59F-BD4AE0621BFB.pdf,88AABD4B-ECB4-4748-B59F-BD4AE0621BFB,NA,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,60,TUMOR FREE,A,95
ucec_tcga,TCGA-EO-A1Y8,TCGA-EO-A1Y8-01,87,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,204,0,NA,37.68,0:DiseaseFree,NA,NA,NA,NA,7/26/11,0.3002,G3,146,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,16,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,49,NA,FALSE,USC,37.68,0:LIVING,NA,de4e13c8-5ad0-46d2-ae54-b9ca22b939d8,5b0a8519-3fea-46d6-8f6d-ec85c403b416,NA,NA,NA,TCGA-EO-A1Y8.61143E14-52BD-499F-901C-4BD1EA83DAC1.pdf,61143E14-52BD-499F-901C-4BD1EA83DAC1,NA,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,170,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,1.6,NA,40,TUMOR FREE,A,58
ucec_tcga,TCGA-EO-A22R,TCGA-EO-A22R-01,56,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,925,0,NA,61.7,0:DiseaseFree,NA,NA,NA,NA,10/26/11,0.0002,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,NA,NA,NA,NA,18,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,61.7,0:LIVING,NA,508BF716-46F9-44DC-8E39-09261DFB073E,8F1F3C76-1CAD-434E-B77A-BC17C7742E76,NA,NA,NA,TCGA-EO-A22R.5B97D87A-5D28-417F-A942-21775156B46C.pdf,5B97D87A-5D28-417F-A942-21775156B46C,negative,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EO,NA,NA,51,TUMOR FREE,A,88
ucec_tcga,TCGA-EO-A22S,TCGA-EO-A22S-01,58,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,919,0,NA,61.5,0:DiseaseFree,NA,NA,NA,NA,10/26/11,0.0001,G3,156,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,5,0,NA,NA,25,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,61.5,0:LIVING,NA,8F2D3495-8CE7-4F6E-A41D-8CFAE5750937,745F2CC5-F0F1-49D1-899E-72B823802B08,NA,NA,NA,TCGA-EO-A22S.DB26485C-BE5C-4874-B79D-7FCFFFF70C4E.pdf,DB26485C-BE5C-4874-B79D-7FCFFFF70C4E,NA,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EO,NA,NA,51,TUMOR FREE,A,84
ucec_tcga,TCGA-EO-A22T,TCGA-EO-A22T-01,56,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,916,0,NA,66.85,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/26/11,0.0499,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,11,0,NA,NA,19,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,66.85,0:LIVING,NA,63170B0E-78CF-45D9-AF9D-CE986AC66991,BF5A963A-4AA7-428B-ACD6-606093A0FF2A,NA,NA,NA,TCGA-EO-A22T.1D5567D9-3015-452E-9888-2E67F91D6B20.pdf,1D5567D9-3015-452E-9888-2E67F91D6B20,NA,NA,NA,NA,NA,NO,ASIAN,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EO,NA,NA,49,TUMOR FREE,A,53
ucec_tcga,TCGA-EO-A22U,TCGA-EO-A22U-01,83,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,758,0,NA,46.22,0:DiseaseFree,NA,NA,NA,NA,10/26/11,0.0004,G3,150,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,46.22,0:LIVING,NA,30BC72D5-07B5-48D2-B025-BBA9BCF2F09F,4EB2E033-34F4-4A2D-837E-C927C1E52359,NA,NA,NA,TCGA-EO-A22U.DB7D72BC-F9C7-4726-98F4-A4F642B125C6.pdf,DB7D72BC-F9C7-4726-98F4-A4F642B125C6,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,51,TUMOR FREE,A,59
ucec_tcga,TCGA-EO-A22X,TCGA-EO-A22X-01,36,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,842,0,NA,57.56,0:DiseaseFree,NA,NA,NA,NA,10/26/11,0.0458,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,10,0,NA,0,26,0,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,57.56,0:LIVING,NA,10EB7DFA-D43D-479F-8C46-C0424207F958,0C6FD9EF-CFFE-4B5B-B2FB-8136285DA058,NA,NA,NA,TCGA-EO-A22X.4D919902-FBCE-4AAC-ACD2-38A2F1D8E901.pdf,4D919902-FBCE-4AAC-ACD2-38A2F1D8E901,negative,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,100,TUMOR FREE,A,56
ucec_tcga,TCGA-EO-A22Y,TCGA-EO-A22Y-01,68,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,692,0,NA,51.48,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/26/11,0.6535,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,NA,NA,NA,NA,33,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,51.48,0:LIVING,NA,E6183A43-24B9-4FE1-95C3-4CFF67E6C1ED,1FCDC9C7-5448-4A87-9AD5-CFB60837C296,NA,NA,NA,TCGA-EO-A22Y.44F2A17C-265B-4C2A-9AA0-42C55A23B592.pdf,44F2A17C-265B-4C2A-9AA0-42C55A23B592,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EO,NA,NA,51,TUMOR FREE,A,NA
ucec_tcga,TCGA-EO-A2CG,TCGA-EO-A2CG-01,69,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,643,0,NA,51.38,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/26/11,0.4929,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,11,0,NA,0,8,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,51.38,0:LIVING,NA,AF363CEC-BEC9-4DE3-8CC2-E98B0EED2858,CF894594-77CC-471E-B112-5EAE1829C415,NA,NA,NA,TCGA-EO-A2CG.CAF671DB-2DD1-43D5-99C8-185253775B37.pdf,CAF671DB-2DD1-43D5-99C8-185253775B37,negative,NA,NA,NA,NA,NA,ASIAN,NA,R0,YES,1,60,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,49,TUMOR FREE,A,68
ucec_tcga,TCGA-EO-A2CH,TCGA-EO-A2CH-01,73,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,802,0,NA,18.89,1:Recurred/Progressed,NA,NA,NA,NA,10/26/11,0.3840,G3,152,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,19.38,1:DECEASED,NA,0CC9A11F-1AC4-431D-8F94-52A3BC02B572,F0906353-4C3B-4F71-9B0B-CB1477450013,NA,NA,NA,TCGA-EO-A2CH.B4A5577E-C043-4D25-8D53-77A43C5EC0CC.pdf,B4A5577E-C043-4D25-8D53-77A43C5EC0CC,NA,NA,NA,NA,NA,NO,NA,NA,R2,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EO,NA,NA,51,WITH TUMOR,A,66
ucec_tcga,TCGA-EO-A3AS,TCGA-EO-A3AS-01,86,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,850,0,NA,34.36,0:DiseaseFree,NA,NA,NA,NA,6/1/12,0.5218,G3,147,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,34.36,0:LIVING,NA,2C3E95B5-2C63-43C7-BAA2-47EF914B25A8,DDB6E07D-8764-4278-978D-7A878522DE6D,NA,NA,NA,TCGA-EO-A3AS.844799B1-4C96-473A-8ECB-71ACB080F95E.pdf,844799B1-4C96-473A-8ECB-71ACB080F95E,NA,NA,NA,NA,NA,NA,NA,NA,NA,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EO,NA,NA,49,TUMOR FREE,A,58
ucec_tcga,TCGA-EO-A3AU,TCGA-EO-A3AU-01,72,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,393,0,NA,38.7,1:Recurred/Progressed,NA,NA,NA,NA,6/1/12,0.0000,G3,150,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,1,0,NA,NA,14,1,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),"Other method, specify:",Endocervical curettage,NA,NA,NA,FALSE,UEC,50.69,0:LIVING,NA,8E225F5F-49C1-4A39-A8B5-41FEA6A79819,C9D250D6-AB13-4FEB-A747-AA3EBFA43503,NA,NA,NA,TCGA-EO-A3AU.B1D13355-6346-4FA4-950A-84114901515C.pdf,B1D13355-6346-4FA4-950A-84114901515C,negative,NA,NA,NA,NA,NA,NA,NA,NA,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,51,TUMOR FREE,A,78
ucec_tcga,TCGA-EO-A3AV,TCGA-EO-A3AV-01,51,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,407,0,NA,35.12,0:DiseaseFree,NA,NA,NA,NA,6/1/12,0.0242,G3,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,3,0,NA,NA,33,6,NA,6,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,35.12,0:LIVING,NA,D383008A-A1BF-4689-B243-3C464C79B818,C3BEEB0B-07F7-44E6-AB4B-8015472B0DD1,NA,NA,NA,TCGA-EO-A3AV.9FF6FADC-4F38-41A2-8B96-24CB1EB2010E.pdf,9FF6FADC-4F38-41A2-8B96-24CB1EB2010E,negative,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,51,TUMOR FREE,A,45
ucec_tcga,TCGA-EO-A3AY,TCGA-EO-A3AY-01,58,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,227,0,NA,38.21,1:Recurred/Progressed,NA,NA,NA,NA,6/1/12,0.0002,G3,164,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,25,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,38.04,0:LIVING,NA,0878E44D-BDC8-4D5F-9BF4-31101F14F797,47BF70A1-6738-495F-9E61-92FEAF33C28C,NA,NA,NA,TCGA-EO-A3AY.330AEFE0-D564-4799-8928-B05280BACA91.pdf,330AEFE0-D564-4799-8928-B05280BACA91,negative,NA,NA,NA,NA,NA,NA,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,50,TUMOR FREE,A,76
ucec_tcga,TCGA-EO-A3AZ,TCGA-EO-A3AZ-01,80,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IB,241,0,NA,27.14,0:DiseaseFree,NA,NA,NA,NA,6/1/12,0.2176,G3,140,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UCEC,27.14,0:LIVING,NA,38BF8476-FDE7-423B-BBAA-15483207DE39,DE7F0A98-8365-4DFC-856F-138EAE9CEF16,NA,NA,NA,TCGA-EO-A3AZ.EA5D2C1C-703B-46BE-8B16-C40CE4BA0B46.pdf,EA5D2C1C-703B-46BE-8B16-C40CE4BA0B46,negative,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,51,TUMOR FREE,A,78
ucec_tcga,TCGA-EO-A3B0,TCGA-EO-A3B0-01,43,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC2,196,0,NA,46.39,0:DiseaseFree,NA,NA,NA,NA,6/1/12,0.0500,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,3,2,NA,NA,7,5,NA,NA,Indeterminate (neither Pre or Postmenopausal),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,46.39,0:LIVING,NA,4C2E6ABF-02E1-4EF7-A0BE-6A6D4069581D,87A5C4D3-9AA2-4A86-9CC9-F99A4B67FEAE,NA,NA,NA,TCGA-EO-A3B0.5B8CD9C0-148B-4421-AA68-C1F2DF7F9B28.pdf,5B8CD9C0-148B-4421-AA68-C1F2DF7F9B28,NA,NA,NA,NA,NA,NA,ASIAN,NA,RX,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EO,NA,NA,NA,TUMOR FREE,A,53
ucec_tcga,TCGA-EO-A3B1,TCGA-EO-A3B1-01,63,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,163,0,NA,26.94,0:DiseaseFree,NA,NA,NA,NA,6/1/12,0.5055,G3,170,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,13,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,26.94,0:LIVING,NA,2CF8DE9F-B305-4D98-BFD4-33377BF6138F,7407E162-9E38-49D0-9957-6E98775F5475,NA,NA,NA,TCGA-EO-A3B1.D3309430-5427-4FAD-BDD6-A6E9BABE29D2.pdf,D3309430-5427-4FAD-BDD6-A6E9BABE29D2,NA,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,51,TUMOR FREE,A,93
ucec_tcga,TCGA-EO-A3KU,TCGA-EO-A3KU-01,68,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage II,93,0,NA,22.24,0:DiseaseFree,NA,NA,NA,NA,6/1/12,0.4710,G3,163,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,9,0,NA,NA,6,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,22.24,0:LIVING,NA,DB67A9CD-65BA-4D6F-A799-031B6B3DF599,72940768-0848-4134-8D1D-C81A02F92134,NA,NA,NA,TCGA-EO-A3KU.B6945BE4-FA4A-4ED4-9233-B32123F41C95.pdf,B6945BE4-FA4A-4ED4-9233-B32123F41C95,NA,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,0,TUMOR FREE,A,65
ucec_tcga,TCGA-EO-A3KW,TCGA-EO-A3KW-01,72,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,205,0,NA,16.33,0:DiseaseFree,NA,NA,NA,NA,6/1/12,0.3475,G3,153,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,21,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,16.33,0:LIVING,NA,5F764AC1-3DE7-4CFD-A77A-D21BAA418834,AC5073EA-51CF-466C-9B31-1D4FBB86F998,NA,NA,NA,TCGA-EO-A3KW.C1CFE3DE-628B-4C0F-881B-588C613498DA.pdf,C1CFE3DE-628B-4C0F-881B-588C613498DA,NA,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,NA,TUMOR FREE,A,62
ucec_tcga,TCGA-EO-A3KX,TCGA-EO-A3KX-01,80,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,184,0,NA,38.44,0:DiseaseFree,NA,NA,HISPANIC OR LATINO,NA,6/1/12,0.0002,G3,145,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,3,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,38.44,0:LIVING,NA,FE2E89F7-8F4D-420A-A551-4877CF0FD1D3,A5CAE971-EEB4-4A9E-AFEC-01814EAB967E,NA,NA,NA,TCGA-EO-A3KX.BB1CD473-0D98-414E-801B-09037E1BF43E.pdf,BB1CD473-0D98-414E-801B-09037E1BF43E,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EO,NA,NA,NA,TUMOR FREE,A,44
ucec_tcga,TCGA-EO-A3L0,TCGA-EO-A3L0-01,76,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,422,0,NA,51.05,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,6/1/12,0.0963,G3,159,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,2,0,NA,NA,11,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,51.05,0:LIVING,NA,423DA953-30AA-4F7E-96B5-1F6FD24F8874,73D4918C-8BAB-4753-9D47-355B51DBBBFA,NA,NA,NA,TCGA-EO-A3L0.AD1F0EEC-20B6-416B-9728-BC103D2B3B87.pdf,AD1F0EEC-20B6-416B-9728-BC103D2B3B87,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EO,NA,NA,49,TUMOR FREE,A,110
ucec_tcga,TCGA-EY-A1G7,TCGA-EY-A1G7-01,86,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,1002,0,NA,3.12,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,4/21/11,0.2201,G2,151,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,FALSE,UEC,6.21,1:DECEASED,NA,6b2e93b9-8271-4205-842e-0b7292b8115a,730cb784-2266-4b5c-98b9-6cd7ebbe989d,NA,NA,NA,TCGA-EY-A1G7.2803014E-7E68-463F-BF3C-C5E4DF9FA421.pdf,2803014E-7E68-463F-BF3C-C5E4DF9FA421,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,96,WITH TUMOR,A,85
ucec_tcga,TCGA-EY-A1G8,TCGA-EY-A1G8-01,83,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,771,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,4/21/11,0.0499,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,40,0,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,FALSE,UEC,14.98,1:DECEASED,NA,db3a4986-55d5-4ecc-be73-59725dce3c33,e95dde06-f397-4b0c-a854-dc91aa3c6f31,NA,NA,NA,TCGA-EY-A1G8.2454950F-8B3D-4690-98CA-B94C79F99552.pdf,2454950F-8B3D-4690-98CA-B94C79F99552,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EY,NA,NA,38,TUMOR FREE,A,49
ucec_tcga,TCGA-EY-A1GC,TCGA-EY-A1GC-01,62,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,519,0,NA,54.11,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/2/11,0.4314,G3,167,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,24,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,FALSE,UEC,54.11,0:LIVING,NA,ebc25a41-becb-4395-ae33-483a304b07d8,06be0e15-e48e-4243-ad8d-86cca9da68f9,NA,NA,NA,TCGA-EY-A1GC.62D18250-0D82-43AB-AADE-E152D6FF74BB.pdf,62D18250-0D82-43AB-AADE-E152D6FF74BB,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,290,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,5,TUMOR FREE,A,96
ucec_tcga,TCGA-EY-A1GD,TCGA-EY-A1GD-01,51,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,511,0,NA,53.84,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/2/11,0.0347,G1,157,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,3,0,NA,0,20,0,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Tumor resection,NA,NA,NA,NA,FALSE,UEC,53.84,0:LIVING,NA,33efe6c6-9159-48e8-b759-fba9ddbde761,486403dc-c250-4088-9eed-a4032391d9d8,NA,NA,NA,TCGA-EY-A1GD.65C636F7-B24D-479C-A607-FEFEE7D7E30D.pdf,65C636F7-B24D-479C-A607-FEFEE7D7E30D,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,230,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,0,TUMOR FREE,A,79
ucec_tcga,TCGA-EY-A1GE,TCGA-EY-A1GE-01,67,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,506,0,NA,24.34,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/2/11,0.0000,G1,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,10,0,NA,0,27,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,24.34,0:LIVING,NA,a28beb70-d309-45b8-a2ba-40558f3c8f4f,8673d69f-530e-4c33-ba96-25cd44adea7b,NA,NA,NA,TCGA-EY-A1GE.432813D0-4B52-4941-940C-5725BCE4211A.pdf,432813D0-4B52-4941-940C-5725BCE4211A,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,410,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,0,TUMOR FREE,A,103
ucec_tcga,TCGA-EY-A1GF,TCGA-EY-A1GF-01,75,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,504,0,NA,27.14,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/11/11,0.0441,G2,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,9,0,NA,0,16,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,27.14,0:LIVING,NA,615ea37d-6302-4d68-b253-d24efd947c3e,f6e156ad-3e24-4e44-94c0-bcf731ad7c80,NA,NA,NA,TCGA-EY-A1GF.0C63BAC2-FD3E-49CB-A352-0B1653B78BDD.pdf,0C63BAC2-FD3E-49CB-A352-0B1653B78BDD,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,11,TUMOR FREE,A,71
ucec_tcga,TCGA-EY-A1GH,TCGA-EY-A1GH-01,70,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,452,0,NA,23.32,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/11/11,0.1841,G2,170,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,23.32,0:LIVING,NA,a45a2343-f425-4e62-9049-7782733b6234,b32b07ac-a84d-4b1d-89c9-ffe2e91ee037,NA,NA,NA,TCGA-EY-A1GH.29D738E9-2F8D-4909-A427-7C056859B89A.pdf,29D738E9-2F8D-4909-A427-7C056859B89A,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,33,TUMOR FREE,A,117
ucec_tcga,TCGA-EY-A1GI,TCGA-EY-A1GI-01,52,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,444,0,NA,23.32,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/18/11,0.0005,G2,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,23,0,NA,0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Excisional Biopsy,NA,NA,NA,NA,FALSE,UEC,23.32,0:LIVING,NA,16bde24f-61b8-458d-aca3-df4806abbd1b,9618747c-19fc-4243-ab49-d277992544e5,NA,NA,NA,TCGA-EY-A1GI.1D56F7CA-A3F0-4078-B8E3-A10CD97873D4.pdf,1D56F7CA-A3F0-4078-B8E3-A10CD97873D4,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,150,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EY,NA,NA,76,TUMOR FREE,A,69
ucec_tcga,TCGA-EY-A1GJ,TCGA-EY-A1GJ-01,73,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,434,0,NA,23.88,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/18/11,0.2352,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,10,0,NA,0,15,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,23.88,0:LIVING,NA,13b97e99-f6b7-4253-b7e1-230cce2d8747,1c956229-70f4-4ccd-aee7-f01979fce5c1,NA,NA,NA,TCGA-EY-A1GJ.505FE0B0-068C-4B2A-AA40-4657FB2E0425.pdf,505FE0B0-068C-4B2A-AA40-4657FB2E0425,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,0,TUMOR FREE,A,85
ucec_tcga,TCGA-EY-A1GK,TCGA-EY-A1GK-01,74,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,409,0,NA,22.77,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/18/11,0.0550,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,12,0,NA,0,14,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,22.77,0:LIVING,NA,972db411-9744-46f0-89c7-efe14135f1b4,d4e702a9-8e4a-4ad7-8b45-691c95dcf298,NA,NA,NA,TCGA-EY-A1GK.B5024D10-E23D-4B3B-8C54-13EBAA423A04.pdf,B5024D10-E23D-4B3B-8C54-13EBAA423A04,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,58,TUMOR FREE,A,105
ucec_tcga,TCGA-EY-A1GL,TCGA-EY-A1GL-01,51,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,366,0,NA,33.31,0:DiseaseFree,NA,NA,NA,NA,5/18/11,0.0655,G2,173,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,6,0,NA,0,13,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,33.31,0:LIVING,NA,d46d5af5-62ae-43eb-a885-4c078e0c956e,4032607d-6cf1-4b53-941e-0c50cb3d0f10,NA,NA,NA,TCGA-EY-A1GL.449C1D9F-6A1F-4523-8C86-AFED911D95D4.pdf,449C1D9F-6A1F-4523-8C86-AFED911D95D4,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EY,NA,NA,83,TUMOR FREE,A,73
ucec_tcga,TCGA-EY-A1GM,TCGA-EY-A1GM-01,60,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IIIA,323,0,NA,25.99,1:Recurred/Progressed,NA,NA,NA,NA,5/18/11,0.3240,G3,157,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,13,0,NA,0,11,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UCEC,32.69,1:DECEASED,NA,1a094c2b-9fba-4bb1-929d-bb2cdf874bee,95fded4f-677e-4dcf-a5c4-6b344fbccfd4,NA,NA,NA,TCGA-EY-A1GM.C3599CB9-3B69-4083-AA2E-5BB52CF1ED93.pdf,C3599CB9-3B69-4083-AA2E-5BB52CF1ED93,positive,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,33,TUMOR FREE,A,71
ucec_tcga,TCGA-EY-A1GO,TCGA-EY-A1GO-01,65,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,259,0,NA,16.98,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/18/11,0.6229,G2,156,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,6,0,NA,0,17,1,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,FALSE,UEC,19.25,0:LIVING,NA,9370e189-8fb7-4bfa-8ef9-2220f3557188,84c460ba-e8a0-43ea-a4c3-c838d5587f99,NA,NA,NA,TCGA-EY-A1GO.82216372-E1EF-47F2-B57A-25C1DCB24E5E.pdf,82216372-E1EF-47F2-B57A-25C1DCB24E5E,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,98,TUMOR FREE,A,76
ucec_tcga,TCGA-EY-A1GP,TCGA-EY-A1GP-01,54,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,262,0,NA,18.82,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/19/11,0.9472,G1,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,18.82,0:LIVING,NA,75fb484d-cd12-4cf0-a99d-faf27aead118,13c41beb-c86d-423f-97a4-8f18bff149be,NA,NA,NA,TCGA-EY-A1GP.D9933BA3-3D3B-4B93-AD6C-22ED47C4DBB1.pdf,D9933BA3-3D3B-4B93-AD6C-22ED47C4DBB1,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,32,TUMOR FREE,A,72
ucec_tcga,TCGA-EY-A1GQ,TCGA-EY-A1GQ-01,76,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,274,0,NA,10.97,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/19/11,0.2584,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,29,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,17.87,0:LIVING,NA,8636db4d-a67b-4d8a-b02f-15fce553cf17,2ce5197d-0239-4df1-85fc-47ae27324028,NA,NA,NA,TCGA-EY-A1GQ.9A8D1D19-18D8-483B-BD87-B686D25C617F.pdf,9A8D1D19-18D8-483B-BD87-B686D25C617F,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,160,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,98,WITH TUMOR,A,81
ucec_tcga,TCGA-EY-A1GR,TCGA-EY-A1GR-01,67,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,263,0,NA,17.61,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/19/11,0.7230,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,9,0,NA,0,16,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,17.61,0:LIVING,NA,70cdb758-26c9-4c11-a495-0c31cbc84949,1c1d49ed-4dea-4fd0-9952-393470502e81,NA,NA,NA,TCGA-EY-A1GR.1C53C957-1A0A-46AF-A53B-0287683D52F6.pdf,1C53C957-1A0A-46AF-A53B-0287683D52F6,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,410,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EY,NA,NA,33,TUMOR FREE,A,93
ucec_tcga,TCGA-EY-A1GS,TCGA-EY-A1GS-01,71,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,211,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,5/19/11,0.6302,G3,161,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,9,7,NA,7,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,213,NA,FALSE,USC,22.01,1:DECEASED,NA,c10b2885-70ea-4d32-bc48-8b85530df702,99540910-61a1-434b-9937-216dfac5f719,NA,NA,NA,TCGA-EY-A1GS.3F953015-45DC-4678-A8B3-DC55339DE717.pdf,3F953015-45DC-4678-A8B3-DC55339DE717,NA,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R2,NO,1,270,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EY,7.066666667,NA,50,WITH TUMOR,A,62
ucec_tcga,TCGA-EY-A1GT,TCGA-EY-A1GT-01,68,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,225,0,NA,16.1,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/24/11,0.0810,G1,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,25,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,16.1,0:LIVING,NA,e0d13e2d-cf48-4b66-bfc2-88f872f67d79,20983a85-478b-4cc1-bbf9-e136773f6288,NA,NA,NA,TCGA-EY-A1GT.2F5AE4E7-9411-461D-ACD9-EB7D51CEF872.pdf,2F5AE4E7-9411-461D-ACD9-EB7D51CEF872,positive,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,380,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,10,TUMOR FREE,A,70
ucec_tcga,TCGA-EY-A1GU,TCGA-EY-A1GU-01,66,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,189,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,5/24/11,0.0341,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,5,0,NA,0,11,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,32.75,1:DECEASED,NA,5dd28537-d24f-4a6d-a454-6f64cf37e16a,ef348984-8c78-46a3-8e76-d5d974819d1b,NA,NA,NA,TCGA-EY-A1GU.7A06A8F8-416F-41CD-B546-95DEA06996D0.pdf,7A06A8F8-416F-41CD-B546-95DEA06996D0,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,380,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,94,TUMOR FREE,A,90
ucec_tcga,TCGA-EY-A1GV,TCGA-EY-A1GV-01,75,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IIIC1,156,0,NA,15.8,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/24/11,0.1646,G3,165,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,11,0,NA,0,17,1,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UCEC,15.8,0:LIVING,NA,e3e39474-c2b0-45af-bbe1-4c24f17cc284,8e9dd4fb-3de9-4bce-bf90-1692904088ca,NA,NA,NA,TCGA-EY-A1GV.87A6A698-71B7-41D8-AE28-C2FCC92F9A94.pdf,87A6A698-71B7-41D8-AE28-C2FCC92F9A94,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,300,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,59,TUMOR FREE,A,79
ucec_tcga,TCGA-EY-A1GW,TCGA-EY-A1GW-01,73,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,155,0,NA,6.24,1:Recurred/Progressed,NA,NA,HISPANIC OR LATINO,NA,5/24/11,0.5739,G3,149,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,11.07,1:DECEASED,NA,f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae,22cb3d87-7fab-419a-b071-1adc6b810719,NA,NA,NA,TCGA-EY-A1GW.52C26330-540E-4409-ACDF-4D56EA1E7D7F.pdf,52C26330-540E-4409-ACDF-4D56EA1E7D7F,positive,NA,NA,NA,NA,YES,WHITE,NA,R1,NO,1,410,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EY,NA,NA,62,WITH TUMOR,A,81
ucec_tcga,TCGA-EY-A1GX,TCGA-EY-A1GX-01,76,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,172,0,NA,24.41,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/24/11,0.1997,G2,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,6,0,NA,0,8,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,37.02,1:DECEASED,NA,a7fd6522-8953-461f-9e5f-fdeb7d180d46,a6a446ff-6dcf-4311-ac05-afb34fcb19a7,NA,NA,NA,TCGA-EY-A1GX.4AD600AE-7CE0-4BBA-B4FC-0EB8C460502B.pdf,4AD600AE-7CE0-4BBA-B4FC-0EB8C460502B,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,370,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,25,TUMOR FREE,A,69
ucec_tcga,TCGA-EY-A1H0,TCGA-EY-A1H0-01,57,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC2,262,0,NA,19.32,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/19/11,0.1423,G2,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,4,1,NA,1,8,3,NA,3,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,FALSE,UEC,19.32,0:LIVING,NA,c71e0986-56c0-45f4-be8d-2236e4418604,3e1472fb-a882-4bb1-b4c0-c0ff3c9e6e25,NA,NA,NA,TCGA-EY-A1H0.CE7F1184-9FFC-4A30-926B-0008915893F2.pdf,CE7F1184-9FFC-4A30-926B-0008915893F2,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,330,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EY,NA,NA,23,TUMOR FREE,A,90
ucec_tcga,TCGA-EY-A210,TCGA-EY-A210-01,82,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IIIC2,70,0,NA,12.58,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,7/6/11,0.2899,G3,155,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,8,7,NA,7,20,6,NA,6,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UCEC,12.58,0:LIVING,NA,ea1c693d-490d-4816-b6e3-d12946ad7cc1,3879caa4-a747-4879-8923-05232476730d,NA,NA,NA,TCGA-EY-A210.51A98C43-6A6A-4027-8E92-B3B9AA1A63D4.pdf,51A98C43-6A6A-4027-8E92-B3B9AA1A63D4,positive,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,840,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,38,TUMOR FREE,A,63
ucec_tcga,TCGA-EY-A212,TCGA-EY-A212-01,83,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC1,112,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,7/8/11,0.3487,G3,159,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8460/3,C54.1,YES,2010,NO,NA,19,0,NA,0,33,1,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,51,NA,FALSE,USC,10.18,1:DECEASED,NA,37981e2c-4761-4f82-aaf2-4e6963a71603,996c027f-d9c7-4a2c-8154-5ef9573fb0d0,NA,NA,NA,TCGA-EY-A212.3E8012E3-97F1-48A2-B1C0-5C814DF8EE01.pdf,3E8012E3-97F1-48A2-B1C0-5C814DF8EE01,positive,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,290,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,1.733333333,NA,45,TUMOR FREE,A,81
ucec_tcga,TCGA-EY-A214,TCGA-EY-A214-01,66,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC1,160,0,NA,14.39,0:DiseaseFree,NA,NA,NA,NA,7/8/11,0.6385,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,19,0,NA,0,31,1,NA,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,14.39,0:LIVING,NA,4125e3e5-51c0-4577-9935-10cd086fc415,5ed2b603-507e-4bef-bacd-46d0e98badb4,NA,NA,NA,TCGA-EY-A214.90B0CBB0-3AC0-44F8-9C49-310CFFE0370C.pdf,90B0CBB0-3AC0-44F8-9C49-310CFFE0370C,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,330,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,72,TUMOR FREE,A,94
ucec_tcga,TCGA-EY-A215,TCGA-EY-A215-01,60,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,293,0,NA,18.86,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,7/8/11,0.0013,G3,168,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,14,0,NA,0,7,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,18.86,0:LIVING,NA,48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db,4d692dbb-bbd7-429b-894e-ccb215ca41cc,NA,NA,NA,TCGA-EY-A215.C0F970E3-E534-4A34-B87A-4383FD261B53.pdf,C0F970E3-E534-4A34-B87A-4383FD261B53,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,210,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,50,TUMOR FREE,A,49
ucec_tcga,TCGA-EY-A2OM,TCGA-EY-A2OM-01,55,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,176,0,NA,22.8,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/14/11,0.0512,G3,152,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,13,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,22.8,0:LIVING,NA,2B60EF45-336C-42E0-AA3F-577069310D1F,2D9888F8-FA53-44A3-8E1C-20479CEE4584,NA,NA,NA,TCGA-EY-A2OM.7C46CE28-FC96-47FD-A133-B95EA93E1D8B.pdf,7C46CE28-FC96-47FD-A133-B95EA93E1D8B,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,640,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,20,TUMOR FREE,A,110
ucec_tcga,TCGA-EY-A2ON,TCGA-EY-A2ON-01,61,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,80,0,NA,7.42,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,11/15/11,0.4427,G3,165,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,20.04,1:DECEASED,NA,BEE58BE0-C2B0-4CDC-ADF6-B99243DA586A,D7090A2C-648A-43DC-A639-A78DFDA2A0EC,NA,NA,NA,TCGA-EY-A2ON.AB1B272C-E1ED-4E7B-AAD2-F6B7E741E134.pdf,AB1B272C-E1ED-4E7B-AAD2-F6B7E741E134,positive,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R2,NO,1,650,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,NA,WITH TUMOR,A,100
ucec_tcga,TCGA-EY-A2OO,TCGA-EY-A2OO-01,56,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IB,715,0,NA,45.73,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/15/11,0.4278,G3,175,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,3,0,NA,0,21,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UCEC,45.73,0:LIVING,NA,068016E2-7829-493C-B8BE-D3B85BEAAB13,E254C2BA-0DE8-42F1-BC83-94ADB11C71F7,NA,NA,NA,TCGA-EY-A2OO.CC94C4BA-FBF6-4F0D-93DD-C2D98D965DF8.pdf,CC94C4BA-FBF6-4F0D-93DD-C2D98D965DF8,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,1,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,14,TUMOR FREE,A,79
ucec_tcga,TCGA-EY-A2OP,TCGA-EY-A2OP-01,63,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,521,0,NA,31.01,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/15/11,0.0803,G3,150,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2010,NO,NA,7,0,NA,0,12,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,31.01,0:LIVING,NA,F7165DEA-C528-44F3-954F-E111A3D77B4E,53076E0C-46B7-4B5A-8082-2C14FABBFA73,NA,NA,NA,TCGA-EY-A2OP.E16B08BE-7F2E-4F0E-9FC8-40FCC29F7BC7.pdf,E16B08BE-7F2E-4F0E-9FC8-40FCC29F7BC7,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,1,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,10,TUMOR FREE,A,57
ucec_tcga,TCGA-EY-A2OQ,TCGA-EY-A2OQ-01,61,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,217,0,NA,29.07,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,11/15/11,0.6205,G3,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,15,0,NA,0,22,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,29.07,0:LIVING,NA,029F0F1D-DD22-44D2-A623-CB9A33CB9438,A5F68889-4F7D-44D7-A999-C01BCB0EE56E,NA,NA,NA,TCGA-EY-A2OQ.BD1FB0FF-176C-42D9-843E-2F2BF2EBCCC2.pdf,BD1FB0FF-176C-42D9-843E-2F2BF2EBCCC2,negative,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,1,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,29,TUMOR FREE,A,79
ucec_tcga,TCGA-EY-A3L3,TCGA-EY-A3L3-01,82,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,198,0,NA,27.33,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,4/23/12,0.5223,G3,161,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2011,NO,NA,3,0,NA,0,14,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,27.33,0:LIVING,NA,06728B1B-6B69-4467-8E10-A8A4E6328AC8,9895A2AD-1C08-4E2E-ACCA-88A3927A2C2D,NA,NA,NA,TCGA-EY-A3L3.DBCC8E6F-3AB9-41B2-8266-341509A9FDB3.pdf,DBCC8E6F-3AB9-41B2-8266-341509A9FDB3,negative,NA,NA,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NA,R0,NO,1,1020,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,28,TUMOR FREE,A,92
ucec_tcga,TCGA-EY-A3QX,TCGA-EY-A3QX-01,64,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,112,0,NA,29.43,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,5/10/12,0.6635,G3,168,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,32.49,1:DECEASED,NA,8BB89C0F-0F04-485E-8E08-801042DFCBA9,8D1365A7-C67C-4073-8483-8693D4683CCD,NA,NA,NA,TCGA-EY-A3QX.8AED036E-FB86-42D1-B840-FB4AD6E8D0EF.pdf,8AED036E-FB86-42D1-B840-FB4AD6E8D0EF,positive,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,659,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,NA,95,WITH TUMOR,A,63
ucec_tcga,TCGA-EY-A4KR,TCGA-EY-A4KR-01,56,NA,NA,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC1,147,0,NA,NA,NA,NO,NA,NOT HISPANIC OR LATINO,NA,1/17/13,0.2889,G3,164,Serous endometrial adenocarcinoma,NO,NA,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,NO,C54.1,8441/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,9,7,NA,7,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,USC,11.37,1:DECEASED,NA,DF27B584-FA45-4A8F-BD12-A018CC63DCA1,DB625F3A-2CF7-4B99-8FA4-AB234F1DC22D,NA,NA,NA,TCGA-EY-A4KR.D8669681-B1D2-4D39-B7BB-5207F901A937.pdf,D8669681-B1D2-4D39-B7BB-5207F901A937,positive,YES,2,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,RX,NO,1,610,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,Progressive Disease,99,WITH TUMOR,A,114
ucec_tcga,TCGA-EY-A547,TCGA-EY-A547-01,75,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,645,0,NA,17.9,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,2/27/13,0.3713,G3,166,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,Yes,Never Used,YES,C54.1,8380/3,C54.1,YES,2011,NO,NA,8,0,NA,0,10,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,17.9,0:LIVING,NA,3424120F-248F-451A-948C-E320C19D1B19,52338734-9EEC-4793-B4A7-5CD84322E797,NA,NA,NA,TCGA-EY-A547.59662419-D77B-4C25-A888-CE993D412FD1.pdf,59662419-D77B-4C25-A888-CE993D412FD1,negative,NO,1,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,610,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,Complete Remission/Response,14,TUMOR FREE,A,108
ucec_tcga,TCGA-EY-A548,TCGA-EY-A548-01,83,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,169,0,NA,14.13,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,2/27/13,0.0001,G1,157,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,12,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,14.13,0:LIVING,NA,56BDB68C-A647-4ABA-94AC-9CD52BB5344A,081AC69B-8390-42B1-917A-D7CD231C0156,NA,NA,NA,TCGA-EY-A548.A9ACF7BF-BB91-4B56-A398-C7A0FD473FC5.pdf,A9ACF7BF-BB91-4B56-A398-C7A0FD473FC5,negative,NO,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,R0,NO,1,850,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,Complete Remission/Response,0,TUMOR FREE,A,67
ucec_tcga,TCGA-EY-A549,TCGA-EY-A549-01,78,NA,NA,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,191,0,NA,19.88,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,2/27/13,0.1560,G3,165,Endometrioid endometrial adenocarcinoma,YES,Never Used,"No, I have never taken menopausal hormone therapy.",No,Yes,Never Used,YES,C54.9,8380/3,C54.9,YES,2012,NO,NA,18,0,NA,0,22,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,19.88,0:LIVING,NA,3D9828AE-EB65-4D0A-8D7A-CC09E98B5E99,2B096DD7-4D46-4C71-91C3-FA084ADE57CB,NA,NA,NA,TCGA-EY-A549.F6D1F090-C601-4212-951E-BEE086DDD24F.pdf,F6D1F090-C601-4212-951E-BEE086DDD24F,NA,NO,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,370,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,Complete Remission/Response,33,TUMOR FREE,A,74
ucec_tcga,TCGA-EY-A54A,TCGA-EY-A54A-01,67,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC2,105,0,NA,14.68,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,2/27/13,0.2869,G3,161,Endometrioid endometrial adenocarcinoma,NO,Former User,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.9,8380/3,C54.9,YES,2012,NO,NA,8,1,NA,1,16,4,NA,4,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,14.68,0:LIVING,NA,75783DBE-E18C-4535-B9EB-2AFFD320E098,6D890026-4221-471A-AFA6-1118ED804F08,NA,NA,NA,TCGA-EY-A54A.E3C3D3B8-550A-4652-9B17-122BC64A437A.pdf,E3C3D3B8-550A-4652-9B17-122BC64A437A,NA,YES,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,500,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,Complete Remission/Response,41,TUMOR FREE,A,70
ucec_tcga,TCGA-EY-A5W2,TCGA-EY-A5W2-01,72,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,105,0,NA,16.95,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,5/20/13,0.0341,G3,161,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,NA,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,7,0,NA,0,16,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,16.95,0:LIVING,NA,1944E155-B765-48C3-9602-6787C105E551,D50BB383-3384-47D9-92B8-1F0604AC2725,NA,NA,NA,TCGA-EY-A5W2.C09EED3C-50CC-47CB-BA81-96D05E53D9F0.pdf,C09EED3C-50CC-47CB-BA81-96D05E53D9F0,negative,NO,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,870,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,EY,NA,Complete Remission/Response,52,TUMOR FREE,A,83
ucec_tcga,TCGA-EY-A72D,TCGA-EY-A72D-01,87,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,120,0,NA,5.88,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,12/9/13,0.7701,G3,162,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,Yes,Never Used,NO,C54.1,8380/3,C54.1,YES,2013,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,5.88,0:LIVING,NA,A12DF3D7-C560-4E7D-A482-1025A6E5B465,F661C070-CFF5-4FDC-BB26-9F1A3EF2592A,NA,NA,NA,TCGA-EY-A72D.6F2C081B-8D36-4DB4-9846-67DC1D3964E0.pdf,6F2C081B-8D36-4DB4-9846-67DC1D3964E0,NA,NO,2,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,R0,NO,1,340,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,EY,NA,Complete Remission/Response,22.5,TUMOR FREE,A,106
ucec_tcga,TCGA-FI-A2CX,TCGA-FI-A2CX-01,82,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1067,0,NA,66.72,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/27/11,0.0044,G3,155,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,3,0,0,0,7,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,66.72,0:LIVING,NA,DFFC7091-BC27-452C-AD94-1EE214107593,B6D24830-0D69-44D7-94CF-7DFDC49E52C4,NA,NA,NA,TCGA-FI-A2CX.0F6F56E4-C4F9-4915-BE4E-1FBF4C6D93AD.pdf,0F6F56E4-C4F9-4915-BE4E-1FBF4C6D93AD,NA,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,FI,NA,NA,33,TUMOR FREE,A,52
ucec_tcga,TCGA-FI-A2CY,TCGA-FI-A2CY-01,60,NA,1988,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IA,1067,0,NA,68.33,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/27/11,0.2356,G3,145,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,2,0,0,0,15,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UCEC,68.33,0:LIVING,NA,B9AB4AB9-BA9C-4A01-9F61-55C82B924936,047B688C-AA29-4A63-B555-9275AF4B0CEE,NA,NA,NA,TCGA-FI-A2CY.2C4CE5F5-AD46-427E-A787-529DF9FA891A.pdf,2C4CE5F5-AD46-427E-A787-529DF9FA891A,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,0,TUMOR FREE,A,100
ucec_tcga,TCGA-FI-A2D0,TCGA-FI-A2D0-01,55,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,945,0,NA,39.85,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.0000,G3,158,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2008,NO,NA,7,0,0,0,21,0,0,0,Peri (6-12 months since last menstrual period),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,39.85,0:LIVING,NA,1B35D083-F7C9-47D2-9A9E-718788F9E39A,A2D2A29A-5ABC-48C3-AC17-76B8B9EE1717,NA,NA,NA,TCGA-FI-A2D0.DCA05B9F-A09D-459F-AAB3-63020E15069D.pdf,DCA05B9F-A09D-459F-AAB3-63020E15069D,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,80,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,0,TUMOR FREE,A,135
ucec_tcga,TCGA-FI-A2D2,TCGA-FI-A2D2-01,66,NA,1988,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage IB,975,0,NA,62.98,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,10/27/11,0.5059,G3,168,Mixed serous and endometrioid,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,42,NA,TRUE,UCEC,77.27,1:DECEASED,NA,46A1FDB9-548D-44D1-AB77-D51D44AC8198,88F8998F-3D6A-4F9D-8B82-3250D26F5065,NA,NA,NA,TCGA-FI-A2D2.75FB8F31-5C30-48C2-B4A5-2DA184DC039C.pdf,75FB8F31-5C30-48C2-B4A5-2DA184DC039C,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,1.366666667,NA,33,TUMOR FREE,A,166
ucec_tcga,TCGA-FI-A2D4,TCGA-FI-A2D4-01,44,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIC,853,0,NA,NA,NA,NA,NA,NA,NA,10/28/11,0.1856,G3,163,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,1,1,0,1,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,7.98,1:DECEASED,NA,490AE247-EE67-48D4-94ED-93DF5B9BBEFE,A8393121-29DF-4525-BF4F-FCE0DEAF25F5,NA,NA,NA,TCGA-FI-A2D4.A6419790-A6CE-47E2-8035-437820EC63EC.pdf,A6419790-A6CE-47E2-8035-437820EC63EC,NA,NA,NA,NA,NA,NO,WHITE,NA,R2,YES,1,50,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,100,WITH TUMOR,A,112
ucec_tcga,TCGA-FI-A2D5,TCGA-FI-A2D5-01,56,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IVB,702,0,NA,9.2,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.0005,G3,160,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,2,1,0,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,13.83,1:DECEASED,NA,DCFBE781-A92A-45B5-B80A-E3BB3BDC0D9A,D5F6444E-C388-42E9-8B20-7B3A4DB8E0DB,NA,NA,NA,TCGA-FI-A2D5.A8F4B3DC-7B7D-4F1F-A909-E23DAE23E52C.pdf,A8F4B3DC-7B7D-4F1F-A909-E23DAE23E52C,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,60,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,100,WITH TUMOR,A,92
ucec_tcga,TCGA-FI-A2D6,TCGA-FI-A2D6-01,74,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,641,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.0456,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,25.2,1:DECEASED,NA,787D313F-9255-4B93-8AC2-0AA8FEBB7909,08F6F51F-9C99-4581-8CDA-BEC9A5208EE8,NA,NA,NA,TCGA-FI-A2D6.829C7791-3872-4EAC-BEC2-6B849056A4B7.pdf,829C7791-3872-4EAC-BEC2-6B849056A4B7,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,74,TUMOR FREE,A,95
ucec_tcga,TCGA-FI-A2EU,TCGA-FI-A2EU-01,68,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,2779,0,NA,96.62,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/27/11,0.3318,G3,168,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2003,NO,NA,2,0,0,0,11,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,96.62,0:LIVING,NA,4284A85D-D9B6-40EE-AAC4-C2C03554528E,AF843246-E00F-40F4-849F-3C5BA74A7479,NA,NA,NA,TCGA-FI-A2EU.95F8FB60-A533-4A37-8B4B-FC6811A77636.pdf,95F8FB60-A533-4A37-8B4B-FC6811A77636,negative,NA,NA,NA,NA,NO,NA,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,0,TUMOR FREE,A,93
ucec_tcga,TCGA-FI-A2EW,TCGA-FI-A2EW-01,71,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIB,2321,0,NA,38.4,1:Recurred/Progressed,NA,NA,NA,NA,10/27/11,0.5549,G3,160,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2005,NO,NA,8,0,0,0,29,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,87,NA,TRUE,USC,58.97,0:LIVING,NA,93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F,C10F91BF-385F-4E50-A9EF-67CF43B279B1,NA,NA,NA,TCGA-FI-A2EW.3DED6690-5A21-4EDC-B9D4-5E1F2F5A9CC1.pdf,3DED6690-5A21-4EDC-B9D4-5E1F2F5A9CC1,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,2.9,NA,75,WITH TUMOR,A,83
ucec_tcga,TCGA-FI-A2EX,TCGA-FI-A2EX-01,58,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,2201,0,NA,7,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,10/27/11,0.5270,G3,154,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2005,NO,NA,6,0,0,0,28,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,54,NA,TRUE,USC,9.33,0:LIVING,NA,3878F58E-76BA-4480-A784-88505BD464D0,0A2EAF88-6C98-409F-BF63-4D62C844193C,NA,NA,NA,TCGA-FI-A2EX.68355069-2D77-4C5C-9AA9-E93A0C3CFD94.pdf,68355069-2D77-4C5C-9AA9-E93A0C3CFD94,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,1.8,NA,13,WITH TUMOR,A,89
ucec_tcga,TCGA-FI-A2EY,TCGA-FI-A2EY-01,63,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,1866,0,NA,18.96,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,10/27/11,0.6687,G3,183,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2006,NO,NA,0,0,0,0,0,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,TRUE,USC,28.91,1:DECEASED,NA,787C3E2F-A708-4985-A5B1-B2383C7BFC52,8C8E5DD2-B8EF-4E5C-9CD6-7D3717E4CDEF,NA,NA,NA,TCGA-FI-A2EY.D529A633-2FC9-4C28-BEA4-994BABD51A48.pdf,D529A633-2FC9-4C28-BEA4-994BABD51A48,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,140,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,93,TUMOR FREE,A,96
ucec_tcga,TCGA-FI-A2F4,TCGA-FI-A2F4-01,64,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IC,860,0,NA,73.26,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/27/11,0.0344,G3,165,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,4,0,0,0,28,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,UEC,73.26,0:LIVING,NA,43476C88-86BC-4A65-9327-F0D24A41C971,79CA02F0-936E-4485-9CB3-85AFA2CEE9A3,NA,NA,NA,TCGA-FI-A2F4.B57570A5-2AE1-4D8B-9284-AB5769DDFDA6.pdf,B57570A5-2AE1-4D8B-9284-AB5769DDFDA6,NA,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,60,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,59,TUMOR FREE,A,74
ucec_tcga,TCGA-FI-A2F8,TCGA-FI-A2F8-01,64,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage II,679,0,NA,30.65,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.3156,G3,173,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2009,NO,NA,6,0,0,0,24,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,58,NA,TRUE,USC,30.65,0:LIVING,NA,601734DA-2D11-4745-A260-0965F58AADEA,500C427B-DB2C-4CA4-8BAD-9F573E99C32A,NA,NA,NA,TCGA-FI-A2F8.9445945A-A7AC-4C36-889B-68A50644D556.pdf,9445945A-A7AC-4C36-889B-68A50644D556,positive,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,70,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,1.9,NA,26,TUMOR FREE,A,99
ucec_tcga,TCGA-FI-A2F9,TCGA-FI-A2F9-01,79,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,709,0,NA,59.23,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/28/11,0.3709,G3,175,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2009,NO,NA,3,0,0,0,35,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,UEC,59.23,0:LIVING,NA,25E7D9D6-7381-40E1-B7ED-1D8C936B7C5C,D62280FD-4B51-4EC9-9DDC-1AA04F6578F3,NA,NA,NA,TCGA-FI-A2F9.5D03E085-0588-47A8-8B1C-E243D8127325.pdf,5D03E085-0588-47A8-8B1C-E243D8127325,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,60,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,44,TUMOR FREE,A,99
ucec_tcga,TCGA-FI-A3PV,TCGA-FI-A3PV-01,68,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,3199,0,NA,NA,NA,NA,NA,NOT HISPANIC OR LATINO,NA,6/15/12,0.4828,High Grade,174,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2003,NO,NA,6,0,0,0,10,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,USC,41.03,1:DECEASED,NA,60E307DD-E11E-40BA-93C1-7E8A1F669F60,1D775E4C-DFB0-4DB1-9495-13CEA9ABA532,NA,NA,NA,TCGA-FI-A3PV.0EBA5D54-65AC-4F79-ACE9-29FB1F924E3A.pdf,0EBA5D54-65AC-4F79-ACE9-29FB1F924E3A,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,60,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,0,WITH TUMOR,A,105
ucec_tcga,TCGA-FI-A3PX,TCGA-FI-A3PX-01,57,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC2,1280,0,NA,78.32,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,6/15/12,0.5130,High Grade,170,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2008,NO,NA,5,2,NA,2,10,4,NA,4,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NA,TRUE,USC,78.32,0:LIVING,NA,3E8E34C8-766A-4514-97F4-8000B5350AB9,9A1614C1-0C60-4A98-AC4C-447BFDF26576,NA,NA,NA,TCGA-FI-A3PX.5E3FD49D-DE9B-4A5B-B4FC-2825CCB48B46.pdf,5E3FD49D-DE9B-4A5B-B4FC-2825CCB48B46,negative,NA,NA,NA,NA,NO,WHITE,NA,R0,YES,1,130,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,FI,NA,NA,92,TUMOR FREE,A,90
ucec_tcga,TCGA-H5-A2HR,TCGA-H5-A2HR-01,71,NA,1988,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,1627,0,NA,1.74,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,10/1/11,0.2775,G3,NA,Endometrioid endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8380/3,C54.1,YES,2006,NO,NA,0,NA,NA,NA,19,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,FALSE,UEC,1.74,0:LIVING,NA,FDB395E7-FF30-400D-861E-0CF2462EE390,731428D0-5CC9-4E8D-A2BE-E2E3D57745B7,NA,NA,NA,TCGA-H5-A2HR.3747A4AC-811E-49A1-8459-93807BB363C6.pdf,3747A4AC-811E-49A1-8459-93807BB363C6,negative,NA,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,110,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,H5,NA,NA,18,TUMOR FREE,A,95
ucec_tcga,TCGA-JU-AAVI,TCGA-JU-AAVI-01,61,NA,1988,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIC1,139,0,NA,16.59,1:Recurred/Progressed,NO,NA,NOT HISPANIC OR LATINO,NA,4/3/14,0.4885,G3,150,Serous endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,YES,C54.1,8441/3,C54.1,YES,2013,NO,NA,2,NA,NA,0,16,NA,NA,2,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Incisional Biopsy,NA,NA,NA,NO,TRUE,USC,17.74,1:DECEASED,NA,3E41CF2F-3DE9-44C1-A819-BCE693BAF67D,1B186F8E-06A6-488B-B4CE-F59CB0318034,NA,NA,NA,TCGA-JU-AAVI.8639CE54-3D67-4E2E-BECB-26755EE726C5.pdf,8639CE54-3D67-4E2E-BECB-26755EE726C5,negative,YES,1,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,20,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,JU,NA,NA,93,TUMOR FREE,A,121
ucec_tcga,TCGA-K6-A3WQ,TCGA-K6-A3WQ-01,60,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IVB,63,0,NA,12.55,1:Recurred/Progressed,NA,NA,NOT HISPANIC OR LATINO,NA,9/26/12,0.7330,G3,171,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,2,1,1,1,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,14.03,1:DECEASED,NA,D6303A05-F705-4413-8860-506A105D5B08,702C78D1-352A-4050-A17E-501BBFD0317A,NA,NA,NA,TCGA-K6-A3WQ.16F848AA-C14C-45F7-A756-414615853761.pdf,16F848AA-C14C-45F7-A756-414615853761,positive,NA,NA,NA,NA,YES,WHITE,NA,NA,NO,1,440,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,K6,NA,NA,95,TUMOR FREE,A,99
ucec_tcga,TCGA-KJ-A3U4,TCGA-KJ-A3U4-01,55,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,56,0,NA,10.05,1:Recurred/Progressed,NA,NA,HISPANIC OR LATINO,NA,5/24/12,0.4859,G1,165,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2012,NO,NA,1,0,NA,0,11,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,TRUE,USC,35.97,0:LIVING,NA,1A36D5DE-A097-4323-90E9-F1B924A8A5D8,7FCBD3E2-4A71-4EF2-96DF-D4BE66352D9E,NA,NA,NA,TCGA-KJ-A3U4.F0B04416-21FE-4DBC-84BB-7188131399B6.pdf,F0B04416-21FE-4DBC-84BB-7188131399B6,NA,NA,NA,NA,NA,YES,WHITE,NA,R0,NO,1,420,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,KJ,NA,NA,21,TUMOR FREE,A,96
ucec_tcga,TCGA-KP-A3VZ,TCGA-KP-A3VZ-01,69,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IV,633,0,NA,23.72,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,7/16/12,0.7216,High Grade,163,Serous endometrial adenocarcinoma,NA,NA,NA,No,Yes,NA,NA,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,7,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NA,TRUE,USC,23.72,0:LIVING,NA,6B35A816-F9C4-44D4-9824-5DEE4804B80D,F73C1CE5-2813-45B2-951F-8AB539B32988,NA,NA,NA,TCGA-KP-A3VZ.FF834E31-78F7-4A56-8EC0-E026BE940FD4.pdf,FF834E31-78F7-4A56-8EC0-E026BE940FD4,positive,NA,NA,NA,NA,NO,WHITE,NA,RX,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,KP,NA,NA,75,WITH TUMOR,A,55
ucec_tcga,TCGA-KP-A3W0,TCGA-KP-A3W0-01,72,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,351,0,NA,13.27,0:DiseaseFree,NO,NA,NA,NA,7/19/12,0.3267,G3,162,Serous endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NO,TRUE,USC,13.27,0:LIVING,NA,C9EBAEFF-6A27-4A6C-A34C-5337A3508A52,570BB596-BAD8-4A83-A7D7-E9FA8C9E16AA,NA,NA,NA,TCGA-KP-A3W0.8623B627-C3E3-469B-A640-2F8BCFC0B711.pdf,8623B627-C3E3-469B-A640-2F8BCFC0B711,positive,YES,2,NA,NA,NO,NA,YES,R0,YES,1,90,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,KP,NA,Complete Remission/Response,75,TUMOR FREE,A,94
ucec_tcga,TCGA-KP-A3W1,TCGA-KP-A3W1-01,76,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,198,0,NA,9.46,0:DiseaseFree,NO,NA,NA,NA,7/19/12,0.5404,G3,170,Serous endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,NO,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NO,TRUE,USC,9.46,0:LIVING,NA,3BCE9803-E74C-462E-BD40-8EC337A66F3A,1AD2A1CA-75E0-4F9F-808D-768CB14BDFF3,NA,NA,NA,TCGA-KP-A3W1.58145248-B111-463A-A1CC-32DA993F0B26.pdf,58145248-B111-463A-A1CC-32DA993F0B26,negative,YES,1,NA,NA,NO,NA,YES,R0,YES,1,710,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,KP,NA,Complete Remission/Response,25,TUMOR FREE,A,66
ucec_tcga,TCGA-KP-A3W3,TCGA-KP-A3W3-01,72,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IB,739,0,NA,21.71,1:Recurred/Progressed,NO,NA,NOT HISPANIC OR LATINO,NA,7/19/12,0.6446,G3,164,Serous endometrial adenocarcinoma,NO,NA,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,YES,TRUE,USC,26.08,0:LIVING,NA,0264C9C2-6B6A-485C-98F5-AED4F52ED0CA,D54F4476-7191-4A52-A310-8392F62404CB,NA,NA,NA,TCGA-KP-A3W3.9D8F170A-A4B1-463A-B92C-357870762EAD.pdf,9D8F170A-A4B1-463A-B92C-357870762EAD,positive,YES,2,NA,NA,NO,WHITE,YES,R0,YES,1,680,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,KP,NA,Complete Remission/Response,75,WITH TUMOR,A,126
ucec_tcga,TCGA-KP-A3W4,TCGA-KP-A3W4-01,63,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,688,0,NA,10.55,1:Recurred/Progressed,NO,NA,NOT HISPANIC OR LATINO,NA,7/19/12,0.1501,G3,151,Serous endometrial adenocarcinoma,NO,Former User,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,NO,C54.1,8441/3,C54.1,YES,2010,NO,NA,0,NA,NA,NA,19,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,YES,TRUE,USC,18.2,1:DECEASED,NA,62DF1BD8-23A8-4E52-A483-6895B2F02494,85363534-A7C9-481E-8D37-B961CE1AD7AE,NA,NA,NA,TCGA-KP-A3W4.5B8C1B60-7046-4A3A-9D65-ECCB91BF9847.pdf,5B8C1B60-7046-4A3A-9D65-ECCB91BF9847,positive,YES,3,NA,NA,NO,WHITE,NO,R0,YES,1,540,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,KP,NA,Partial Remission/Response,75,WITH TUMOR,A,61
ucec_tcga,TCGA-PG-A5BC,TCGA-PG-A5BC-01,72,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage II,205,0,NA,23.23,0:DiseaseFree,NA,NA,NOT HISPANIC OR LATINO,NA,5/20/13,0.4200,G3,163,Serous endometrial adenocarcinoma,NA,NA,NA,No,No,NA,NA,C54.1,8441/3,C54.1,YES,2012,NO,NA,NA,NA,NA,NA,NA,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,USC,23.23,0:LIVING,NA,22669A01-21D3-404C-AC19-CF0A6C03BB1D,0A63BF84-A720-4B8B-8312-4EC59D14982E,NA,NA,NA,TCGA-PG-A5BC.040F4583-2683-42A8-B185-56A08874F3A0.pdf,040F4583-2683-42A8-B185-56A08874F3A0,NA,NO,NA,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NO,NA,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,NA,NA,NA,PG,NA,NA,NA,TUMOR FREE,A,87
ucec_tcga,TCGA-PG-A6IB,TCGA-PG-A6IB-01,68,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,160,0,NA,21.29,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,2/5/14,0.0006,G3,NA,Serous endometrial adenocarcinoma,NO,Former User,NA,No,No,Never Used,YES,C54.1,8441/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,USC,21.29,0:LIVING,NA,E8C7195B-A26B-4D98-B1C5-0AA18385E9C8,C9C01AE7-BFDF-4077-B9D7-5D3698AFD32F,NA,NA,NA,TCGA-PG-A6IB.C975AE5D-7370-4D1D-81AE-D3ABE5364055.pdf,C975AE5D-7370-4D1D-81AE-D3ABE5364055,negative,NA,2,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,PG,NA,Complete Remission/Response,38,TUMOR FREE,A,NA
ucec_tcga,TCGA-PG-A7D5,TCGA-PG-A7D5-01,62,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,618,0,NA,38.67,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,2/5/14,0.4382,G3,158,Serous endometrial adenocarcinoma,NA,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8441/3,C54.1,YES,2011,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,USC,38.67,0:LIVING,NA,4ADC20D7-5AF1-4126-9073-C7D7AE465D92,F408C11A-CBC3-4D31-8CF3-C204423E798F,NA,NA,NA,TCGA-PG-A7D5.2E996CFE-9F6E-432F-9B09-6FBC2A920B24.pdf,2E996CFE-9F6E-432F-9B09-6FBC2A920B24,negative,NO,4+,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NO,R0,YES,1,100,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,PG,NA,Stable Disease,47,TUMOR FREE,A,79
ucec_tcga,TCGA-PG-A914,TCGA-PG-A914-01,73,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,263,0,NA,22.57,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,4/23/14,0.6161,G3,NA,Serous endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8461/3,C54.1,YES,2013,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,NA,NO,TRUE,USC,22.57,0:LIVING,NA,FF6B5FC8-0572-4B58-B3A5-BCDA41BADBC8,6086978B-8F73-458E-9624-B99BCD6B50C8,NA,NA,NA,TCGA-PG-A914.B073614D-A6E3-4A83-96C4-1F189F8D16B4.pdf,B073614D-A6E3-4A83-96C4-1F189F8D16B4,negative,NO,4+,NA,NA,NO,BLACK OR AFRICAN AMERICAN,YES,R0,YES,1,260,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,PG,NA,Complete Remission/Response,13,TUMOR FREE,A,NA
ucec_tcga,TCGA-PG-A915,TCGA-PG-A915-01,60,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IA,238,0,NA,8.18,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,4/25/14,0.4091,G3,NA,Serous endometrial adenocarcinoma,NO,Former User,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,NO,C54.1,8461/3,C54.1,YES,2013,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,NA,NO,TRUE,USC,8.18,0:LIVING,NA,EA95897E-3FE0-4C79-B170-88B0F229794C,CAFFE64C-1FB0-4229-B355-4B798D9506B0,NA,NA,NA,TCGA-PG-A915.F2869E10-B5EB-4AB7-9CC9-A7B2E5DDBB7C.pdf,F2869E10-B5EB-4AB7-9CC9-A7B2E5DDBB7C,negative,NO,2,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NO,R0,YES,1,410,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,PG,NA,Complete Remission/Response,NA,TUMOR FREE,A,NA
ucec_tcga,TCGA-PG-A916,TCGA-PG-A916-01,70,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage I,224,0,NA,17.15,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,4/28/14,0.0000,G2,NA,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2013,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,TRUE,UEC,17.15,0:LIVING,NA,5EDAED6D-9914-4DF2-A843-D6009C36CBCC,2004FF38-A2BF-43BE-8B72-B2994A53D890,NA,NA,NA,TCGA-PG-A916.3E66FA38-0D87-47CA-A72D-63C0619A2182.pdf,3E66FA38-0D87-47CA-A72D-63C0619A2182,negative,NO,1,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NO,R0,YES,1,220,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,PG,NA,Complete Remission/Response,NA,TUMOR FREE,A,NA
ucec_tcga,TCGA-PG-A917,TCGA-PG-A917-01,74,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IA,583,0,NA,6.96,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,4/28/14,0.0516,G2,NA,Endometrioid endometrial adenocarcinoma,NO,Former User,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Cytology (e.g. Peritoneal or pleural fluid),NA,NA,NA,NO,TRUE,UEC,6.96,0:LIVING,NA,B1B9173C-B370-4FE5-A263-C807E8A9709C,4F849148-48BB-4E89-B0B9-F7EC6E85E0B9,NA,NA,NA,TCGA-PG-A917.9836008F-81F7-4029-9A28-10AB6021DFEA.pdf,9836008F-81F7-4029-9A28-10AB6021DFEA,positive,NO,2,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NO,R0,YES,1,390,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,PG,NA,Complete Remission/Response,NA,TUMOR FREE,A,NA
ucec_tcga,TCGA-QF-A5YS,TCGA-QF-A5YS-01,57,NA,2009,Endometrial Cancer,Endometrial Carcinoma,NA,NA,NA,Stage II,158,0,NA,22.63,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,6/25/13,0.0000,G2,162,Mixed serous and endometrioid,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,5,0,NA,0,2,0,NA,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UCEC,22.63,0:LIVING,NA,DF15901C-2508-42C9-BF06-026EFD89E51F,A7646717-9292-4321-9EA1-259573D8A1F0,NA,NA,NA,TCGA-QF-A5YS.2608B03E-0D29-49EF-BC3D-A26D5017C265.pdf,2608B03E-0D29-49EF-BC3D-A26D5017C265,NA,YES,2,NA,NA,NO,BLACK OR AFRICAN AMERICAN,YES,R0,YES,1,120,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,QF,NA,Complete Remission/Response,22,TUMOR FREE,A,79
ucec_tcga,TCGA-QF-A5YT,TCGA-QF-A5YT-01,57,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage II,804,0,NA,39.91,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,6/25/13,0.0001,G1,170,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,NO,C54.0,8380/3,C54.0,YES,2010,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,39.91,0:LIVING,NA,E4BCCEA0-0104-40C4-9E3C-2AD7262D918E,E62EA0D8-61CB-41ED-9D15-A0C5ADD11249,NA,NA,NA,TCGA-QF-A5YT.1CCA2D47-BA5D-46A9-89F9-681C58EFC10D.pdf,1CCA2D47-BA5D-46A9-89F9-681C58EFC10D,NA,YES,0,NA,NA,NO,BLACK OR AFRICAN AMERICAN,YES,R0,YES,1,40,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,QF,NA,Complete Remission/Response,50,TUMOR FREE,A,146
ucec_tcga,TCGA-QS-A5YQ,TCGA-QS-A5YQ-01,55,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIA,43,0,NA,24.93,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,5/14/13,0.0003,G1,160,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,NO,C54.1,8380/3,C54.1,YES,2013,NO,NA,0,NA,NA,NA,7,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,24.93,0:LIVING,NA,03381D49-E25F-4376-8E36-F47063A7D3FB,C38114C8-744B-4919-8F2A-C8F30FBA38B3,NA,NA,NA,TCGA-QS-A5YQ.D1631D6F-F055-4D35-A6DD-FE7A251BD4C2.pdf,D1631D6F-F055-4D35-A6DD-FE7A251BD4C2,NA,YES,1,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,370,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,QS,NA,NA,10,TUMOR FREE,A,83
ucec_tcga,TCGA-QS-A5YR,TCGA-QS-A5YR-01,61,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIB,118,0,NA,23.62,0:DiseaseFree,YES,NA,NOT HISPANIC OR LATINO,NA,5/13/13,0.0001,G2,168,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,0,NA,NA,NA,5,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Dilation and curettage procedure,NA,NA,NA,NO,FALSE,UEC,23.62,0:LIVING,NA,6696CF88-3C43-482C-AABB-F1EA5CF565AA,FF0189BA-F127-4093-B92C-5E37388C7A54,NA,NA,NA,TCGA-QS-A5YR.D9417AEE-FD30-42FA-986E-26C98E29C428.pdf,D9417AEE-FD30-42FA-986E-26C98E29C428,NA,NO,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,RX,NO,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,QS,NA,Stable Disease,13,WITH TUMOR,A,100
ucec_tcga,TCGA-QS-A744,TCGA-QS-A744-01,86,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IIIB,44,0,NA,14.82,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,11/12/13,0.1992,G2,163,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,Never Used,YES,C54.0,8380/3,C54.0,YES,2013,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,14.82,0:LIVING,NA,8E8F19BD-DBAA-4738-BAD2-207F634CD63D,100F19F6-F2C6-456B-8A54-E6ED68B1FB05,NA,NA,NA,TCGA-QS-A744.F37C9C5C-8AAA-47FB-8BAD-AE2EB0F70B4F.pdf,F37C9C5C-8AAA-47FB-8BAD-AE2EB0F70B4F,NA,YES,4+,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,R0,NO,1,310,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,QS,NA,NA,86,TUMOR FREE,A,76
ucec_tcga,TCGA-QS-A8F1,TCGA-QS-A8F1-01,85,NA,2009,Endometrial Cancer,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,NA,NA,NA,Stage IIIA,29,0,NA,NA,NA,NO,NA,NOT HISPANIC OR LATINO,NA,2/13/14,0.6549,G3,168,Serous endometrial adenocarcinoma,NO,Never Used,NA,No,No,Never Used,NO,C54.3,8441/3,C54.3,YES,2013,NO,NA,0,NA,NA,NA,0,NA,NA,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NO,FALSE,USC,4.43,1:DECEASED,NA,54AC877A-52FF-450C-9DF9-B7CD3FC8E2E2,7BC29ACD-1306-4439-9042-27A9115EB563,NA,NA,NA,TCGA-QS-A8F1.563BDC27-AFA6-4DE0-AB17-8CFD93D1CA81.pdf,563BDC27-AFA6-4DE0-AB17-8CFD93D1CA81,negative,YES,0,NA,NA,YES,BLACK OR AFRICAN AMERICAN,NO,NA,NO,1,250,Primary,1,Female,NA,Other  Specify,Matched,NA,NA,NA,NA,Minimally Invasive,NA,NA,QS,NA,Progressive Disease,50,WITH TUMOR,A,75
ucec_tcga,TCGA-SJ-A6ZI,TCGA-SJ-A6ZI-01,64,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,88,0,NA,20.73,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,11/11/13,0.0275,G1,66,Endometrioid endometrial adenocarcinoma,NO,Never Used,"No, I have never taken menopausal hormone therapy.",No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2013,NO,NA,9,0,0,0,18,0,0,0,NA,"Other method, specify:","Radical hysterectomy, bilateral salpingo-oophorectomy",NA,NA,NO,FALSE,UEC,20.73,0:LIVING,NA,3C2A6E30-A507-49F6-8B1F-36EB3AA41E60,629770A3-4982-480B-A066-E85C609DFA3F,NA,NA,NA,TCGA-SJ-A6ZI.2CA0FD3F-7635-4395-A13B-C3BB9D3FF0D8.pdf,2CA0FD3F-7635-4395-A13B-C3BB9D3FF0D8,negative,NO,2,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,880,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,SJ,NA,Complete Remission/Response,75,TUMOR FREE,A,93
ucec_tcga,TCGA-SJ-A6ZJ,TCGA-SJ-A6ZJ-01,61,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,216,0,NA,18.27,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,11/11/13,0.0466,G2,168,Endometrioid endometrial adenocarcinoma,NO,Former User,NA,No,No,Never Used,YES,C54.1,8380/3,C54.1,YES,2012,NO,NA,NA,NA,NA,NA,28,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Office Endometrial Biopsy,NA,NA,NA,NO,FALSE,UEC,18.27,0:LIVING,NA,FBFED398-2A44-44A9-83CF-657C29CB7D28,C3064816-C2C1-4AF0-8F0E-89D900E47D20,NA,NA,NA,TCGA-SJ-A6ZJ.B7C3C4EC-E494-4290-AFDA-FEFEBA8A3BA5.pdf,B7C3C4EC-E494-4290-AFDA-FEFEBA8A3BA5,negative,NO,1,NA,NA,YES,BLACK OR AFRICAN AMERICAN,YES,R0,NO,1,580,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,SJ,NA,NA,62.5,TUMOR FREE,A,132
ucec_tcga,TCGA-SL-A6J9,TCGA-SL-A6J9-01,73,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,86,0,NA,0.07,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,11/12/14,0.4226,G3,167,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,NA,YES,C54.1,8380/3,C54.1,YES,2013,NO,NA,2,0,0,0,9,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,TRUE,UEC,0.07,0:LIVING,NA,C1F1DC90-2C67-4862-9E5F-078B861FFC6E,8A93E942-EE48-421A-A696-2B367C6C3867,NA,NA,NA,TCGA-SL-A6J9.DFD43EFD-E91F-487F-A737-93C57C065A49.pdf,DFD43EFD-E91F-487F-A737-93C57C065A49,negative,NA,2,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NA,RX,YES,1,280,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,SL,NA,NA,50,NA,A,88
ucec_tcga,TCGA-SL-A6JA,TCGA-SL-A6JA-01,77,NA,2009,Endometrial Cancer,Uterine Endometrioid Carcinoma,NA,NA,NA,Stage IB,45,0,NA,0.23,0:DiseaseFree,NO,NA,NOT HISPANIC OR LATINO,NA,11/12/14,0.0488,G3,167,Endometrioid endometrial adenocarcinoma,NO,NA,NA,No,No,NA,YES,C54.1,8380/3,C54.1,YES,2013,NO,NA,1,0,0,0,11,0,0,0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Tumor resection,NA,NA,NA,NA,TRUE,UEC,0.23,0:LIVING,NA,2A19051E-3AD1-444A-9D02-F895C26AC02C,691FC8B9-2221-444B-8DE6-960AABD0CDDD,NA,NA,NA,TCGA-SL-A6JA.60CDA761-5DF1-4580-AD84-1CE9A15F31F8.pdf,60CDA761-5DF1-4580-AD84-1CE9A15F31F8,NA,NO,4+,NA,NA,NO,BLACK OR AFRICAN AMERICAN,NO,NA,YES,1,200,Primary,1,Female,NA,Endometrial,Matched,NA,NA,NA,NA,open,NA,NA,SL,NA,Complete Remission/Response,50,TUMOR FREE,A,129
